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Abstract 
Serum amyloid P component (SAP) is a conserved, constitutively-expressed, 
plasma protein and member of the pentraxin family of secreted pattern 
recognition receptors. It is present in all individuals at concentrations of 30 to 
50 mg/L, and was first discovered in 1965 as a ubiquitous constituent of 
amyloid plaques. Its physiological function remains unclear despite considerable 
work to elucidate its pathological role.  
 
SAP has been identified as the only serum protein that exhibits calcium-
dependent DNA-binding and has been shown to bind and solubilise native long 
chromatin. Due to its abundance in the serum it has been suggested that SAP’s 
normal role may be as a scavenger of extracellular DNA. However, there is very 
little information regarding the precise molecular nature of this interaction. 
Several biophysical methods were employed to investigate the affinity, 
stoichiometry, specificity and structure of the SAP-DNA interaction.  
 
SAP was found to bind with high affinity to double stranded DNA of 25 bp or 
longer, regardless of sequence, although binding is not entirely sequence 
independent. Mutational analysis using HEK 293 cell expressed recombinant 
protein has identified a number of positively charged amino acids that play a 
key role in the formation of the complex. The stoichiometry of SAP-DNA binding 
has been shown to be complicated, with little evidence for the formation of a 
discrete complex, but rather an indication that multiple SAP molecules decorate 
longer DNA strands. This may explain the difficulties in obtaining a crystal 
structure of the complex. SAP has also been shown to bind to nucleosome core 
particles, albeit with significantly weaker affinity than to naked DNA. 
 
The apparent promiscuity of SAP-DNA binding appears to support claims that 
SAP acts as a serum DNA scavenger, providing further evidence that SAP’s main 
physiological role is in the prevention of autoimmune reactions against nuclear 
material. 
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1. Introduction 
1.1 Overview of serum amyloid P component   
Serum amyloid P component (SAP) is a member of the pentraxin family of 
calcium-dependent ligand-binding lectins and secreted pattern recognition 
receptors (PRRs). SAP was first discovered in 1965 when amyloid fibrils from 
liver tissue were solubilised and used to immunise rabbits (Cathcart et al., 
1965). The antibodies generated were subsequently found to recognise a 
specific serum protein, which was later confirmed to be identical to the amyloid 
protein (Pepys & Dash, 1977). This amyloid protein constituent was therefore 
termed amyloid plasma component (AP), and its serum counterpart was named 
serum AP (SAP) (Cathcart et al., 1967).  
 
SAP is ubiquitous in all amyloid deposits, constituting 14% of their mass 
(Skinner et al., 1980). Many studies, spanning the last fifty years since its 
discovery, have concluded that the association of SAP with amyloid plaques 
contributes significantly to their persistence and pathogenicity (reviewed by 
Pepys et al., 1997). SAP has therefore become a valuable therapeutic target for 
the treatment of amyloid related diseases, which include systemic amyloidosis, 
Alzheimer’s disease, prion diseases and diabetes mellitus type 2, among others 
(Tennent et al., 1995). Recent reports suggest that clearance of SAP from 
amyloid using the novel drug R-1-[6-[R-2-carboxy-pyrrolidin-1-yl]-6-oxo-
hexanoyl] pyrrolidine 2-carboxylic acid (CPHPC), combined with antibody 
therapy, have been successful in reducing the amyloid load of patients with 
systemic amyloidosis (see section 1.4.3) (Pepys et al., 2002; Richards et al., 
2015).  
 
SAP is very closely related to the human classical acute phase reactant C-
reactive protein (CRP), with which it shares 52% strict amino acid-sequence 
identity (Levo et al., 1977; Srinivasan et al., 1994). CRP and SAP were the first 
described members of the pentraxin family, so called due to their 
homopentameric structure, which is arranged with five-fold radial symmetry 
(see section 1.3.1) (Osmand et al., 1977). Pentraxins are characterised by their 
 2 
calcium-dependent ligand binding of pathogenic structures and constitute an 
ancient family of PRRs that predate the adaptive immune system (reviewed by 
Du Clos, 2013). Unlike CRP, SAP is not an acute phase protein in man and is 
maintained at a constant serum concentration of between 30-50 mg/L (Nelson 
et al., 1991; Pepys et al., 1978). 
 
The physiological function of SAP has not been so well defined as its pathogenic 
role in amyloid disease. Whilst there have been reports that SAP performs a 
similar role to CRP within the innate immune system, by binding certain strains 
of pathogenic bacteria and also interacting with Fcγ receptors (see section 
1.4.2), one significant difference between the two proteins is the ability of 
human SAP to bind to DNA and chromatin under physiological conditions (Hind 
et al., 1985; Pepys & Butler, 1987). Although the physiological significance of 
SAP-DNA binding is not known, it has been suggested that SAP might play an 
important role in the clearance of nuclear material in order to prevent an 
autoimmune response such as that observed in systemic lupus erythematosus 
(SLE) (Breathnach et al., 1989). However, little is known about the precise 
molecular nature of this interaction.  
 
1.2 The innate immune system and pattern recognition 
receptors 
The human body has two major defence systems to protect against pathogenic 
invasion, the innate immune system and the adaptive immune system (for 
reviews see Medzhitov, 2007; Pancer & Cooper, 2006). The innate immune 
system is the first line of defence, incorporating barrier methods of protection 
such as the skin and mucus membranes and also pattern recognition receptors 
that recognise conserved pathogenic features (Hooper, 2015; Janeway & 
Medzhitov, 2002; Whitsett & Alenghat, 2015). It can act immediately but will 
not provide lasting protection against a specific pathogen. In contrast, the 
adaptive immune system is an acquired immune response that typically 
responds when the innate immune system becomes overwhelmed, and will 
result in immunological memory that can provide longer-term protection 
(Hammarlund et al., 2003). It can however take days rather than hours for the 
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adaptive immune system to respond upon the first encounter of a pathogen 
and requires the innate system for initiation. In this time, a population of 
bacteria for example could increase exponentially, hence the requirement for 
the much faster innate response. The innate immune system is present in 
almost all organisms in some form or another and phylogenetically pre-dates 
the adaptive system, which is restricted to vertebrates (Flajnik & Kasahara, 
2010).  
 
To generate an innate immune response, that both attempts to immediately 
neutralise pathogenic attack and also leads to the induction of the adaptive 
immune response, the body must first be able to recognise pathogens. To 
achieve this, instead of specific antibodies, the innate immune system utilises 
germline-encoded molecules with much broader specificity to distinguish 
between self and non-self. These molecules are called pattern recognition 
receptors and they have evolved to recognise conserved structures common to 
pathogenic microorganisms called pathogen-associated molecular patterns 
(PAMPs) (Kumagai & Akira, 2010).  
 
The first and perhaps the most well characterised family of PRRs are the Toll-
like receptors (TLRs). In total, ten TLRs have been identified in humans and 
have been shown to recognise a wide variety of pathogenic molecules that 
include: a variety of bacterial, viral and fungal sugars; various bacterial and 
viral proteins and lipoproteins; and also bacterial and viral nucleic acids. PAMP 
binding by TLRs initiates a signal cascade, leading to expression of 
proinflammatory cytokines and type I interferons (IFNs), which leads to 
dendritic cell maturation, and hence, activation of T cells and the adaptive 
immune system (Akira et al., 2006; Janeway & Medzhitov, 2002).   
 
The nucleotide-oligomerisation domain (NOD)-like receptors (NLRs) are a 
superfamily of intracellular PRRs present in the cytoplasm of a variety of cell 
types, particularly macrophages and neutrophils. There have been 23 NLRs 
identified in humans (Franchi et al., 2009; Harton et al., 2002). Binding by NLRs 
to bacterial peptidoglycan cell wall components leads to the activation of NF-κ
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and mitogen-activated protein kinases (MAPKs) and the expression of 
proinflammatory cytokines and chemokines (Kanneganti et al., 2007).  
 
Like the NLRs, retinoic acid-inducible gene 1 (RIG-I)-like receptors (RLRs) are a 
family of cytoplasmic PRRs. So far, three members of the RLR family have been 
identified - RIG-I, melanoma differentiation-associated factor 5 (MDA5) and 
laboratory of genetics and physiology 2 (LGP2). Their primary function is to 
identify RNA viruses and to then initiate inflammation by inducing expression of 
type I IFN (Yoneyama et al., 2005). 
 
The C-type lectin receptors (CLRs), or simply, C-type lectins, are another 
superfamily of PRRs found in animals. The name of this superfamily of proteins 
is derived from their calcium dependent binding of sugars. CLRs are 
characterised by the presence of at least one C-type lectin domain, which has 
now been identified in more than 1000 proteins (Zelensky & Gready, 2005). In 
humans, a number of CLRs are involved in both the innate and adaptive 
immune responses, recognising microbial sugars. One important family within 
the CLR superfamily is that of the collectins, which contains mannose-binding 
lectin (MBL) and the ficolins that activate the complement system via the lectin 
pathway. Like the pentraxins, these are secreted PRRs that are found free in 
the serum. 
 
The complement system is a major component of innate immunity (although it 
does also play a part in adaptive immunity via the classical pathway) and 
comprises approximately 20 soluble proteins that are mainly synthesised by the 
liver (Alper & Rosen, 1976; Reid & Porter, 2003). Jules Bordet first described 
the complement system in the late 19th century as a component of serum that 
complements the antibacterial action of antibodies, hence the name (Nesargikar 
et al., 2012). When activated by an invading pathogen, an enzyme cascade is 
initiated on the surface of a pathogen in one of three ways - the classical 
pathway, the lectin pathway or the alternative pathway.  
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Figure 1.1 Overview of the classical complement cascade. 
Upon binding to antibodies present on a pathogen surface, C1s and C1r activate one another, 
thus activating the C1 protein and enabling it to digest C4 (1). Digestion of C4 (into C4a and 
C4b) allows C4b to bind to the pathogen surface via a highly reactive (and previously buried) 
thioester linkage (2). C2 then binds and is activated by C4b, giving rise to the C4bC2a complex, 
or C3 convertase (3). C3 convertase activates C3, allowing C3b to bind to the pathogen surface 
in the same way as C4b, via a thioester linkage (4). Many C3b proteins can bind to the 
pathogen surface, further opsonising it for phagocytosis. The C3b proteins localise close to the 
C3 convertase, which allows it to activate the C5 protein (5). The C5b protein recruits C6 and 
C7 and subsequently C8, allowing the complex to anchor itself into the pathogen membrane 
(6). Up to 20 C9 proteins are then recruited to the complex (which is called the membrane 
attack complex), which form a transmembrane pore, thus lysing the pathogen (7). 
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The classical pathway, which is summarised in figure 1.1, relies on the actions 
of the C1 protein for activation, whereas the lectin pathway, which is identical 
in every other respect, requires the PRRs MBL or ficolin in place of C1 (Bohlson 
et al., 2007). However, the classical pathway is not only activated by binding to 
antibodies; the pentraxin CRP is also able to activate the classical complement 
pathway (in the place of an antibody) by opsonising bacteria and binding to C1 
(Volanakis, 1982). 
 
The outcome of pathogen recognition by many of the PRRs mentioned above, 
and one of the key stages of the innate immune response, is inflammation. 
Inflammation prevents microbial infection taking hold in three different ways. 
The first is to increase the blood flow to the site of infection, in order to 
transport leukocytes into the tissues to combat pathogens. The second is to 
initiate blood clotting, to form a physical barrier and prevent the spread of 
pathogens, and the third role is to initiate tissue repair (Medzhitov, 2008). 
 
As well as a local inflammatory response, cytokines expressed as a result of 
PRR activation induce a change in expression of several specific proteins by 
hepatocytes (Gruys et al., 2005). While the expression of some plasma proteins 
is reduced, many proteins are upregulated and act to opsonise pathogens and 
aid in restoring homeostasis. These are called the acute phase proteins and 
include the C-type lectin MBL and several complement-related proteins. The 
first recognised acute phase protein, and the so-called ‘classical’ acute phase 
protein in humans, was CRP (Abernethy & Avery, 1941), which is a member of 
the pentraxin family of proteins. This is another family of PRRs and is 
summarised in the following section.  
 
1.3 The Pentraxins 
1.3.1 Overview 
The pentraxins are a lectin family of secreted pattern recognition proteins that 
exhibit calcium-dependent ligand binding. They are characterised by the 
presence of the pentraxin fold (pentraxin domain) that includes the specific 
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pentraxin signature sequence (HxCxS/TWxS, where x can be any amino acid) 
(Inforzato et al., 2012).  
 
The high-resolution structures of the human pentraxins CRP and SAP have been 
determined using X-ray crystallography (Emsley et al., 1994; Thompson et al., 
1999). Prior to this, however, negative stain electron microscopy showed that 
CRP is comprised of five identical subunits that exhibit five-fold radial symmetry 
(Osmand et al., 1977). This family of proteins was therefore given the name 
pentraxin, which is derived from the Greek words ‘penta’ and ‘ragos’, meaning 
‘five berries’ (Osmand et al., 1977). The pentraxin fold is a flattened β-jelly roll 
motif, very similar to that of the legume lectins such as concanavalin A (figure 
1.2) (Hardman & Ainsworth, 1972; Thompson et al., 1999). Pentraxins exhibit 
calcium-dependent ligand binding and contain a binding site in which, in SAP 
and CRP, two calcium ions are coordinated in physiological conditions (Emsley 
et al., 1994; Thompson et al., 1999).  
 
Pentraxins are highly evolutionarily conserved and have been found in animals 
as phylogenetically distant as the horseshoe crab, Limulus polyphemus, which 
have existed unchanged for around 500 million years (Robey & Liu, 1981). 
However, in horseshoe crabs the pentraxin monomers are arranged differently 
than in humans. Limulus SAP for instance contains eight rather than five 
subunits, which are arranged radially (Shrive et al., 1999). It is thought that 
pentraxins may have fulfilled the role of ancient innate antibodies long before 
the adaptive immune system came into existence (Lu et al., 2012).  
 
The pentraxin family is divided into two groups that are characterised by their 
N-terminal domains. In humans, the short pentraxins (CRP and SAP) and the 
long pentraxins (PTX3 and the neuronal pentraxins) each contain C-terminal 
pentraxin domains. However, the long pentraxins differ in that they possess 
much larger N-terminal domains that bare no relation to the pentraxin domain 
(reviewed by Armstrong, 2015). They also differ in their localisation, as the 
expression of short pentraxins is restricted to the liver, whereas various tissues 
express the long pentraxins (Garlanda et al., 2005). 
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Figure 1.2 Structure of the CRP and concanavalin A monomers. 
These cartoon depictions of the CRP and concanavalin A monomer topology (PBD IDs 1B09 and 
3CNA, respectively) demonstrate the resemblance between the respective legume lectin and 
pentraxin fold flattened β-jelly roll motifs. The two monomers can be aligned with a root-mean-
square deviation (RMSD) of 3.0 Å, for the main-chain alpha carbons, indicating significant 
structural similarity (Chandra, Prabu, Suguna & Vijayan, 2001). This figure was using the 
PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC.  
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1.3.2 C-reactive protein  
The first secreted PRR and pentraxin discovered was CRP in 1930 (Tillett & 
Francis, 1930). The name C-reactive protein relates to the observation that CRP 
from acutely ill patients binds to and precipitates the Streptococcus 
pneumoniae C-polysaccharide. CRP is termed ‘the classical acute phase protein’ 
because its serum concentration rapidly increases in response to 
proinflammatory cytokines such as interleukin 6 (IL-6), IL-1 and tumor necrosis 
factor alpha (TNFα) ( Du Clos, 2013; Pepys & Baltz, 1983). The normal serum 
concentration of CRP varies but is typically below 3 mg/L in the absence of 
infection, yet this can increase more than 1000-fold during inflammation (Pepys 
& Hirschfield, 2003). This increase in concentration can occur only a day after 
initiation of inflammation and is unaffected by immunosuppressant or anti-
inflammatory drugs, making CRP a convenient diagnostic marker of 
inflammation and infection, particularly when other symptoms are absent. In 
addition, it has been shown that the serum concentration of CRP can be used 
as an indication of the type of infection, as bacterial infections cause a much 
greater response than viral infections (Sasaki et al., 2002). A study in 1992 
suggested that if the serum CRP concentration of children with suspected viral 
or bacterial respiratory infections was greater than 40 mg/L, then the infection 
was unlikely to contain a viral component (Korppi & Kröger, 1993).   
 
The CRP monomer consists of 206 amino acids (not including an 18 amino acid 
signal peptide that is cleaved upon secretion) and has a mass of 23.03 kDa 
(Pepys & Hirschfield, 2003). CRP is very closely related to SAP, the other short 
pentraxin found in humans (although SAP is glycosylated), sharing 51% 
sequence identity (figures 1.3 and 1.4). The CRP and APCS (SAP) genes are 
located very close to one another on the q arm of chromosome 1 in humans, 
and it has been suggested that the two proteins may be the result of a gene 
duplication event (Rubio et al., 1993). A CRP pseudogene had also been 
recorded approximately 7 kb downstream of the CRP gene (Goldman et al., 
1987). This gene is between 50 and 80% homologous to the original gene, but 
contains numerous frame-shifts and stop codons.  
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Figure 1.3 Alignment of CRP and SAP peptide sequences.   
The residues highlighted in blue correspond to the signal peptide that is cleaved upon secretion 
of the proteins, and residues 93-100 in SAP, or 95-102 in CRP, correspond to the pentraxin 
signature peptide HxCxS/TWxS. The SAP and CRP sequences are highly homologous, displaying 
51% identity (areas highlighted red), and it has been suggested that CRP and SAP may be the 
result of a gene duplication event, as the CRP and APCS genes are located very close to one 
another on the q arm of chromosome 1 (Rubio et al., 1993). However, one key difference 
between SAP and CRP is the glycosylation of SAP at Asn 32 (*). This figure was produced using 
Clustal Omega (Krissinel & Henrick, 2004) and ESPript 3.0 (Robert & Gouet, 2014). 
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Figure 1.4 The short pentraxins, CRP and SAP. 
Both CRP and SAP form a pentameric disc with five-fold radial symmetry. This pentameric 
structure was first visualised using electron microscopy by Osmand et al. in 1977, and hence, 
the name ‘pentraxin’ meaning ‘five berries’ was coined. Although the SAP and CRP monomers 
align very closely, their arrangement within the pentamer varies slightly, with the SAP 
monomers being rotated 22° away from the five-fold axis with respect to those of CRP. The 
major difference however is that SAP is glycosylated at position Asn 32 (not shown) (figure 
1.10). Although the exact function of the SAP glycan is unclear, it is thought to be involved in 
SAP turnover. The PDB IDs of the structures shown are 1B09 (CRP) and 3KQR (SAP). This 
figure was using the PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC.  
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However, regardless of the similarity between CRP and SAP, they behave 
differently and appear to have different roles within innate immunity. One 
ligand that is specifically targeted by CRP (in vitro) is phosphocholine (PC), 
which binds in the calcium-binding pocket on the planar B face of the pentamer 
with a Kd of approximately 2.2 μM (Mikolajek et al., 2011). This small anionic 
molecule is a constituent of the streptococcal C-polysaccharide, a known 
physiological target of CRP (Brundish & Baddiley, 1968; Volanakis & Kaplan, 
1971). CRP also binds various other ligands from a number of endogenous or 
exogenous sources (Pepys & Hirschfield, 2003). Endogenous ligands include the 
polar head groups of lecithin and sphingomyelin within damaged phospholipid 
bilayers (Volanakis & Wirtz, 1979), small nuclear ribonucleoproteins (Du Clos, 
1989) and apoptotic cells (Gershov et al., 2000). Like other PRRs, CRP’s 
exogenous ligands include membrane and cell wall components of many 
different bacteria and other pathogen related molecules (Pepys & Hirschfield, 
2003). Once bound to a ligand, CRP is able to bind and activate the 
complement component C1 via C1q, therefore initiating the complement 
cascade via the classical pathway (Volanakis, 1982). As well as activating the 
complement, CRP can bind to Fc receptors, allowing it to opsonise microbial 
pathogens in a similar way to antibodies (Mold et al., 2002). Fc receptors are 
expressed by many cell types and contain an extracellular immunoglobulin (Ig)-
like domain and an intracellular ITAM (Nimmerjahn & Ravetch, 2008). Binding 
by CRP to the extracellular domain initiates a proinflammatory response and 
phagocytosis of the pathogen. 
 
CRP is also used as a diagnostic marker of cardiovascular disease and has been 
shown to be involved in the pathological process of ischemic tissue injury 
following myocardial infarction and atherosclerosis (Pepys & Hirschfield, 2003). 
CRP binding to damaged tissue and atherosclerotic plaques activates 
inflammation via complement activation, which exacerbates tissue injury. Pepys 
et al. showed that the drug 1,6-bis(phosphocholine)-hexane (bis(PC)-H) can be 
used to prevent tissue damage by proinflammatory CRP. Bis(PC)-H, a 
palindromic molecule containing two PC head groups joined by a six-carbon 
linker, joins two CRP pentamers via the calcium-binding site, forming a CRP 
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decamer. Bis(PC)-H binds with a Kd of approximately 300 nM, thereby 
preventing CRP binding to damaged tissues and activating the complement 
cascade (Pepys et al., 2006). 
 
1.3.3 Pentraxin 3 
Pentraxin 3 (PTX3) was the first recognised member of the long pentraxins, 
discovered in 1992 by Breviario et al. when its expression was demonstrated in 
vascular endothelial cells in response to IL-1β (Breviario et al., 1992). The PTX3 
monomer is 364 amino acids in length (not including a cleaved, 17 amino acid 
long signal peptide) (Mantovani et al., 2013). The monomer is approximately 40 
kDa, which does not include the glycosylation at Asn 203, and contains a C-
terminal pentraxin fold that is highly homologous to both the CRP and SAP 
monomers (Deban et al., 2009). It also contains an N-terminal domain that 
bears no apparent similarity to the short pentraxins (Inforzato et al., 2010). The 
structure of the PTX3 N-terminal region has yet to be determined, although 
structural prediction has concluded that there are likely to be four α-helices 
connected by short loops, with the three helices toward the C-terminal region 
likely to be in a coiled-coil conformation (Presta et al., 2007). Cryo-electron 
microscopy (cryo-EM) and small-angle X-ray scattering (SAXS) have revealed 
that unlike the short pentraxins, which form symmetrical pentameric discs, 
PTX3 adopts an unsymmetrical octamer as depicted in figure 1.5 (Inforzato et 
al., 2010). 
 
Various cells of myeloid lineage, endothelial, epithelial and smooth muscle cells 
express PTX3 in response to proinflammatory cytokines, and high-density 
lipoproteins (HDLs) (Bottazzi et al., 2016). As with CRP, PTX3 has a wide range 
of pathogenic ligands. These include a number of Gram-positive and Gram-
negative bacteria such as Klebsiella pneumoniae, fungi such as Aspergillus 
fumigatus, Paracoccidioides brasiliensis, the fungal sugar zymosan, and viral 
targets such as human and murine cytomegalovirus (CMV) and influenza virus 
type A (IVA) (Mantovani et al., 2013).  
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Figure 1.5 The predicted structure of PTX3. 
Although no high-resolution structural information is currently available for PTX3, small-angle X-
ray scattering (SAXS) and cryo-electron microscopy (cryo-EM) have been used to determine the 
conformation of the multimer complex at low resolution (Inforzato et al., 2010). These data 
suggest that PTX3 is unique among the pentraxins in that it assembles to form an 
unsymmetrical octomer. The long N-terminal region (absent in the short pentraxins) is divided 
into a helical component and a globular component. The helical component contains three α-
helices that, depending on the disulphide bonds that form between them, are either elongated 
or fold up to form coiled-coils. Therefore the centre of the protein complex contains eight 
pentraxin-fold domains, from which extend elongated, N-terminal domains on one side opposite 
shortened, coiled, N-terminal domains on the other.  
 
  
 15 
Whilst PTX3 can induce inflammation via complement activation by binding to 
C1q, MBL and ficolin and also binding Fcγ receptor IIa (FcγRIIa), there is also 
evidence to suggest that it can act in an anti-inflammatory manner, regulating 
the immune response (Mantovani et al., 2013). PTX3 binds to P-selectin present 
on the vascular endothelium, therefore preventing rolling adhesion of 
leukocytes and neutrophil recruitment. Following myocardial infarction in Ptx3-
deficient mice, infarcts were found to be larger than those in wild-type mice, 
indicating that the role of PTX3 as an inflammatory regulator may therefore aid 
in the prevention of tissue damage during chronic inflammatory diseases (Salio 
et al., 2008).  
 
1.3.4 Neuronal pentraxins 
Neuronal pentraxin 1 (NPTX1) was identified in 1995 as a snake venom 
(taipoxin)-binding protein in rat neurons (Schlimgen et al., 1995). Shortly 
afterwards another novel pentraxin, NPTX2, with 54% sequence identity to 
NPTX1, was discovered in human neurons (Hsu & Perin, 1995). Whilst NPTX1 
expression is restricted to neurons of the cerebellum, hippocampus and 
cerebral cortex, a range of tissues in locations other than the brain express 
NPTX2. The highest level of expression was detected in the testis and was also 
detected in the pancreas, liver, heart and skeletal muscle. In 1997 a third 
neuronal pentraxin, neuronal pentraxin receptor (NPR), was also identified in 
neurons, and is currently the only known membrane-bound pentraxin (Dodds et 
al., 1997). Although no structural information has been obtained for the NPTXs, 
Kirkpatrick et al. have shown that they appear to form pentameric multimers in 
the same way as the short pentraxins (Kirkpatrick et al., 2000).  
 
Although physiological function of the NPTXs has yet to be clearly understood, 
they have been implicated in a number of processes, though none directly 
involved in the immune system. NPTX1 binds to the presynaptic neurotoxin 
taipoxin in a calcium-dependent manner and appears to facilitate its 
internalisation by neurons via NPR binding (Kirkpatrick et al., 2000). It has been 
suggested therefore that NPTX1 and NPR work to clear synaptic debris (Dodds 
et al., 1997). NPTX1 may also be involved in neuronal apoptosis in the 
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depolarising conditions of low potassium, as apoptosis can be significantly 
inhibited when NPTX1 expression is knocked-down (DeGregorio-Rocasolanoet 
al., 2001).  
 
It has also been hypothesised that the NPTXs play a role in the formation of 
synapses during development. Juvenile mice lacking NPTXs have reduced 
synaptic transmission via the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid receptor (AMPR) in the visual thalamus (Koch & Ullian, 2010), though not 
in other areas of the developing brain. NPTXs are thought to be involved in the 
recruitment of AMPRs (O'Brien et al., 2002) and therefore this reduction in 
synaptic signalling is attributed to a reduction in the levels of AMPR localised at 
the retinogeniculate synapses.  
 
Knockdown of NPTX1 expression in brain cortical neurons cultured with 
amyloid-β peptides appears to reduce the neurotoxic effect and cell-death 
caused by the amyloid plaques. NPTX1 has therefore also been implicated in 
the pathological progression of Alzheimer’s disease (Abad et al., 2006).   
 
1.4 SAP structure and function 
SAP is the only short pentraxin other than CRP that has been identified in 
humans. SAP is constitutively expressed by hepatocytes, but unlike CRP it is not 
an acute phase protein in man (Pepys et al., 1978). Even during the 
inflammatory response, the serum concentration of SAP remains at 
approximately 30-50 mg/L, unlike CRP, which, as previously discussed, can 
increase more than 1000-fold during inflammation from a typical concentration 
of less than 3 mg/L (Nelson et al., 1991; Pepys & Hirschfield, 2003). Since its 
discovery (Cathcart et al., 1965), much work has been undertaken to 
characterise the pathological role that SAP plays in amyloid related diseases 
and investigate its potential as a therapeutic target. Despite this effort the 
physiological function of SAP remains obscure, with little being understood 
about its role within the innate immune system, particularly with regard to its 
function as the main calcium-dependent DNA-binding protein in human serum 
(Pepys & Butler, 1987). The sequence and structure of SAP have been 
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extremely well conserved throughout evolution with no reported structural 
polymorphisms in man, and the glycostructure of SAP is invariant (Pepys et al., 
1994). This suggests that SAP has undergone strong evolutionary pressure to 
maintain its structure for a presumably biologically important function. The 
following sections provide an overview of the structure and pathological role of 
SAP and the current understanding of its physiological function.     
 
1.4.1 The structure of SAP 
The high-resolution structure of SAP was determined in 1994 by X-ray 
crystallography, and this was the first time that the structure of a pentraxin had 
been seen in atomic detail (Emsley et al., 1994). The SAP monomer exhibits a 
flattened β-jelly roll tertiary structure, and despite sharing a high level of 
homology with CRP, the SAP monomer is rotated 22° away from the five-fold 
axis with respect to the CRP structure (Thompson et al., 1999). Figure 1.6 
shows the SAP and CRP monomers overlaid and figure 1.7 shows a schematic 
diagram of the pentraxin fold in SAP. A single SAP monomer is 25,462 Da in 
size (including an N-linked biantennary glycan) and contains 204 residues 
(Pepys et al., 1994). Five SAP monomers assemble to form a planar, 
pentameric ring with a largely negatively charged A face and a largely positively 
charged B face (figure 1.8) (Emsley et al., 1994).  
 
The B face of the protomer contains a calcium-dependent ligand-binding site, 
wherein two calcium ions are bound (figure 1.9a) (Emsley et al., 1994). Asp 58, 
Asn 59, Glu 136, Gln 137 and Asp 138 coordinate the first calcium and Glu 136, 
Asp 138 and Gln 148 coordinate the second, which is therefore associated more 
loosely. These three residues are located within a large unstructured loop 
(residues 138 to 145) that is only held in place by association with the calcium 
ions. All other loops are closely associated with the central β-sheet of the 
protomer that forms a compact structure, highly resistant to proteolytic attack. 
This explains why in the absence of calcium, SAP can be cleaved by proteases 
at the C-terminal of Phe 144 (Kinoshita et al., 1992). A small hydrophobic 
groove formed by Leu 62, Tyr 64 and Tyr 74 is located adjacent to the calcium 
ions.  
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Figure 1.6 Overlay of the SAP and CRP monomers. 
In this figure, the SAP monomer has been rotated by 22° towards the five-fold axis to allow 
close alignment with the CRP monomer. This overlay demonstrates the close homology 
between SAP and CRP, with an RMSD of only 1.3 Å (Thomson et al., 1999). There are only 
three locations where the structures deviate slightly (red arrows); these are the loops at 
positions 41-46, 68-69 and 84-81 (in SAP), and when these loops are omitted, the RMSD drops 
to 0.83 Å. The PDB IDs of the structures shown are 1B09 (CRP) and 3KQR (SAP). This figure 
was using the PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC.  
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Figure 1.8 SAP surface charge. 
The SAP pentamer (depicted without N-linked glycans) is highly polarised, with a largely 
negatively charged A face and a largely positively charged B face. The negatively charged 
patches on the B face correspond to the calcium-binding sites and are neutralised by the 
addition of calcium ions in physiological conditions. This figure was produced using the APBS 
PyMOL plugin with 3KQR (Baker et al., 2001; Dolinsky et al., 2007).  
 
 21 
 
 
Figure 1.9 SAP calcium-binding site and monomer interactions. 
A shows a single phosphoethanolamine (PE) molecule within the SAP ligand-binding pocket. 
Within the pocket, one calcium ion is coordinated by Asp 58, Asn 59, Glu 136, Gln 137 and Asp 
138, and the a second is coordinated by Glu 136, Asp 138 and Gln 148. The phosphate group 
of PE interacts with the calcium ions whilst the hydrocarbon chain is channelled into a 
hydrophobic grove formed by Leu 62, Tyr 64 and Tyr 74, and the amine group forms a 
hydrogen bond with a water molecule (not shown). B shows the three salt bridges that form 
between the SAP monomers to provide a highly stable pentameric structure. These interactions 
bury 15.4% of the surface of each monomer. This figure was using the PyMOL Molecular 
Graphics System, Version 1.5 Schrödinger, LLC.  
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Along with the calcium-binding site, this hydrophobic region defines the ligand-
binding pocket on the B face. Figure 1.9a shows phosphoethanolamine (PE) 
within with the binding pocket of SAP. The negatively charged phosphate group 
interacts with the calcium ions and the remainder of the molecule is directed 
into the hydrophobic groove. The amine group at the opposite end of the PE 
forms a hydrogen bond with a water molecule (not shown), while the 
hydrocarbon chain packs against Tyr 64 in the hydrophobic region (Mikolajek et 
al., 2011).  
 
One of the main differences between SAP and CRP is their differing affinities for 
the small anionic molecules PE and PC. As mentioned previously, CRP binds PC 
with a Kd of approximately 2.2 μΜ, and also binds PE with a Kd of approximately 
32.1 μM. SAP on the other hand does not bind to PC and binds to PE with a Kd 
of approximately 36.9 μM. Structural analysis showed that Thr 76 of CRP allows 
a greater number of available low energy states for PE binding than the 
equivalent Tyr 74 of SAP. Also, the three methyl groups of PC are not able to 
pack into the hydrophobic region of the SAP binding pocket due to the presence 
of a tyrosine instead of a threonine (Mikolajek et al., 2011). It has also been 
suggested that the salt bridge present between Glu 66 and Lys 79 of SAP 
(which is not present in CRP as the equivalent residues are Ser 68 and Glu 81), 
restricts the binding site further, and that the replacement of Lys 79 for a 
glycine (performed using recombinant SAP expressed in insect cells) allows PC 
to bind (Booth et al., 1998). 
 
On the opposite side of the protomer, the largely acidic A face contains a single 
α-helix that rests along the surface, protruding from which is Glu 167 (Emsley 
et al., 1994). This residue is thought to be the cause of calcium-dependent 
aggregation of SAP at physiological pH (Baltz et al., 1982; Booth et al., 1998; 
Pinteric & Painter, 1979). It has been suggested that this protruding glutamic 
acid associates with the calcium-binding pocket on the B face of adjacent 
molecules, with previous small-scale site-directed mutagenesis experiments (in 
which recombinant E167Q and E167S SAP was expressed in insect cells using 
the baculovirus system) apparently preventing SAP aggregation (Booth et al., 
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1998). SAXS and negative stain electron microscopy performed in the absence 
of calcium (conditions in which SAP is soluble) demonstrated that the loop from 
residues 138 to 145 associates with an adjacent pentamer, thus binding them 
together, A face to A face, to form a stable decamer (Ashton et al., 1997). It 
was believed therefore that this was its natural form in the serum until it was 
later discovered that the high concentration of albumin in the serum prevents 
aggregation in the presence of calcium, meaning SAP is pentameric in the 
serum, even without the presence of a ligand (Hutchinson et al., 2000). 
 
The diameter of the SAP pentamer was calculated to be approximately 100 Å 
and the depth approximately 35 Å. The pore in the centre is approximately 20 Å 
in diameter (values calculated using PyMOL measurement wizard with 3KQR). 
The interactions that hold the protomers together are purely non-covalent and 
bury 15.4% of the surface of each protomer. The inter-subunit interactions 
consist of three salt bridges (figure 1.9b), hydrophobic interactions and 
hydrogen bonding, which together confer considerable stability to the 
pentameric structure (Emsley et al., 1994; Pepys & Baltz, 1983).  
 
Each protomer is glycosylated at residue Asn 32, displaying a complex 
biantennary oligosaccharide, which unlike other glycoproteins remains invariant 
and does not display any microheterogeneity (Hamazaki, 1990; Hess et al., 
1988; Pepys et al., 1994). Figure 1.10 shows the SAP pentamer with the 
glycosylation modelled and a schematic diagram of the glycan. The function of 
the SAP glycan has been shown to play a role in SAP turnover. In humans, SAP 
has a typical half-life of approximately 24 hours, but the half-life of SAP that 
has been desialylated is reduced to minutes, as it is cleared by the liver 
(Tennent & Pepys, 1994). This indicates that an intact glycan is required for the 
persistence of circulating SAP. 
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Figure 1.10 SAP glycostructure. 
SAP is N-glycosylated at Asn 32 with a complex biantennary glycan. Due to the flexibility of this 
sugar, usually only the first N-acetylgalactosamine is observed in crystallographic structural 
analysis of SAP; panel A, however, shows the glycan modelled with the SAP pentamer. B shows 
a schematic diagram of the entire biantennary glycan. The function of the glycan is not clear, 
but it is thought to be involved in SAP turnover via the asialoglycoprotein receptors present in 
the liver (Tennant & Pepys, 1994). This figure was using the PyMOL Molecular Graphics System, 
Version 1.5 Schrödinger, LLC.  
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1.4.2 The physiological role of SAP 
Although the physiological role of SAP remains largely unknown, there are no 
known polymorphisms or deficiencies of SAP in humans, indicating that it is 
likely to have a significant biological function (Pepys et al., 1997). Several 
properties of SAP that may prove to be significant have now been identified. 
These include the binding of SAP to several pathogenic bacteria (Hind et al., 
1985), the interaction with Fcγ receptors displayed by granulocytes in humans 
(Bharadwaj et al., 2001) and the binding of SAP to extracellular nucleic acids 
(Pepys & Butler, 1987).  
 
As well as amyloid deposits, SAP is a normal component of the glomerular 
basement membrane and is associated with the elastic microfibrils present in 
the extracellular matrix of connective tissue, albeit at a much lower 
concentration (Breathnach et al., 1981; Dyck et al., 1980). In these conditions 
it is often called tissue amyloid P component (TAP). It is still unclear as to the 
reason for this distribution of SAP, although it has been speculated that it may 
act to protect the structures within the matrix from protease attack (reviewed 
by Pepys et al., 1997).  
 
Although it is not an acute phase protein, SAP is thought to have a significant 
role in human innate immunity as a secreted pattern recognition receptor 
(PRR). Like CRP, SAP was found to bind the extracellular domain of the Fcγ 
receptors that are expressed by granulocytes (Bharadwaj et al., 2001; 
Landsmann et al., 1994). This suggests SAP may have a role as an innate 
immune mediator, opsonising antigens prior to Fcγ receptor activation and 
phagocytosis. Lu et al. published the structure of the interaction between SAP 
and the extracellular domain of FcγRIIa in 2008 (shown in figure 1.11), and 
showed that zymosan particles opsonised by SAP and IgG, respectively, were 
phagocytosed by macrophages displaying FcγRIIa in comparable fashion (Lu et 
al., 2008). In 1984 it was shown that SAP is able to recognise the sugars in the 
cell walls of bacteria via the calcium-binding site on its B face (Hind et al., 
1984).  
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Figure 1.11 Fcγ receptor IIa binding by SAP. 
This figure shows the structure published by Lu et al. in 2008 of SAP bound to the FcγRIIa 
ectodomain (PDB ID 3D5O) (Lu et al., 2008). The Fc receptor ectodomain is bound to the A 
face of SAP, which is particularly interesting as SAP is known to bind certain pathogenic 
bacteria via the calcium-binding site on its B face. Lu et al. also showed that SAP is able to 
opsonise zymosan particles (a fungal sugar) in a similar way to IgG. This supports the theory 
that SAP and the pentraxins may have fulfilled the role of early antibodies prior to the evolution 
of the immunoglobulins. This figure was using the PyMOL Molecular Graphics System, Version 
1.5 Schrödinger, LLC.  
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SAP binds with particularly high affinity to bacteria expressing the cyclic 4,6-
pyruvate acetal of galactose (MOβDG) such as Klebsiella rhinoscleromatis and 
also to Streptococcus pyogenes but via an unknown sugar (Hind et al., 1985). 
This is particularly interesting as the Fcγ receptors and bacteria appear to bind 
on opposite faces of SAP, indicating that they may be able to bind 
simultaneously.  
  
As mentioned previously, the pentraxin family of proteins are highly 
phylogenetically conserved and, as members of the innate immune system, 
have existed for far longer than the antibodies of the adaptive immune system. 
However, it has been identified that SAP shares many of the characteristics of 
antibodies, such as the ability to recognise and bind to pathogenic molecules 
and can possibly bind to Fcγ receptors simultaneously. It has therefore been 
suggested that SAP (and other pentraxins) may have been conserved as a 
family of primitive antibodies that had the ability to opsonise pathogens long 
before the occurrence of the adaptive immune system (Lu et al., 2008).   
 
A study performed in 1998 suggested that SAP could bind, and thus inhibit the 
binding of IgM autoantibodies, to sulphatide in patients with Lepromatous 
leprosy, in whom these antibody levels were raised (Wheeler et al., 1998). 
Sulphatide is commonly found in cells of the nervous system and is a major 
constituent of myelin sheaths. It was therefore suggested that although SAP 
may be a primitive opsonin, it might also act to protect the body to some 
extent, particularly the nervous system, from autoimmune related damage in 
patients with leprosy.    
 
Reports about whether or not SAP activates the complement cascade in vivo 
are mixed. This confusion stemmed initially from SAP being mistaken as being 
part of the complement C1 complex (and therefore named C1t), but it was later 
discovered that it had been mistakenly co-purified with other C1 proteins due to 
its calcium-dependent binding to sepharose (Painter, 1977). Calcium-dependent 
binding of SAP to C1q and subsequent activation of C3 has been demonstrated 
in vitro using supraphysiological concentrations of SAP, which undergo calcium-
 28 
dependent aggregation. However, when SAP is added to acute phase or normal 
human serum containing chromatin, activation of the complement is not 
observed (reviewed by Pepys et al., 1997). This is presumably because SAP 
binding to the chromatin (see below) solubilises SAP, thus preventing 
complement activation. Whilst calcium-dependent aggregation of SAP is a well-
defined phenomenon in vitro, it is not observed physiologically (at normal 
concentrations), because, as previously mentioned, SAP is stabilised and 
remains soluble due to the presence of albumin (Hutchinson et al., 2000). The 
observed activation of the complement cascade by aggregated SAP is probably 
physiologically irrelevant. However, it has been reported that SAP in complex 
with histone H2A activates the complement, as indicated by the binding of the 
complement protein C3, and also the production of the C4 cleavage product 
C4d when incubated in serum (Hicks et al., 1992). It was subsequently 
suggested however that the complement activation observed in this study was 
caused by aggregated SAP (Pepys et al., 1997). 
 
SAP is the only serum protein that binds various forms of DNA (including single 
and double stranded DNA, chromatin, H1-stripped chromatin and nucleosome 
core particles (NCP)) in a calcium dependent manner in vitro (Pepys & Butler, 
1987) and, due to its role as a PRR, it was proposed that SAP might clear 
extracellular DNA and chromatin from the circulation to prevent the occurrence 
of antinuclear autoimmunity (Bickerstaff et al., 1999). This suggestion that SAP 
protects the body from autoimmune attack is similar to that made previously by 
Wheeler et al. who proposed that SAP prevents autoimmune recognition of 
endogenous sulphatides. DNA can be present in the serum for a number of 
reasons including, but not limited to: cell leakage during apoptosis and necrosis 
(Jahr et al., 2001; Lo et al., 2000), lysis of tumor cells (Sorenson, 2000), or 
foetal DNA in pregnant women (Sekizawa et al., 2000).  
 
Another source of extracellular DNA is present in the form of neutrophil 
extracellular traps (NETs). NETosis, first described by Brinkmann et al. in 2004, 
is form of programmed cell death in which neutrophils secrete their nuclear 
material and antimicrobial proteins in response to tissue injury (reviewed by Liu 
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et al., 2014). These traps consist mainly of chromatin and help to sequester 
pathogenic microorganisms to prevent their circulation and also kill them by 
concentrating them around antimicrobial neutrophil granular proteins. Due to 
its ability to bind chromatin (Butler et al., 1990), it is likely that SAP also 
localises around NETs and may also play a role in the opsonisation of 
sequestered bacteria. However, NETs have also been implicated in the 
facilitation inflammatory tissue damage and autoimmune diseases, such as 
systemic lupus erythematosus (SLE) (reviewed by Almyroudis et al., 2013). 
Based on the findings of Bickerstaff et al. in 1999 that SAP might control 
extracellular chromatin clearance, this might also suggest that SAP has a role in 
NET clearance and the prevention of autoimmune responses.    
 
The theory that SAP is a DNA scavenger was supported by the observation that 
SAP binds to the nuclei of human keratinocytes in vitro and extracellular 
chromatin in vivo, deposited in the skin lesions of patients with systemic lupus 
erythematosus (SLE) (Breathnach et al., 1989). SAP was found to bind 
chromatin in vitro with an affinity sufficient to completely displace histone H1 
and also solubilise the chromatin at physiological ionic strength, at which it 
would usually be completely insoluble (Butler et al., 1990).  
 
More recently, the clinical implications of the DNA binding properties of SAP 
have come to light. DNA vaccination is a procedure that has been used to 
produce immune responses to a wide variety of protein targets in mammals, 
with potential implications for cancer and virus treatment in humans (Donnelly 
et al., 2005; Gurunathan et al., 2000; Rice et al., 2008). The mechanism of 
DNA vaccination involves introducing plasmid DNA, which encodes the protein 
to which an immune response is required, into professional antigen presenting 
cells (APCs). These cells (usually dendritic cells) then express the protein and 
generate an immune response against it by activating T cells (reviewed by Rice 
et al., 2008). Once injected, only a small proportion will directly transfect 
dendritic cells. A greater proportion of the DNA transfects keratinocytes or 
myocytes and the expressed protein is subsequently taken up by dendritic cells 
via apoptotic vesicles in a process called cross-priming (Albert et al., 1998). 
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Dendritic cells then activate CD4+ and CD8+ T cells by presenting the 
expressed protein via MHC class II and MHC class I, respectively (reviewed by 
Gurunathan et al., 2000). Thus far DNA vaccination has been used with success 
in mice and other mammals but not so successfully in humans, as it appears 
that the introduced plasmid DNA fails to elicit a significant immune response 
(Stevenson et al., 2010). It is now thought that SAP may be the primary cause 
of this failure, as human SAP binds and clears all known extracellular DNA from 
circulation, unlike mouse SAP which binds DNA very weakly (Gillmore et al., 
2004; Wang et al., 2011a; Wang et al., 2011b). If this is indeed the case, then 
SAP provides a promising therapeutic target for the progression of DNA 
vaccination in humans.  
 
However, regardless of the apparent significance of SAP-DNA binding, virtually 
nothing is known about the precise nature of the interaction in terms of its 
strength, sequence specificity or stoichiometry and there is currently no high-
resolution structural information regarding the SAP-DNA complex.  
 
The tertiary structure of most DNA-binding proteins contain specific, conserved, 
DNA-binding motifs, examples of which are displayed in figures 1.12 to 1.14 
(Luscombe et al., 2000). These motifs allow the interaction between positively 
charged amino acids and the negatively charged DNA sugar-phosphate 
backbone, and in the case of sequence-specific DNA binding they allow 
hydrogen bonding and hydrophobic interactions between amino acid side-
chains and DNA bases. However, structural analysis of SAP has revealed no 
obvious DNA recognition motifs.  
  
Prior to the high-resolution structure of SAP being available, Du Clos et al. 
reported that SAP and CRP contain putative nuclear localisation peptide 
sequences (Du Clos et al., 1990). SAP however did not appear to show 
significant localisation at the nuclei of the VERO cells that were tested. This 
sequence (residues 113-121, PLVKKGLRQ) is now known to be situated at the 
interface between the SAP monomers, and residues Lys 16 and Lys 17 are 
directly involved in monomer-to-monomer binding. As individual SAP monomers 
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are yet to be observed in vivo, this seems an unlikely sequence for nuclei 
binding by SAP. Prior to the report by Du Clos et al., it was suggested that this 
same peptide sequence bears resemblance to a decapeptide found in histones 
H1 and H4 (Turnell et al., 1988). However, while in histone H4 this proposed 
homologous peptide forms part of the H4α1 helix that contacts the DNA minor 
groove, in SAP this peptide does not have any helical structure and is buried 
between monomers. 
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Figure 1.12 The helix-turn-helix (HTH) and leucine zipper DNA-binding motifs. 
A shows the HTH motif within the bacteriophage 434 Cro repressor (PDB ID 3CRO). The 
recognition helix is shown in magenta and sits within the DNA major groove where it makes 
nucleotide base-specific interactions. The scaffold helix is positioned perpendicular to the 
recognition helix and is shown in blue. Along with the short loop that separates it from the 
recognition helix, the scaffold helix makes stabilising contacts with the DNA backbone. B shows 
the leucine zipper motif from the human MafA transcription factor (PDB ID 4EOT). The leucine 
zipper binds DNA as a homodimer, the two α-helical proteins associated via hydrophobic 
interactions mediated by leucine residues spaced every seven amino acids. The proteins are 
separated at the DNA-binding region, where a patch of basic residues allows the interaction 
with the DNA major groove. This figure was using the PyMOL Molecular Graphics System, 
Version 1.5 Schrödinger, LLC.  
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Figure 1.13 The helix-loop-helix (HLH) and zinc-finger DNA-binding motifs. 
A shows the HLH motif within the murine MyoD transcription factor (PDB ID 1MYD). The HLH 
motif is very similar to the leucine zipper motif with the exception that the dimerisation and 
DNA-binding domains are separated by a loop that can vary in size from 5-24 residues, allowing 
greater flexibility. B shows the zinc-finger motif from the Xenopus TFIIIA transcription factor 
(PDB ID 1TF3). The zinc finger comprises a two-stranded β-sheet followed by an α-helix, 
between which a zinc ion is coordinated. The zinc ion can be coordinated either by four 
cysteine, four histidine, or two cysteine and two histidine residues (C). The zinc-finger motif 
lacks a large hydrophobic core for stabilising the DNA-binding α-helix, and therefore the zinc-
coordination is able to fulfil this role. Residues 6, 3, 2 and -1 (in relation to the start of the 
helix) contact the nucleotide bases 1, 2, 3 and 4 (in a 4 bp sequence). This figure was using the 
PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC.  
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Figure 1.14 The histone fold. 
A shows the entire nucleosome core particle that is comprised of the core histone octomer 
around which a 147 bp double-stranded DNA oligomer is wrapped 1.65 times (PDB ID 1KX5). B 
shows the interaction between the histone H3-H4 dimer and the DNA minor groove at the L1L2 
sites and the α1α1 sites. The L1L2 sites contain the most protein-DNA contacts, which comprise 
a number of types of interaction. These include hydrogen bonding and salt-bridges directly 
between positively charged amino acid side chains and the DNA backbone. There is also water-
mediated hydrogen bonding and hydrogen bonding between the histone main-chain and the 
sugar-phosphate DNA backbone, and nucleotide bases (though this is sequence independent). 
This figure was using the PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC. 	
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1.4.3 The pathophysiological role of SAP 
SAP is a constituent part of all pathogenic amyloid fibres in all tissues, including 
those observed in type II diabetes, Alzheimer’s disease and Creutzfeldt-Jakob 
disease (reviewed by Pepys et al., 1997). In contrast to its relatively low, yet 
constant, serum concentration of approximately 30-50 mg/L, SAP accumulates 
at amyloid fibrils in far greater concentrations than any other serum protein 
(Gallo et al., 1988; Nelson et al., 1991). SAP makes up 14% of the mass of 
amyloid deposits, which is why I123-labelled SAP scintigraphy is the main 
diagnostic tool used to detect pathogenic amyloid (Hawkins et al., 1990; 
Skinner et al., 1980).  
 
SAP has been shown to contribute to both the formation and persistence of 
amyloid fibres. In mice, systemic amyloid A (AA) amyloidosis can be induced by 
repeated casein injections, which maintain a high serum concentration of the 
acute phase amyloid A protein. The serum concentration of SAP rises with the 
formation of the AA amyloid. However, in mice strains that are resistant to 
amyloid formation (A/J), the SAP concentration drops significantly soon after, 
and remains low even during continued casein injections. In strains susceptible 
to amyloid formation (CBA, C57BI), SAP concentration is maintained at a high 
level (Baltz et al., 1980). In addition to this, SAP knockout mice have been 
produced in which induced AA amyloid formation is significantly retarded, 
demonstrating that SAP plays a significant role in the pathogenesis of amyloid-
associated diseases at least in the mouse (Botto et al., 1997). However, it 
should be noted that the acute phase response of murine SAP and CRP appears 
to be opposite to that observed in humans, i.e. SAP is an acute phase protein 
and CRP is not (Pepys et al., 1979). 
 
As previously noted, SAP in the presence of calcium is highly resistant to 
proteolytic degradation and it is believed that amyloid deposits are protected 
from proteolytic attack when coated by it. Indeed it has been shown that in the 
absence of SAP, amyloid fibrils are far more susceptible to various proteases in 
vitro (Tennent et al., 1995). It is also known that amyloid deposits can slowly 
degrade over time as long as no new fibrils are being deposited (Hawkins et al., 
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1993a; Hawkins et al., 1993b; Holmgren et al., 1993). This has lead some to 
believe that reduction of SAP may be a viable therapeutic target for treatment 
of amyloidosis. Temporary removal of SAP from the serum has now been 
achieved via the introduction of the small, palindromic drug R-1-[6-[R-2-
carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl] pyrrolidine 2-carboxylic acid (CPHPC) 
which binds two SAP pentamers, B face to B face with a Kd of 10 nM, causing 
them to be cleared from the circulation via the liver. Figure 1.15 shows the 
structure of this SAP decamer with the CPHPC cross-links. This action has now 
been combined with antibody therapy and has shown to be successful, during 
phase I clinical trials, in reducing the amyloid present in patients with systemic 
amyloidosis following clearance of SAP using CPHPC (Richards et al., 2015). 
This treatment has now therefore progressed to phase II clinical trials.  
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Figure 1.15 Crystal structure of two human SAP pentamers cross-linked with 
CPHPC. 
The two SAP pentamers are shown cross-linked via five palindromic CPHPC molecules (red) 
spanning calcium-binding sites (one on each pentamer) simultaneously (PDB ID 4AVT). The 
calcium ions are shown in yellow. The pentamers are therefore bound B face to B face and one 
pentamer is rotated by approximately 10° with respect to the other. The image below depicts 
the CPHPC molecule, displaying its palindromic structure. This figure was using the PyMOL 
Molecular Graphics System, Version 1.5 Schrödinger, LLC.  
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1.5 Project aims 
As described in section 1.4.2, it has been well documented that the human 
pentraxin, SAP, binds to DNA, chromatin and NCP (Pepys & Butler, 1987). SAP 
is the only serum protein that binds to DNA in a calcium-dependent manner, 
yet the reason for this is unclear. Due to its significant evolutionary 
conservation, it has been suggested that SAP must have an important biological 
function, and that this might be to scavenge nuclear material from the serum in 
order to prevent an autoimmune response (Breathnach et al., 1989). However, 
structural investigation of SAP has not revealed the presence of any obvious 
DNA-binding motifs, which are usually conserved in DNA-binding proteins, and 
there is currently no information regarding the precise molecular nature of the 
interaction.   
 
The primary aim of this project was to characterise the SAP-DNA interaction in 
terms of its strength, sequence specificity and stoichiometry, and to elucidate 
the structural mechanism of SAP-DNA binding. In order to achieve this it was 
first necessary to subclone, express and purify recombinant SAP using the 
mammalian HEK 293 cell expression system (chapter 2). Having a source of 
recombinant protein also enabled mutational analyses to identify the DNA-
interacting residues. Residues were selected for mutation by aligning the amino 
acid sequence of human SAP with that of murine SAP, which does not bind DNA 
strongly (Wang et al., 2011b). Positively charged residues (arginine, lysine and 
histidine) that were not conserved across both species were selected.  
 
Due to the ability of SAP to bind and solubilise native long chromatin, as well as 
a range of other DNA species, it was hypothesised that SAP might bind to 
naked DNA in a sequence independent manner. To test this hypothesis, 
electrophoretic mobility shift assays (EMSA) were performed using recombinant 
native sequence SAP with a range of varying double-stranded DNA sequences 
and lengths. Further kinetic analysis was performed using switchSENSE, which 
also utilised various lengths of random sequence DNA. The stoichiometry of the 
complex was subsequently investigated using sedimentation velocity analytical 
ultracentrifugation (SV-AUC). The aim of these experiments was to determine if 
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there is any sequence and/or DNA length requirement for SAP-DNA binding 
(chapter 3). EMSA was also subsequently performed using mutant SAP, in order 
to investigate the effect of the various mutations on the stability of the SAP-
DNA complex.  
 
Crystallisation of the SAP-DNA complex was also attempted in order to gain a 
detailed structural analysis of the SAP-DNA interaction using single crystal X-ray 
diffraction (chapter 5). This method was used to determine four structures of 
recombinant native sequence SAP (two of which presented unique unit cell 
parameters) and two mutant SAP structures (k87Q and KR193Q), in order to 
compare them to previously published structure of ex vivo human SAP.  
 
Finally, to investigate the binding of SAP to chromatin, characterisation of the 
interaction between SAP and nucleosomes (in terms of affinity, stoichiometry 
and kinetics) was undertaken using EMSA, SV-AUC and surface plasmon 
resonance (SPR). This was performed using recombinant reconstituted human 
NCP with recombinant human SAP (chapter 6). The aim of this work was partly 
to continue the investigation performed by Butler, Tennant and Pepys (1990), 
whom performed similar experiments using sucrose-gradient ultracentrifugation 
with ex vivo SAP and chicken erythrocyte NCP. However, with current 
information regarding the physiological structure of SAP, more accurate 
assumptions could be made regarding the stoichiometry of SAP-NCP binding 
and experiments could be performed using more appropriate buffer conditions.  
 
  
 40 
2. Expression of human SAP 
 
2.1 Overview 
To investigate the structure and kinetics of DNA-binding by SAP it was 
necessary to obtain milligram quantities of pure, homogeneous protein. The 
majority of previous work on SAP has been performed using ex vivo protein, 
purified directly from human pleural fluid. However, in order to pinpoint 
residues that are integral to DNA binding, recombinant SAP was required for 
mutational analyses. 
 
Recombinant protein is most commonly expressed using bacterial systems, 
typically E. coli, due to high protein yields and relative ease of maintenance. 
Prokaryotic cells, however, lack the molecular machinery required to properly 
fold and post-translationally modify many mammalian proteins that often 
contain specific glycosylation patterns (Barton & Dalton, 2014). Unlike CRP, SAP 
is glycosylated and therefore past attempts to obtain soluble protein in bacteria 
have been largely unsuccessful, invariably leading to insoluble inclusion bodies 
(Dr. Simon Kolstoe & Prof. Steve Wood, personal communication). For this 
reason, a higher-level expression host was required for recombinant SAP. 
 
Human embryonic kidney 293 cells (HEK 293 cells) were chosen as a suitable 
system for expression of recombinant SAP. HEK 293 cells are commercially 
available, immortalised human cells transformed with sheared Adenovirus 5 
(Ad5) DNA, and have proven useful for the expression of soluble proteins 
where post-translational modifications are required (Aricescu & Owens, 2013). 
This system allows expression of human protein that is as close to the 
physiological form as possible. For expression of native sequence SAP, a stably 
expressing cell line was constructed using standard HEK 293 cells, in which the 
transfected DNA is integrated into the HEK cell genome and the protein is 
constitutively expressed. For mutant SAP, transient transfections were 
performed using the HEK 293T cell variant in which the expression plasmid is 
episomally replicated and the protein expressed for a finite period.  
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Cloning and expression screening was initially carried out at the Oxford Protein 
Production Facility (OPPF) where the transfection protocol was originally 
designed (Nettleship et al., 2015). Using ligation-independent cloning (InFusion 
- Clontech), a construct was designed for expression of native sequence SAP 
including an N-terminal signal peptide for secretion of the SAP into the growth 
media. This construct was used as a template for further site-directed 
mutagenesis, allowing individual amino acids to be altered for DNA-binding 
analysis. All protein was expressed without a polyhistidine tag (His-tag) as 
phosphoethanolamine (PE)-affinity chromatography was used for SAP 
purification (section 2.3.9). The presence of a His-tag may cause DNA-
interactions that are not observed in native human SAP. 
 
2.2 Human embryonic kidney cells 
HEK 293 cells are human embryonic kidney cells that have been transformed by 
the addition of sheared Adenovirus 5 (Ad5) DNA. Transformation of the cell line 
was first described in 1977 when the Ad5 E1A and E1B transcription units were 
inserted into chromosome 19 of the HEK cells (Graham et al., 1977; Louis et 
al., 1997). The incorporation of Ad5 DNA not only immortalised the cells, but 
also meant that they could be used as hosts for the generation of recombinant 
adenoviral vectors that lack the E1 cassette, making them replication-
incompetent (Schaack et al., 1996). More recently they have been utilised as a 
host for expression of recombinant proteins. HEK 293T cells are a variation of 
the original HEK cells that contain and express the simian virus 40 (SV40) large 
T antigen. The large T antigen facilitates the replication of vectors containing 
the SV40 origin of replication, leading to very high plasmid copy numbers and 
greater levels of expression (Du Bridge et al., 1986; Rio et al., 1985).  
 
2.3 Methods 
2.3.1 Heat shock transformation of competent E. coli  
Competent E. coli DH5-α cells (NEB5-α; New England Biolabs) were gently 
thawed on ice and 50 μL transferred to a pre-chilled, sterile 1.5 mL tube. 50 ng 
of plasmid DNA containing a suitable antibiotic resistance cassette (typically 
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ampicillin resistance) was added to the cells and mixed gently. The cells were 
then incubated on ice for 30 minutes prior to being heat-shocked at 42 °C for 
50 seconds in a dry block heater. The cells were immediately returned to the 
ice for further 5 minutes. A 900 μL volume of SOC media (2% Vegetable 
Peptone, 0.5% Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM 
MgSO4, 20 mM Glucose) (New England Biolabs) was added to the cells, which 
were placed in a shaking incubator at 37 °C, 250 rpm, for 1 hour. A 100 μL 
volume of the cells was spread onto LB (Luria-Bertani) agar (Fisher Scientific) 
containing the appropriate antibiotic (typically 50 μg/mL ampicillin). LB agar 
plates were incubated upside down overnight at 37 °C, and colonies were 
subsequently picked to construct overnight cultures. 
 
2.3.2 Construction of overnight E. coli cultures 
Following E. coli transformation, single colonies were picked using sterile 
pipette tips. Tips were immediately placed into 20 mL sterile tubes containing 6 
mL Luria-Bertani broth (LB broth) supplemented with the appropriate antibiotic 
(typically 50 μg/mL ampicillin). The lid of the tubes were placed loosely on top 
and taped in position. Tubes were then placed in a shaking incubator at 37 °C, 
250 rpm, overnight (but for no longer than 16 hours).  
 
2.3.3 Construction of DH5α E. coli glycerol stocks 
A 1125 μL volume of E. coli overnight culture (2.3.2) was added to a sterile 
screw-cap 2.0 mL tube. A 375 μL volume of 60% glycerol (autoclaved and 
sterile filtered) was added to the tube, which was briefly vortexed. The tube 
was snap-frozen in liquid nitrogen prior to being transferred to an -80 °C 
freezer. 
 
2.3.4 Preparation of plasmid DNA from E. coli 
Plasmid DNA was typically purified from E. coli overnight cultures using the 
PureYield miniprep kit (Promega) following the manufacturer’s protocol for a 6 
mL bacterial culture (appendix 1). For large-scale plasmid DNA preparation for 
transient transfection, the Plasmid Plus Mega kit (QIAGEN) was used, following 
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the manufacturer’s protocol (appendix 1). In all cases, plasmid DNA was eluted 
using ultrapure deionised water. 
 
2.3.5 Agarose gel electrophoresis 
Agarose gels (1% (w/v)) were used to verify DNA and PCR products by 
separation through size. Typically, Tris-borate-EDTA (TBE) gels were used for 
analytical gels and Tris-acetate-EDTA (TAE) gels were used for DNA preparation 
as they allow for higher extracted yields. Agarose powder was resuspended in 
either TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA), or TAE buffer 
(40 mM Tris, 20 mM acetic acid, 1 mM EDTA) to give a 1% (w/v) solution in a 
conical flask and heated briefly using a microwave until the agarose had 
dissolved. Molten agarose was poured into a gel cast and a comb inserted 
(typically 10 teeth, 1 mm thickness). Once set, gels were placed into an 
electrophoresis tank and covered with buffer (TBE or TAE). Approximately 100 
ng of DNA sample was made up to a volume of 15 μL using deionised water, to 
which 5 μL STEB buffer (40% (w/v) sucrose, 10 mM Tris-HCl pH 7.4, 1 mM 
EDTA, 0.25% bromophenol blue) was added. Samples were loaded including a 
DNA marker for size quantification (typically NEB 1 kb DNA ladder). Samples 
were electrophoresed towards the anode at 100 V until the dye front had 
migrated to the desired position (bromophenol blue migrates at approximately 
400-500 bp on a 1% agarose gel). Gels were then placed in 1 × SyBr Safe 
solution for 30 minutes on a rocking platform before being visualised using a 
FLA-5000 phosphorimager (Fujifilm).  
 
2.3.6 Ligase independent In-Fusion cloning  
Protein coding sequences were cloned into the pOPINTTG expression vector 
(section 2.3.6.1) for HEK 293 cell expression, using the In-Fusion ligase 
independent cloning kit (Clontech). See appendix 2 for the full pOPINTTG 
sequence. Figure 2.1 shows an overview of the In-Fusion cloning protocol. 
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Figure 2.1 Overview of the In-Fusion cloning protocol. 
1. Primers were designed to amplify the desired sequence from the parent vector and to 
include 15 base pair extensions on each side that were complementary to the ends of the 
linearised recipient vector. 2. The recipient vector was linearised via restriction endonuclease 
double-digest. 3. The linear recipient vector and the insert were added to the In-Fusion 
reaction, which includes a proofreading exonuclease that generates complementary 15 base 
overhangs in both the insert and vector. These are hybridised to form a complete (nicked) 
recombinant plasmid. 4. The plasmid was then used to transform competent E. coli, which were 
subsequently plated on selective media to generate colonies. 
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2.3.6.1 pOPIN vectors 
The pOPIN vectors were developed at the OPPF for high-throughput expression 
screening of proteins in a range of expression systems (Berrow et al., 2009) 
and are based on the pTriEx2 mammalian expression vector (Novagen). Figure 
2.2 shows the pOPINTTG vector that was designed for expression of proteins in 
HEK 293T cells and was used for the expression of SAP (kindly gifted by Prof. 
Ray Owens of the Oxford Protein Production Facility, see appendix 2 for the full 
sequence).  
 
Protein expression is under the control of the hybrid CMV and Chicken β-actin 
promoter/enhancer combination (CAG promoter), which has been shown to 
provide strong levels of expression in eukaryotic cells (Miyazaki et al., 1989). 
This is coupled with a high plasmid copy number in HEK 293T cells, as the 
plasmid contains the SV40 origin of replication. pOPINTTG encodes the μ-
phosphatase (RPTPμ) secretion signal peptide at the N-terminus, which allows 
secretion of the protein from the cell and is cleaved upon exit by eukaryotic 
signal peptidase. The RPTPμ signal peptide has been previously shown to 
provide high levels of secreted protein using HEK 293 cells (Aricescu et al., 
2006; Berrow et al., 2007). The pOPINTTG plasmid also encodes a C-terminal 
His-tag that can be used for immobilised metal-affinity chromatography (IMAC) 
of the secreted protein.  
 
The template plasmid containing the SAP coding sequence used to clone into 
the pOPINTTG vector was designed and kindly gifted by Dr. Raj Gill of the 
Centre for Amyloidosis & Acute Phase Proteins, University College London.  
 
2.3.6.2 pOPINTTG restriction endonuclease double digest 
The recipient plasmid pOPINTTG was first linearised by digesting using the 
restriction endonucleases KpnI (NEB) and PmeI (NEB). To set up a double 
digest, a volume of plasmid DNA corresponding to 2 μg was added to 5 μL NEB 
CutSmart buffer and the volume made up to 46 μL using deionised water. The 
solution was mixed thoroughly and 2 μL of each enzyme (10,000 U/mL) added 
prior to incubating at 37 °C for 1 hour.   
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Figure 2.2 Plasmid map showing the pOPINTTG vector including the cloning site and 
μ-phosphatase signal peptide. 
The pOPINTTG vector was designed for protein expression in HEK 293T cells, encoding an N-
terminal secretion signal peptide and C-terminal His-tag. When linearised by restriction 
endonucleases KpnI and PmeI, In-Fusion cloning was used to insert the protein coding DNA. 
The start codon is highlighted in green, and the signal peptide-coding region is shown in bold. 
The underlined sections mark the complementary flanking regions added to the 5’ and 3’ ends 
of the insert (figure 2.1). The His-tag coding region and stop codon are highlighted in yellow 
and red, respectively. The N-terminal signal peptide allows the secretion of the protein from the 
cell into the media. Upon exit, the peptide is cleaved at the marked position by eukaryotic 
signal peptidase enzyme.      
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After incubation, 10 μL NEB purple loading dye was added (which includes 
EDTA to inhibit the digestion) and the reaction was loaded onto a 1% (w/v) 
TAE agarose gel across three lanes and electrophoresed (described in section 
2.3.5). After staining with SyBr Safe stain, the gel was visualised using a Dark 
Reader transilluminator (Clare Chemical Research), the bands corresponding to 
linearised plasmid were excised and the DNA purified from the gel fragments. 
 
2.3.6.3 Agarose gel DNA purification 
DNA was purified using the NucleoSpin Gel and PCR Clean-up kit (Macherey-
Nagel). Prior to elution, the elution buffer NE was heated to 70 °C using a dry 
block heater, as per the manufacturer’s instructions, in order to increase the 
DNA yield. A 20 μL volume was loaded onto the column, which was also 
incubated at 70 °C for 5 minutes before centrifuging first at 50 × g for 1 minute 
and then 11,000 × g for 1 minute at room temperature to elute the DNA. The 
DNA concentration of the eluent was quantified using UV spectrophotometry 
assuming 50 ng/μL = 1 absorbance unit (260 nm). 
 
2.3.6.4 PCR amplification of insert 
PCR master mix was constructed comprising 25 μL 2 × Phusion Flash master 
mix (Thermo Scientific), 17 μL deionised water and 2 μL template plasmid (20 
ng/μL) per reaction. A 44 μL volume was aliquoted into individual PCR tubes 
followed by 3 μL 10 μM forward primer and 3 μL 10 μM reverse primer 
(Eurogentec). Samples were placed in a thermocycler, and the following 
program was used: 
 
1. 98 °C for 10 seconds 
2. (98 °C for 1 second, 60 °C for 5 seconds, 72 °C for 15 seconds) × 30 
3. 72 °C for 2 minutes 
4. 4 °C hold 
 
Following the PCR, 5 μL DpnI enzyme (diluted to 1 U/μL in NEB CutSmart 
buffer) was added to each reaction, which were incubated at 37 °C for an hour 
to remove the template DNA. PCR fragments were purified using the 
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NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel) used in section 2.3.6.3. 
Each reaction was mixed with 100 μL buffer NTI and the protocol followed as 
previously described. 
 
2.3.6.5 In-Fusion cloning 
A single In-Fusion EcoDry tube was centrifuged briefly to ensure the powder 
premix was at the bottom of the tube. A 10 μL solution containing 100 ng of 
gel-purified, linearised plasmid and 100 ng of insert dissolved in deionised 
water was used to resuspend the dried reaction premix. The tube was then 
placed in a thermocycler and incubated at 37 °C for 15 minutes, then 50 °C for 
15 minutes. A 2.5 μL volume of the reaction mixture was used to transform 50 
μL Stellar competent cells (Clontech) using the previously described protocol 
(2.3.1). Following the transformation, six colonies were picked and used to 
construct small-scale overnight cultures as previously described (2.3.2). Plasmid 
DNA was subsequently prepared (2.3.4.1) and sent for sequencing (Source 
Bioscience).  
 
2.3.7 Site-directed mutagenesis 
Site-directed mutagenesis was carried out using the QuikChange II site-directed 
mutagenesis kit (Agilent). Forward and reverse mutagenic primers were 
ordered from Eurogentec and designed according to the kit guidelines 
(appendix 3). Reactions were set up using thin-walled PCR tubes and comprised 
125 ng of each primer, 50 ng template pOPINTTG-SAP, 5 μL 10 × reaction 
buffer, 1 μL dNTP mix and deionised water to bring the reaction volume to 50 
μL. Finally, 1 μL Pfu Ultra HF DNA polymerase (2.5 U/μL) was added and 
reactions placed in the thermocycler. The following program was followed:  
 
1. 95 °C for 30 seconds 
2. (95 °C for 30 seconds, 55 °C for 1 minute, 68 °C for 8 minutes) × 16 
3. 37 °C hold 
 
When reactions had reached the 37 °C hold, 1 μL DpnI enzyme (10 U/μL) was 
added and incubated for a further hour at 37 °C. A 1 μL volume of the reaction 
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mixture was used to transform XL1-Blue supercompetent cells (Agilent) 
following the previously described protocol (2.3.1). Following transformation, 
six colonies were picked and used to construct small-scale overnight cultures as 
previously described (2.3.2). Plasmid DNA was subsequently purified (2.3.4.1) 
and sent for sequencing (Source Bioscience). 
 
2.3.8 HEK 293 cell culture 
All HEK 293 cell manipulations were performed using a Class 2 laminar flow 
hood in aseptic conditions. Transient protein expression was performed using 
HEK 293T cells (ATCC) and stably expressing cell lines were produced using 
HEK 293 cells (Sigma-Aldrich). 
 
2.3.8.1 Thawing HEK 293 cell stocks 
A single vial of frozen HEK 293 cells was thawed rapidly in a water bath at 37 
°C. As soon as the contents of the vial were completely thawed, the cells were 
transferred to a sterile 15 mL tube containing 5 mL complete media (DMEM 
(Lonza) with 2 mM L-glutamine (Gibco) and 10% (v/v) heat-inactivated FCS 
(Gibco)). The cells were centrifuged at 180 × g for 5 minutes at 4 °C. The 
supernatant was removed and the cell pellet gently resuspended in 5 mL 
complete media. This was added to a T-75 cell culture flask (75 cm2 growth 
area with a filtered cap) containing a further 10 mL complete media. The flask 
was incubated overnight at 37 °C in a humidified, 5% CO2 atmosphere. The 
next day cells were passaged (if at least approximately 80% confluent, gauged 
by eye) and used to seed a T-175 cell culture flask (175 cm2 growth area with a 
filtered cap). After two passages, stably expressing cell lines were cultured in 
complete media containing 1.25 mg/mL G418 antibiotic (see 2.3.8.3). 
 
2.3.8.2 Maintenance of HEK 293 cells  
HEK 293 cells were maintained in T-175 cell culture flasks and passaged every 
3-4 days when they reach approximately 80% confluence. Spent media was 
removed and replaced with 5 mL PBS (Gibco) to wash the cells. The PBS was 
then removed and replaced with 5 mL trypsin/EDTA (Gibco) to separate the 
cells from the flask. The flask was gently tapped until the cells were completely 
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separated. A 15 mL volume of complete media was added to the cells to 
neutralise the trypsin. To count the cells, a 10 μL sample was first mixed with 
10 μL 0.4% trypan blue stain and applied to a Countess cell counting chamber 
slide (Life Technologies). The sample was subsequently analysed using the 
Countess automated cell counter (Life Technologies). A suspension of 3 × 106 
cells was used to seed a new T-175 flask containing 40 mL complete DMEM.  
 
2.3.8.3 Construction of stably expressing HEK 293 cell lines 
To make stably expressing cell lines, HEK 293 cells were transfected using the 
JetPRIME transfection reagent (Polyplus). HEK 293 cells were used to seed a 
24-well plate (1.8 cm2 growth area) containing 0.5 mL complete media in each 
well. When the cells were approximately 70% confluent they were transfected 
following the JetPRIME manufacturer’s protocol. A volume corresponding to 0.5 
μg plasmid DNA was mixed with 50 μL JetPRIME buffer and vortexed 
thoroughly. A 1 μL volume of JetPRIME reagent was then added and the 
solution vortexed again. The transfection cocktail was incubated at room 
temperature for 10 minutes before it was added to a single well of the 24-well 
plate. The cells were incubated for 4 hours before the media was replaced. 
Once confluent the cells were passaged and used to seed a six-well plate (9.6 
cm2 growth area), each well containing 2 mL complete media and 1.25 mg/mL 
G418.  
 
G418 is an aminoglycoside antibiotic that inhibits protein synthesis and was 
used to select successfully transfected cells. Resistance to G418 is conferred by 
the E. coli transposon Tn5 neo gene (present within the pOPINTTG plasmid. 
Shown as Kan/NeoR in figures 2.2 and 2.4). Once a cell has been transfected 
with the pOPINTTG plasmid, the Tn5 neo gene confers a selective advantage 
upon the cell, allowing it to persist and outcompete non-transfected cells.  
 
The cells were incubated until colonies formed. Several colonies were picked 
(typically approximately 30) and used to seed a 48-well plate, each well 
containing 0.5 mL complete media with 1.25 mg/mL G418. When the cells were 
approximately 70% confluent a small volume of media was taken for western 
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blot analysis to check expression (2.3.11). Successfully expressing cultures 
were then gradually expanded into larger flasks prior to cryopreservation for 
storage (section 2.3.8.6). Stably expressing cell lines were cultured in media 
containing 1.25 mg/mL G418 thereafter. For large-scale expression, cells were 
used to seed four expanded surface roller bottles containing 250 mL complete 
media (Greiner Bio-One) at 37 °C in a humidified, 5% CO2 atmosphere and 
rotated at 0.3 rpm for the first 24 hours after seeding and 1.0 rpm thereafter 
(one confluent T-175 flask was used to seed one roller bottle). The bottles were 
incubated for a week prior to the media being harvested for purification.  
 
2.3.8.4 Small-scale transient expression in HEK 293T cells 
HEK 293T cells were transfected using the JetPRIME transfection reagent 
(Polyplus) as described previously. Cells were transfected in a 24-well plate and 
when confluent, a small volume of media was taken for western blot analysis to 
verify expression (2.3.11). 
 
2.3.8.5 HEK 293T cell transient transfection 
HEK 293T cells were transfected based on the protocol previously described by 
Nettleship et al. (2015). Cells were cultured in four expanded surface roller 
bottles as described in section 2.3.8.3, and were incubated for 4-5 days until 
the cells were approximately 70% confluent. The media was then removed 
from the roller bottles and replaced with 200 mL DMEM containing 2 mM L-
glutamine and 2% (v/v) heat-inactivated FCS. To make the transfection 
cocktail, 200 mL DMEM with 2 mM L-glutamine was divided equally between 
two vessels. To the first, 2 mg plasmid DNA was added and to the second, 3.5 
mL 1 mg/mL polyethylenimine (PEI), pH 7.5. The two solutions were combined 
and incubated at room temperature for 10 minutes. A 50 mL volume of the 
transfection cocktail was subsequently added to each of the four roller bottles, 
which were then incubated at 37 °C, 5% CO2 and rotated at 1.0 rpm for a 
week.      
 
2.3.8.6 Cryopreservation of HEK293 cell lines 
A T-175 flask of HEK 293 cells was passaged as previously described (2.3.8.2) 
and the cells were pelleted by centrifuging at 180 × g for 5 minutes at 4 °C. 
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The cells were resuspended in 2.7 mL cryopreservation media (56% (v/v) heat-
inactivated FCS, 44% DMEM with 2 mM L-glutamine). A 0.9 mL volume of the 
cells was added to three separate sterile cryogenic vials and 0.1 mL DMSO 
(Sigma-Aldrich) was subsequently added. The vials were sealed and inverted to 
mix. The vials were placed in a freezing container and allowed to freeze 
gradually at -80 °C overnight prior to being transferred to liquid nitrogen for 
long-term storage. 
 
2.3.9 Phosphoethanolamine (PE) – affinity purification of SAP 
PE-affinity relies on the calcium-dependent binding of SAP to PE. When the 
SAP-containing HEK cell media is run over the column, SAP binds to the 
immobilised PE and the media washed off. When an EDTA-containing buffer is 
introduced to the column the calcium is removed, thus releasing the SAP. The 
following method was adapted from that previously described by Hawkins et al. 
in 1991. HEK cell DMEM media was pooled and centrifuged at 5000 × g for 15 
minutes. It was then filtered first through a glass fibre filter, then a 0.2 μm 
filter. All subsequent steps were performed using an ÄKTA prime or ÄKTA start 
instrument (GE Healthcare). A 30 mL column containing phosphoethanolamine 
(PE)–sepharose was equilibrated with TC buffer (10 mM Tris-HCl pH 8.0, 150 
mM NaCl and 5 mM CaCl2). The media was flown over the column at 0.5 
mL/min followed by washing off the unbound fraction with TC buffer. SAP was 
eluted with TE buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl and 5 mM EDTA) 
and 1.5 mL fractions were collected. Absorbance at 280 nm was monitored 
throughout and fractions corresponding to a peak in absorbance were analysed 
via SDS-PAGE.   
 
2.3.10 Denaturing polyacrylamide gel electrophoresis (SDS-
PAGE) 
Polyacrylamide minigel tank (ATTO AE-6500 Dual Mini Slab) cassettes were 
cleaned and assembled. A 12% polyacrylamide resolving gel (30% (v/v) 
acrylamide/bis 19:1 40% (w/v), 375 mM Tris-HCl pH 8.8, 0.1% (w/v) SDS, 
0.1% (w/v) ammonium persulphate, 0.1% tetramethylethylenediamine 
(TEMED), 1 mm thickness) was poured between the gel plates to approximately 
 53 
1.5 cm below the bottom of the comb. Water-saturated butanol was layered on 
top of the gel to ensure an even surface to the resolving layer. Once set, the 
butanol was removed and the gel rinsed with deionised water before pouring 
on the 5% stacking gel solution (12.5% (v/v) acrylamide/bis 19:1 40% (w/v), 
126 mM Tris-HCl pH 6.8, 0.1% (w/v) SDS, 0.1% (w/v) ammonium persulphate, 
0.1% TEMED) to just below the top of the gel plates. The comb (typically 12 
teeth, 1 mm thickness) was then inserted and the gel allowed to set. Once set, 
the clamps, spacer and comb were removed and the gel secured in the 
electrophoresis tank. The upper and lower reservoirs were filled with SDS-PAGE 
running buffer (25 mM Tris-HCl pH 8.3, 250 mM glycine, 3.5 mM SDS) and the 
wells were rinsed thoroughly with a syringe and 21-gauge needle to remove all 
acrylamide particles. The protein sample (typically 5 μL HEK 293 cell media or 5 
μL purified protein eluate) was mixed with 10 μL SDS-PAGE loading buffer (50 
mM Tris-HCl pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 95 mM β-
mercaptoethanol, 0.2% (w/v) bromophenol blue) and heated to 90 °C in a dry 
block heater for 3 minutes to ensure denaturation of the protein. Samples were 
then loaded onto the gel using gel-loading pipette tips, including a protein 
marker for size quantification (typically Precision Plus Protein Dual Colour 
Standard - Bio-Rad) (appendix 4). Samples were electrophoresed towards the 
anode at 80 V until the dye front reached the resolving gel, at which point the 
voltage was increased to 150 V and electrophoresed until the dye front reached 
the bottom of the gel. The gel was carefully removed from the glass plates and 
placed in a container for staining. The gel was covered with Coomassie stain 
(0.01% (w/v) Coomassie R-250, 30% (v/v) methanol, 10% (v/v) acetic acid) 
and placed on a rocking platform for 1 hour. The staining solution was then 
removed and replaced with destain solution (10% (v/v) methanol, 10% (v/v) 
acetic acid). The container was placed back on the rocking platform and the 
destain replaced after 10 minutes. The gel was destained overnight and 
visualised the following day. 
 
2.3.11 Western blot 
Denaturing polyacrylamide gel electrophoresis was performed as described 
above (2.3.10). following electrophoresis, the gel was carefully removed from 
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the glass plates and placed within the western blot cassette as shown in figure 
2.3. The casing was clipped together and placed into the electrophoresis tank, 
which was filled with transfer buffer (25 mM Tris-HCl pH 8.3, 250 mM glycine, 
3.5 mM SDS, 20% (v/v) methanol) to cover the cassette. Electrophoresis 
proceeded at 100 V for 1 hour, and the membrane was subsequently removed 
and rinsed with deionised water. The membrane was inserted into a 50 mL 
centrifuge tube, which was then filled with TBST-Marvel blocking solution (20 
mM Tris-HCl pH 7.5, 10 mM NaCl, 0.05% (w/v) Tween 20, 5% (w/v) Marvel 
milk powder) and placed on a rolling platform for 1 hour (all subsequent 
washes were performed using a rolling platform). The blocking solution was 
removed and replaced with 10 mL primary antibody solution (20 mM Tris-HCl 
pH 7.5, 10 mM NaCl, 0.05% (w/v) Tween 20, 2% (w/v) Marvel milk powder, 
0.02% (v/v) primary antibody) and washed for 2 hours. Typically, a polyclonal 
rabbit anti-human SAP antibody was used (gifted by Prof. Mark Pepys of the 
Centre for Amyloidosis & Acute Phase Proteins, University College London). The 
membrane was then washed three times with 5 mL blocking solution, prior to 
replacing with 10 mL secondary antibody solution (20 mM Tris-HCl pH 7.5, 10 
mM NaCl, 0.05% (w/v) Tween 20, 2% (w/v) Marvel milk powder, 0.01% (v/v) 
secondary antibody solution) and washing for 1 hour. A goat anti-rabbit HRP-
conjugated secondary antibody (Sigma-Aldrich) was used. The membrane was 
then given a further three, 5-minute washes with blocking solution. The 
membrane was subsequently washed twice for 5 minutes with TBST (20 mM 
Tris-HCl pH 7.5, 10 mM NaCl, 0.05% (w/v) Tween 20) and three times for 5 
minutes with PBS (137 mM NaCl, 2.7 mM KCl, 8.16 mM disodium phosphate). 
Chemiluminescence (CL) solutions A (100 mM Tris-HCl pH 8.5, 2.5 mM luminol, 
0.396 mM p-coumaric acid) and B (100 mM Tris-HCl pH 8.5, 0.036% (v/v) H2O2) 
were mixed together in equal volumes and pipetted onto the surface of the 
membrane. The membrane was incubated for 30 seconds prior to detection 
using the ImageQuant LAS-4000 (GE Healthcare Life Sciences).    
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Figure 2.3 Construction of the western blot cassette. 
All elements of the western blot cassette (apart from the polyacrylamide gel and cassette 
casing) were soaked in transfer buffer prior to assembly. The PVDF membrane is hydrophobic 
and was therefore rinsed with methanol to hydrate prior to soaking with transfer buffer.  
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2.3.12 Analytical size-exclusion chromatography 
Size exclusion chromatography separates proteins by size and shape. Smaller 
proteins take longer to pass through the size exclusion resin and hence, have 
larger elution volumes than larger proteins. If a protein is correctly folded and 
homogeneous, a single peak is usually observed. Analytical size exclusion 
chromatography was performed using an ÄKTA basic instrument (GE 
Healthcare). A Superose 12 10/300 GL column (GE Healthcare Life Sciences, 
separation range: 1 kDa – 300 kDa, exclusion limit: 2000 kDa, void volume: 7.9 
mL) was equilibrated with TE buffer at a flow rate of 0.8 mL/min until a stable 
UV absorbance baseline at 280 nm was reached. A 200 μL volume sample loop 
was attached to the ÄKTA and flushed through thoroughly with TE buffer. A 50 
μL volume of SAP solution at approximately 1 mg/mL was briefly centrifuged at 
maximum speed in a microcentrifuge to pellet any insoluble particulates prior to 
loading into the sample loop, ensuring that all air was ejected. The sample was 
injected onto the column and TE flown through at a flow rate of 0.8 mL/min for 
1.5 column volumes (45 minutes, 36 mL). The UV absorbance at 280 nm was 
recoded throughout, and a pressure limit of 1.0 MPa was set to ensure the 
resin was not crushed.      
 
2.4 Results 
2.4.1 Cloning of the SAP sequence into the pOPINTTG vector 
The SAP coding sequence was cloned into the pOPINTTG vector as described in 
section 2.3.6, using PCR primers that were designed according to the OPPF 
protocol (appendix 5). IMAC was not required however, for SAP purification, as 
a robust method for affinity purification of SAP utilising the calcium-dependent 
binding of SAP to PE was already in place (2.3.9). The His-tag was therefore 
removed by including a stop codon in the reverse primer used to clone the SAP 
sequence into the pOPINTTG vector (appendix 5), terminating translation after 
the SAP coding sequence, prior to the His-tag.  
 
The resulting plasmid DNA was sent to Source Bioscience for sequencing using 
the pTT_fwd sequencing primer for pOPINTTG, the results of which are shown 
in appendix 6, and a map of the pOPINTTG-SAP vector is shown in figure 2.4.  
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Figure 2.4 Plasmid map showing the SAP sequence cloned into the pOPINTTG 
vector. 
SAP encoding DNA was cloned into the pOPINTTG vector (figure 2.2) using In-Fusion cloning. 
The start codon is highlighted in green, and the signal peptide-encoding region is shown in 
bold. The SAP encoding DNA is coloured grey and ends with the stop codon ‘TGA’, which was 
incorporated via the reverse primer used for cloning. This stop codon removes the His-tag, 
which was not required for purification. 
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An aliquot of transformed E. coli was used to make permanent glycerol stocks 
(section 2.3.3). 
 
2.4.2 SAP mutagenesis 
In order to pinpoint the amino acids that are involved in DNA binding, 
orthologous SAP peptide sequences were aligned with the human SAP 
sequence. Wang et al. showed that murine SAP does not interact with DNA 
despite its similarity to the human orthologue (Wang et al., 2011). Figure 2.5 
shows the peptide sequence of human, chimpanzee and gorilla SAP aligned 
against that of other mammals to highlight the differences. The positively 
charged amino acids arginine, lysine and histidine were specifically targeted as 
they can interact with the negatively charged sugar-phosphate backbone of 
DNA. These residues typically have an important role in protein-DNA 
interactions, particularly in sequence-independent DNA binding, as observed in 
the histone-DNA interaction (Luger & Richmond, 1998). By aligning the 
orthologue sequences, five specific amino acids were highlighted as potential 
targets for investigation. These residues were mutated individually to glutamine 
using site-directed mutagenesis to provide five separate SAP mutants: R77Q, 
H78Q, K87Q, K143Q and R193Q. 
 
When undertaking mutational analyses, alanine scanning is typically used 
because it removes the entire side chain of the target residue up to the β-
carbon (Cunningham & Wells, 1989). It was thought, however, that replacing a 
charged amino acid for an alanine, which is hydrophobic and contains only a 
methyl group side chain, could destabilise the protein and lead to low levels of 
expression. Glutamine was therefore chosen as a suitable replacement because 
although it has no charge, it has a polar side chain of a more comparable size 
to arginine, lysine and histidine.  
 
Mutagenic primers were designed according to the Quick-Change II kit protocol 
(appendix 7) and the mutagenesis performed as described in section 2.3.7.  
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Figure 2.5 SAP orthologue peptide sequence alignment. 
The human SAP peptide sequence was aligned with that of other primates (chimpanzee and 
gorilla) and also other mammals to highlight which positively charged amino acids are not 
conserved throughout all species. Amino acids highlighted in red are perfectly conserved 
whereas those not highlighted show variation. The five residues marked with red arrows are 
positively charged in humans and conserved in the primates, but not throughout the other 
mammals. Arg 77, His 78, Lys 87, Lys 143 and Arg 193 were therefore chosen for mutational 
analysis. This figure was produced using Clustal Omega (Krissinel & Henrick, 2004) and ESPript 
3.0 (Robert & Gouet, 2014).  
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The resulting plasmid DNA was sent for sequencing (Source Bioscience), the 
results of which are shown in appendix 8 and an aliquot of transformed E. coli 
for each mutant was used to make permanent glycerol stocks (section 2.3.3). 
 
2.4.3 SAP expression and purification 
2.4.3.1 Native sequence SAP expression 
A stably expressing HEK 293 cell line was constructed  for the production of 
native sequence SAP as it was anticipated that a large amount of native 
sequence SAP would be needed for other studies. Although stable cell lines are 
initially more labour intensive and time-consuming to set up than transiently 
expressing cell lines, once complete, they continually express protein without 
the need for re-transfection. Using the pOPINTTG-SAP vector, HEK 293 cells 
were transfected as described in section 2.3.8.3. A total of 34 colonies were 
picked and small-scale cultures set up in 24-well plates for expression 
screening, the results are shown in figure 2.6.  
 
Of the three strongest expressing clones that were selected (17, 18 and 19), 
only clone 19 survived. Clone 19 appeared to express SAP at slightly reduced 
levels compared to that of clones 18 and 19, indicating that high concentrations 
of SAP (or increased expression) may be the cause of cell death. Clone 19 was 
subsequently scaled up and batch-cultured so that aliquots could be cryocooled 
to make permanent stocks as described in section 2.3.8.6. Clone 19 was then 
used to seed roller bottles for large-scale expression. The media was harvested 
after a week and the SAP purified via PE-affinity chromatography (section 
2.3.9). Figure 2.7 shows the purification of native sequence SAP and 
subsequent verification of the eluted fractions analysed using an overloaded 
SDS-PAGE gel (section 2.3.10). The gel showed that the eluted protein 
appeared to be free of other contaminating proteins, eliminating the need for 
downstream polishing such as preparative size exclusion chromatography. A 
small volume was, however, assayed for purity using analytical size exclusion 
chromatography (gel filtration) as described in section 2.3.12, and the result is 
shown in Figure 2.8. Gel filtration confirmed that no further purification was 
necessary and that the native protein appeared to be correctly folded.  
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Figure 2.6 Screening of native sequence SAP expressing clones.  
A 5 μL volume of media was taken from each of 34 of the small-scale cultures and used for 
western blot analysis using 90 ng of ex vivo human SAP as a control. Polyclonal rabbit anti-
human SAP primary antibody was used followed by an HRP-conjugated goat ant-rabbit 
secondary antibody.  
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Figure 2.7 Purification of native sequence SAP. 
Recombinant native sequence SAP was purified from HEK cell media by PE-affinity purification 
(A), and fractions corresponding to a peak in absorbance at 280 nm were analysed by SDS-
PAGE on a 12% gel (B). The samples were overloaded so that any contaminating proteins 
could be visualised. 
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Figure 2.8 Analytical size exclusion chromatography of ex vivo and recombinant 
native sequence SAP. 
Purified recombinant native sequence SAP (blue) was analysed using size exclusion 
chromatography and compared to ex vivo human SAP (red). The chromatograph shows the 
recombinant protein elutes at the same volume, and has the same shaped peak as that 
corresponding to the ex vivo protein.  
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Size exclusion chromatography was also performed using ex vivo human SAP 
for comparison. The chromatograph shows that the recombinant protein eluted 
at the same volume as the ex vivo protein, indicating that the recombinant 
protein is very similar to the ex vivo protein. The ex vivo SAP appeared to 
contain a small amount of impurity, indicated by the small peak at 
approximately 18 mL. This may be degraded protein due to the age of the 
sample.  
2.4.3.2 Mutant SAP expression 
Prior to large-scale transient expression of the SAP mutants in HEK 293T cells, 
small-scale expression screens were performed as described in section 2.3.8.4. 
Figure 2.9 shows the results of these screens, using native sequence SAP as an 
expression control. All mutants expressed comparably to the native sequence 
protein and therefore large-scale transient expression was pursued.  
 
Following a week of expression (section 2.3.8.5), the mutants were purified by 
PE-affinity purification and the fractions analysed by SDS-PAGE (figures 2.10-
2.14). All of the mutants appeared to be free of impurities with the exception of 
K143Q, for which bands corresponding to higher molecular weight proteins 
were observed (figure 2.13). High levels of expression of the K143Q mutant 
seemed to lead to aggregation in some of the most concentrated fractions. 
When the fractions were pooled however, the aggregated protein dissolved 
back into solution, and no higher molecular weight proteins were observed 
following analytical size exclusion chromatography (figure 2.15). All of the 
mutants were subsequently verified using analytical size exclusion 
chromatography and compared to the recombinant native sequence protein. 
Figure 2.15 shows that each mutant eluted at the same volume as the native 
sequence protein, and the samples contained no other contaminating proteins. 
The single peak indicates that all mutants were expressed and folded correctly.  
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Figure 2.9 Small-scale expression screening of SAP mutants. 
Small-scale screens were performed on each of the SAP mutants to test expression prior to 
scaling up to large-scale transient expression in roller bottles. A 5 μL volume of media was 
taken from each transfected culture for western blot analysis, and 90 ng of ex vivo human SAP 
was used as a control. Polyclonal rabbit anti-human SAP primary antibody was used followed by 
an HRP-conjugated goat ant-rabbit secondary antibody.  
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Figure 2.10 Purification of the R77Q SAP mutant. 
The R77Q mutant was purified from HEK cell media by PE-affinity purification (A), and the 
fractions were subsequently analysed by SDS-PAGE on a 12% gel (B). The samples were 
overloaded so that any contaminating proteins could be visualised. 
 
  
 67 
 
 
Figure 2.11 Purification of the H78Q SAP mutant. 
The H78Q mutant was purified from HEK cell media by PE-affinity purification (A), and the 
fractions were subsequently analysed by SDS-PAGE on a 12% gel (B). The samples were 
overloaded so that any contaminating proteins could be visualised. 
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Figure 2.12 Purification of the K87Q SAP mutant. 
The K87Q mutant was purified from HEK cell media by PE-affinity purification (A), and the 
fractions were subsequently analysed by SDS-PAGE on a 12% gel (B). The samples were 
overloaded so that any contaminating proteins could be visualised. 
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Figure 2.13 Purification of the K143Q SAP mutant. 
The K143Q mutant was purified from HEK cell media by PE-affinity purification (A), and the 
fractions were subsequently analysed by SDS-PAGE on a 12% gel (B). The samples were 
overloaded so that any contaminating proteins could be visualised. 
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Figure 2.14 Purification of the R193Q SAP mutant. 
The R193Q mutant was purified from HEK cell media by PE-affinity purification (A). Due to high 
levels of expression, the absorbance of the protein at 280 nm exceeded the limit of the 
detector; hence a flattened peak is observed. As previously observed with the K143Q mutant, 
aggregation was visible in some of the most concentrated fractions. Therefore, the fractions 
were pooled to allow the aggregate to dissolve back into solution, and dilutions of the sample 
were analysed by SDS-PAGE on a 12% gel (B). Lane 1 contained the undiluted sample, 
followed by 2×, 4× and 8× dilutions in wells 2, 3 and 4, respectively. The samples were 
overloaded so that any contaminating proteins could be visualised. 
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Figure 2.15 Analytical size exclusion chromatography of SAP mutants. 
Following affinity purification, all SAP mutants were analysed via size exclusion chromatography 
and compared to recombinant native sequence SAP. All proteins appeared to elute at the same 
volume and had the same shaped peak. N.B. The contaminating bands visible following SDS-
PAGE of the K143Q SAP mutant (figure 2.13) were not observed following gel filtration, for 
which the protein was completely soluble. 
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2.5 Discussion 
Using ligase-independent In-Fusion cloning, the SAP coding sequence was 
successfully cloned into the pOPINTTG vector for expression in HEK 293 cells. 
The pOPINTTG-SAP construct subsequently formed the template for site-
directed mutagenesis to produce five more constructs for mutant SAP 
expression. The amino acids selected for mutation were highlighted as 
potentially important residues involved in the SAP-DNA interaction by 
comparing the human SAP peptide sequence with orthologous SAP sequences.  
 
A HEK 293 cell line that stably expresses native sequence SAP was constructed 
and the culture scaled up to seed roller bottles for large-scale protein 
expression. The SAP was successfully purified by PE-affinity purification, and 
the quality of the sample was verified by SDS-PAGE and analytical size 
exclusion chromatography.  
 
The SAP mutants (R77Q, H78Q, K87Q, K143Q and R193Q) were expressed via 
large-scale transient expression in HEK 293T cells. They were each purified by 
PE-affinity chromatography and the samples compared to the native sequence 
protein. SDS-PAGE and analytical size exclusion chromatography indicated that 
all mutants were pure and similar to ex vivo SAP with the exception of the 
K143Q mutant, which initially appeared to contain higher molecular weight 
contaminants. For the K143Q mutant, several of the fractions eluted following 
PE-affinity purification (corresponding to the greatest absorbance at 280 nm) 
appeared to contain precipitated protein. It was thought that this aggregate 
was not adequately denatured during the preparation of the sample for SDS-
PAGE analysis, therefore leading to the bands corresponding to higher 
molecular weight protein in figure 2.13. Once the fractions were pooled, the 
protein appeared to re-solubilise, and the higher molecular weight 
contaminants were not observed following analytical size exclusion 
chromatography.  
 
All proteins were expressed using the pOPINTTG plasmid, which encodes the 
RPTPμ signal peptide at the N-terminus. Upon expression, this signal peptide is 
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cleaved, with the exception of three residues (Glu-Thr-Gly), resulting in a non-
native N-terminal extension on each SAP monomer. Mass spectrometry could 
be performed in order to confirm that this is the case. In future experiments 
the RPTPμ signal peptide could be replaced with the native SAP signal peptide 
in order to remove the non-native residues. 
 
The total yield (in milligrammes of protein per litre of cell culture media) for 
each protein preparation described in section 2.4.3 are as follows: native 
sequence SAP – 11 mg/L, R77Q SAP – 5 mg/L, H78Q SAP – 2 mg/L, K87Q SAP 
– 10 mg/L, K143Q SAP – 27 mg/L and R193Q SAP – 23 mg/L. All proteins 
produced were expressed and purified in sufficient quantities and to sufficient 
purity for subsequent biophysical analysis of SAP-DNA binding (chapter 3), 
structural analysis of recombinant SAP and SAP-DNA complexes (chapter 4) and 
biophysical characterisation of SAP-nucleosome binding (chapter 5).   
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3. Analysis of SAP-DNA binding 
 
3.1 Overview 
It has been well documented that SAP binds to nucleic acids and chromatin 
(Butler et al., 1990; Pepys & Butler, 1987) but details about the specificity and 
strength of the interaction are largely unknown. Several biophysical methods 
were therefore used, including electrophoretic mobility shift assays (EMSA), 
switchSENSE and sedimentation velocity analytical ultracentrifugation (SV-AUC), 
to investigate the affinity, kinetics and stoichiometry of SAP-DNA binding. The 
information gained from these experiments was subsequently used to direct 
crystallisation screens for the SAP-DNA complex.  
 
Electrophoretic mobility shift assays (EMSA) were primarily used to determine 
the affinity of native sequence SAP for double stranded DNA using a range of 
DNA sequences and lengths. This work was subsequently extended by using 
switchSENSE (section 3.2.4) in order to analyse the kinetics of DNA binding by 
SAP.  
 
Once the affinity and specificity of the interaction had been determined with 
native sequence SAP, mutational analysis was used to investigate the specific 
amino acids involved in DNA binding. As described in the previous chapter, 
orthologous SAP peptide sequences were aligned with the human SAP 
sequence to determine conserved residues that might be involved. Five specific 
amino acids - Arg 77, His 78, Lys 87, Lys 143 and Arg 193 - were highlighted as 
potential targets for investigation.  
 
Finally, sedimentation velocity analytical ultracentrifugation (SV-AUC) was used 
to determine the stoichiometry of SAP-DNA binding. This was important not 
only to understand the nature of the SAP-DNA complex, but also for the 
construction of crystallisation screens that might yield crystals of the SAP-DNA 
complex for structural analysis (chapter 4). 
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3.2 Methods 
3.2.1 32P end-labelling of DNA  
Single-stranded DNA oligomers (shown in table 3.1) of 10, 15, 20, 25, 30 or 40 
nucleotides in length and 25, 50 or 75% G+C content (Eurogentec) were 
dissolved in annealing buffer (10 mM Tris-HCl pH 8, 140 mM NaCl) and the 
concentration estimated by UV spectrophotometry assuming 33 ng/μL = 1 
absorbance unit (260 nm). Equimolar amounts of the complementary strand 
were added and the sample heated at 90 °C for 10 minutes and left to cool at 
room temperature overnight. Duplexes were gel-purified and ethanol 
precipitated (section 3.2.2) before being re-solubilised in deionised water and 
the concentration estimated by UV spectrophotometry assuming 50 ng/μL = 1 
absorbance unit (260 nm). Approximately 5 μg oligonucleotide was mixed with 
10 U T4 polynucleotide kinase and 10 μCi [γ-32P] ATP in PNK buffer [(70 mM 
Tris-HCl pH 7.6, 10 mM MgCl2, 5 mM DTT) New England Biolabs] and incubated 
at 37 °C for 30 minutes. The unincorporated [γ-32P] ATP was then removed 
using G-25 spin columns (GE Healthcare) and the dsDNA concentration again 
estimated by UV spectrophotometry.  
 
3.2.2 Gel-purification and ethanol precipitation 
Polyacrylamide midi-gels (16%) were constructed using TBE buffer (89 mM 
Tris-borate, pH 8.3, 2 mM EDTA). The wells were cleaned thoroughly and the 
gel was pre-electrophoresed for 1 hour prior to loading samples. Concentrated 
orange G loading buffer (50% glycerol, 100 mM EDTA, 0.125% (w/v) orange G) 
was added to the DNA sample in a 1:4 ratio and sample was then loaded across 
several lanes. Samples were electrophoresed towards the anode at 100 V for 5 
hours and subsequently stained in 50 μg/mL ethidium bromide solution for 30 
minutes on a rocking platform. Gels was visualised on a Dark Reader 
transilluminator (Clare Chemical Research) and duplex DNA excised. Excised 
polyacrylamide segments were crushed into small fragments and placed into a 
sterile tube and covered with elution buffer (10 mM Tris-HCl pH 8.5). Gel 
fragments were shaken at 2000 rpm overnight at 4 °C on a shaking platform.  
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The following day, the elution buffer was transferred to a separate tube and 
replaced with absolute ethanol. This was placed back on a shaking platform 
until the gel fragments had been entirely dehydrated, at which point the 
ethanol was removed and added to the previously aspirated elution buffer. 
 
Ethanol precipitation was performed by adding 0.1 volumes 3 M sodium acetate 
pH 5.2 and 3 volumes ice-cold absolute ethanol to the sample. The sample was 
then incubated at -20 °C overnight before centrifuging at 27,000 × g at 4 °C 
for 30 minutes. The supernatant was removed and replaced with 1 mL ice-cold 
70% (v/v) ethanol to remove precipitated salt. The sample was again 
centrifuged at 27,000 × g at 4 °C for 30 minutes and the supernatant 
subsequently removed being careful not to disturb the pellet. The tube was 
incubated horizontally at room temperature to allow the pellet to air-dry before 
dissolving the pellet in the desired buffer.     
 
3.2.3 Electrophoretic mobility-shift assay (EMSA) 
3.2.3.1 Background 
The electrophoretic mobility shift assay is a sensitive method for quantitative 
analysis of protein-DNA interactions. Although the separation of free and bound 
DNA species had previously been described (Bakayeva & Bakayev, 1978), 
quantitative analysis of these interactions using EMSA was first described in 
1981 (Fried & Crothers, 1981; Garner & Revzin, 1981). The EMSA is based on 
the separation of DNA and DNA-protein complexes by their differing 
electrophoretic mobility in a polyacrylamide gel matrix. In most cases, free DNA 
will rapidly migrate through a polyacrylamide gel towards a positive charge 
much faster than DNA in complex with protein (figure 3.1). Free and bound 
DNA can then be identified using either a DNA stain, or the DNA can be labelled 
fluorescently or radioactively for a more sensitive and quantifiable approach. 
For the experiments described in this thesis DNA was radioactively labelled by 
incorporating a 5’ Adenosine triphosphate (ATP) that contained a γ-32P group. 
The 32P isotope is commonly used for labelling DNA due to its high emission 
energy (allowing the detection of small quantities of DNA), and because it can 
be readily incorporated into the sugar-phosphate backbone. 
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Figure 3.1 An overview of EMSA analysis. 
Samples containing a fixed concentration of DNA and an increasing concentration of protein are 
electrophoresed on a low percentage polyacrylamide gel (A). The DNA that is not bound to 
protein migrates more rapidly than bound DNA, which migrates to a fixed position. Bound and 
free DNA can then be quantified and plotted with respect to protein concentration (B) to obtain 
the Kd.   
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Most commonly, EMSA are used for the determination of the equilibrium 
dissociation constant (Kd) of protein-DNA complexes, which is a measure of the 
strength of the interaction. The Kd corresponds to the ratio between the molar 
concentrations of free reactants and those in complex at equilibrium. The 
formation of a protein-DNA (PD) complex (where there is a single binding site) 
can be described by the following equation: 
 P + D ⇌ PD																																																																																																																																 3.1  
 
The Kd corresponds to the ratio between the product of the molar 
concentrations of (free) reactants and that of the complex at equilibrium as 
follows: 
 𝐾/ = 	 P [D][PD] 																																																																																																																														(3.2) 
 
where [P] is the molar concentration of free protein, [D] is the molar 
concentration of free DNA and [PD] is the molar concentration of protein-DNA 
complex. The Kd has the units of molar concentration (M) and is the reciprocal 
of the equilibrium association constant (Ka) which has units of M-1. For 
convenience, the Kd is typically used in preference to the association constant, 
because the units of concentration can be used with reference to reactant 
concentration. 
 
Following a typical EMSA, the intensity of the bands, corresponding to free DNA 
and bound DNA, are compared with respect to the protein concentration (figure 
3.1). The fraction of bound DNA (Θb) can be expressed as follows; where 
[PD]+[D] (the molar concentration of complex in addition to the molar 
concentration of free DNA) is equal to the total molar concentration of DNA: 
 𝛩7 = 	 [PD]PD + [D]																																																																																																																					(3.3) 
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Therefore, by rearranging and inserting equation 3.2, this becomes: 
 𝛩7 = 	 11 + ([D] [PD]) 		= 			 11 + ([𝐾/] [P]) 	= 		 [P]P +	𝐾/ 																																											(3.4) 
 
Equation 3.4 therefore shows that when the fraction of bound DNA is 0.5, the 
Kd is equal to the concentration of free protein. However, although the fraction 
of bound DNA is easy to determine using EMSA, the concentration of free 
protein cannot be accurately determined. For this reason, the ‘bound versus 
total’ model can be fitted to the data, allowing the fraction of bound DNA to be 
compared to total protein, and used to plot a binding curve. The bound versus 
total model is described below, where ‘y’ is the concentration of bound DNA at 
a given protein concentration ([PD]), ‘t’ is the total protein concentration ([PD] 
+ [P]) and ‘Cap’ is the capacity or maximum possible concentration of bound 
DNA ([PD] max): 
 𝑦 = 	−− 𝐾/ + 𝑡 + 𝐶𝑎𝑝 + 𝐾/ + 𝑡 + 𝐶𝑎𝑝 ? − 4 ∙ 𝑡 ∙ 𝐶𝑎𝑝2 																																							(3.5) 
 
This allows the Kd to be determined using parameters that can be readily 
determined for 1:1 binding (equation 3.5 was obtained from the GraFit User’s 
Guide, version 6).     
 
3.2.3.2 Method 
EMSA were performed using non-denaturing gel electrophoresis. Polyacrylamide 
mini gels (5%) were constructed using 0.5 × TA buffer (a final concentration of 
20 mM Tris, 10 mM acetic acid). Aliquots of SAP (purified as described in 
chapter 1) were incubated at various concentrations (0, 25, 50, 75, 100, 150, 
200, 300, 400 and 500 nM final concentration) with 50 nM [γ-32P]-labelled DNA 
duplexes (of the six fragment lengths and three different% G+ C contents) in 
reaction buffer (20 mM Tris-HCl pH 7.2, 20 mM NaCl, 1 mM 
phosphoethanolamine, 2 mM CaCl2, 4% (w/v) Ficoll 400) at 4 °C for a period of 
30 minutes. Samples were then loaded onto a pre-electrophoresed 5% native 
polyacrylamide gel. After electrophoresis at 100 V for 50 (10 bp), 55 (15 bp), 
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60 (20 bp), 65 (25 bp), 70 (30 bp) or 80 (40 bp) minutes, the gels were dried 
using a 583 Electrophoresis Gel Dryer (Bio-Rad). Following overnight exposure 
to a BAS-IP MS 2325 imaging plate (Fujifilm), images were visualized using a 
Fujifilm FLA-5000 phosphorimager (Fujifilm). The fraction of bound DNA in each 
lane was determined using Image Gauge version 4.0 software (Fujifilm). When 
considering the bound versus free DNA, the lanes containing SAP were 
compared to the lane containing DNA only. In the lanes containing SAP, all 
signal above the lowest band (corresponding to free DNA) used to calculate the 
bound fraction, with the corresponding area of the SAP-free lane subtracted. 
Following quantitation of the free and bound fractions, Kd were estimated by 
fitting the data using the ‘Bound versus Total’ model contained within the GraFit 
software (Erithacus Software). The EMSA described in this thesis were 
performed with the help of Dr. Simon Streeter (Institute of Biomedical and 
Biomolecular Sciences, University of Portsmouth).  
 
3.2.4 SwitchSENSE  
3.2.4.1 Background 
SwitchSENSE is a relatively recent technique that can be used to gain 
information about the kinetics of macromolecular interactions, as well as 
information regarding thermodynamics and protein size. The system utilises 
DNA ‘nanolevers’, which are immobilised at one end to a gold surface via a 
disulphide linkage (figure 3.2a). Due to the use of these DNA nanolevers, 
switchSENSE is particularly suited to experiments involving protein-DNA 
interactions, and was therefore used to investigate SAP-DNA binding.  
 
Depending on the charge that is placed over the gold surface, the DNA 
nanolevers are either attracted or repelled. When the nanolevers are repelled, 
they stand upright and the Cy3 label can fluoresce, but when the nanolevers 
are attracted to the surface the fluorescence is quenched. Figures 3.2 and 3.3 
give an overview of the system and the two methods (dynamic response and 
fluorescence down) used to obtain association and dissociation rate constants 
for SAP-DNA binding. In the dynamic response method, the surface charge is 
rapidly switched between positive and negative at a speed of 10 kHz.  
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Figure 3.2 Overview of the kinetic analysis of protein-DNA binding, using 
switchSENSE by the dynamic response method.  
A gold surface contains DNA duplexes immobilised at one end by a thiol linkage and labelled at 
the other with a Cy3 dye (A). The charge across the surface is rapidly switched between 
positive and negative, causing the DNA nanolevers to be attracted and repelled. When the Cy3 
is in close proximity to the surface, its signal is quenched, and when it stands up, it fluoresces. 
The speed of this ‘flashing’ of the Cy3 is measured as protein is flowed across the surface (B). 
When protein binds, the speed (or dynamic response) decreases, due to the hydrodynamic drag 
of the larger molecule. In this way, association and dissociation of the protein can be measured 
with respect to time (C).    
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Figure 3.3 Overview of the kinetic analysis of protein-DNA binding, using 
switchSENSE by the fluorescence down method.  
A constant positive charge is applied to the gold surface, forcing the DNA nanolevers to lie flat 
and the fluorescent signal of the Cy3 label is quenched. Protein is flowed over the surface and 
as protein binds the DNA is slightly lifted from the surface, allowing a small amount of 
fluorescence (A). The change in fluorescence is measured with respect to time during protein 
association and dissociation (B). 
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When protein binds to the DNA, the speed at which the nanolever moves (its 
dynamic response) is slowed, due to hydrodynamic drag. The time-resolved 
measurement of dynamic response, during the association and dissociation of 
the protein analyte, provides the binding rate constants (using the method 
described below). For the fluorescence down method, a constant positive 
charge is applied to the surface causing the nanolevers to lie flat. When protein 
binds, the nanolevers become slightly raised, allowing a small increase in 
fluorescence. The change in this fluorescence is measured with respect to time 
during the association and dissociation phases. All equations described in the 
following section (3.6-3.13) were obtained from the following sources: Dynamic 
Biosensors technology note – Binding Theory; Fitting Models to Biological Data 
using Linear and Nonlinear Regression – Motulsky & Christopoulos; Majka & 
Speck, 2007.    
 
Equation 3.1 describes the formation of a protein-DNA complex. Including the 
association and dissociation rate constants (kon and koff) gives equation 3.6: 
 
P + D 		 𝑘CD⇌𝑘CEE		 PD 																																																																																																																(3.6) 
 
The rate of association and dissociation of the complex can be described by 
equation 3.7; where t is time: 
 𝑑	[PD]𝑑	𝑡 = 	𝑘CD	 ⋅ P ⋅ D 																									𝑑	 PD𝑑	𝑡 = 	−𝑘CEE 	 ⋅ PD 																																			(3.7) 
 
For a switchSENSE experiment, equation 3.7 can be written in the form of 
equation 3.8 where Θb is the fraction of bound DNA on the biosensor surface, 
and Θb eq. is the maximum fraction of bound DNA for a given concentration of 
analyte (SAP) at equilibrium. These values are proportional to the signal, i.e. 
the dynamic response or fluorescence being measured. Θb eq. is proportional to 
the total number of binding sites (DNA) on the surface, and Θb is proportional 
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to the current concentration of protein-DNA complex, [PD]. Θb eq. - Θb is 
therefore equal to the concentration of free DNA, [D].  
 𝑑	𝛩7𝑑	𝑡 = 	𝑘CD	 ⋅ P ⋅ 𝛩7	JK. − 𝛩7 																									𝑑	𝛩7𝑑	𝑡 = 	−𝑘CEE 	 ⋅ 	𝛩7																										(3.8) 
  
The net rate of association of a protein-DNA complex is the sum of the rate of 
association and the rate of dissociation: 
 𝑑	𝛩7𝑑	𝑡 = 𝛩7	JK. − 	𝛩7 ⋅ P ⋅ 	𝑘CD −	𝛩7 	 ⋅ 	𝑘CEE																																																																	(3.9) 
 
Equation 3.9 can be rearranged to give equation 3.10: 
 𝑑	𝛩7𝑑	𝑡 = 	𝛩7	JK. 	 ⋅ P ⋅ 	𝑘CD −	𝛩7	 	𝑘CD P +	𝑘CEE 																																																								(3.10) 
 
Equation 3.10 can then be integrated to give equation 3.11:  
 𝛩7 = 		𝛩7	JK. 	 ⋅ 1 − expR STU V 	W	STXX	 ⋅Y 																																																																								(3.11) 
 
This equation therefore provides the observed association rate constant, or kob 
(kob = kon [P] + koff). It is important to note that the observed association rate 
constant is dependent on both the association rate and dissociation rate as a 
small amount of dissociation still occurs during the association phase. As the 
concentration of analyte increases, the observed association rate constant also 
increases linearly. Therefore, to determine rate constants using switchSENSE, 
several experiments are performed using increasing concentrations of protein. 
The analysis software then determines the observed association rate constant 
for each concentration of protein (SAP) and fits the data by linear regression. 
The slope of this function is the association rate constant (kon, M-1min-1), and 
the y-intercept is the dissociation rate constant (koff, min-1). The determination 
of the dissociation rate constant using this method is however unreliable, 
because a small change in the association rate greatly alters the value obtained 
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for the koff. During a switchSENSE experiment therefore, the dissociation is 
measured by flowing buffer over the surface, allowing bound protein to 
dissociate, and then monitoring either the increase in dynamic response or 
decrease in fluorescence (depending on the method used). The differential 
equation describing the dissociation rate (equation 3.8) can then be described 
as follows, where the gradient of the function is the dissociation rate constant, 
Θb0 is the fraction of bound DNA at the start of dissociation and t0 is the time at 
the start of dissociation. 
 ln 𝛩7\𝛩7 = 	𝑘CEE 	 ⋅ 	 𝑡 − 𝑡\ 																																																																																																					(3.12) 
 
According to the law of mass action, the Kd can then be determined by 
equation 3.13: 
 𝐾/ = 	𝑘CEE𝑘CD 																																																																																																																															(3.13) 
 
3.2.4.2 Method 
Kinetic analysis of SAP-DNA binding using switchSENSE was performed based 
on methods previously described (Knezevic et al., 2012; Langer et al., 2013) 
using a DRX 2400 Analyzer (Dynamic Biosensors). SwitchSENSE 4 × 6 biochips 
were used to which Cy3-labelled, double stranded oligonucleotides (24, 48, 72 
and 96 bp) were immobilised via a 5’ thiol group. Sequences of the DNA 
oligonucleotides can be found in appendix 9. 
 
All experiments were performed at a flow rate of 100 μL/min, and the 
frequency of the DNA ‘switching’ (caused by the change in electrode charge) 
was 10 kHz. Recombinant native sequence SAP was dialysed into reaction 
buffer (10 mM Tris-HCl pH 7.4, 40 mM NaCl, 10 mM PE, 5 mM CaCl2, 0.05% 
(v/v) Tween 20), which was also used as the running buffer. A range of SAP 
dilutions were constructed (between 0 nM and 81 nM) using reaction buffer. All 
data was analysed using switchSENSE analysis software.   
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3.2.5 Sedimentation velocity analytical ultracentrifugation 
3.2.5.1 Background 
Analytical ultracentrifugation (AUC) is a powerful technique for the 
hydrodynamic analysis of macromolecules in solution. It provides a relatively 
straightforward method to determine the molecular mass distribution of 
macromolecules over a large range of sizes and concentrations. This technique 
was used to investigate the stoichiometry of SAP-DNA binding by measuring the 
molecular mass of the complex. Information about the stoichiometry will allow 
crystallisation screens to be set up with the appropriate ratios of SAP and DNA, 
and will also provide information about distribution of complexes that are 
present.    
 
Sedimentation velocity (SV) is one of two commonly used AUC methods, in 
which the sample is spun at very high speeds (up to 182,000 × g) to sediment 
macromolecules. As the particles sediment, a distinct boundary is formed where 
the particles are depleted close to the meniscus (figure 3.4). During the 
experiment, absorbance along the sedimentation path (or radial path) of the 
AUC cell is measured periodically so that the movement of the boundary can be 
recorded. All equations described in the following section were obtained from 
the following sources: Introduction to Analytical Ultracentrifugation – Greg 
Ralston; Cole, Lary, Moody & Laue, 2008.  
 
Three forces act upon a particle in solution: sedimenting force (Fs), buoyant 
force (Fb) and frictional force (Ff). The sedimenting force can be described as 
follows, where M is molar mass, N is Avogadro’s number, ω is the angular 
velocity (in radians per second) and r is the distance of the particle to the rotor 
axis (in cm): 
 𝐹 = 	𝑀𝑁 	 ⋅ 	𝜔?𝑟																																																																																																																								(3.14) 
 
Note that M/N is equal to the mass of a single particle in grammes (m).  
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Figure 3.4 Overview of sedimentation velocity analytical ultracentrifugation. 
Panel A shows a single compartment within an AUC cell, which contains a sample of 
macromolecules in solution. The blue colouring represents the concentration of the 
macromolecules. As the cell rotates the molecules sediment, causing the concentration close to 
the meniscus to drop and a sharp concentration gradient to form (the boundary), shown in 
panel B. By monitoring the movement and diffusion of the boundary over time, it is possible to 
obtain information about the size and shape of the molecules present.  
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The buoyant force is described by equation 3.15, where m0 is the mass of 
solvent displaced by the particle, 𝜈  is the partial specific volume (volume of 
solvent displaced per mass of particle), ρ is the buoyant density (density of 
solvent) and ρpart is the particle density: 
 𝐹7 = 	−𝑚\ ⋅ 	𝜔?𝑟															𝑚\ = 	𝑀𝑁 	 ⋅ 	𝑣𝜌														𝜈 = 1𝜌ghiY 																																								(3.15) 
 
Finally, the frictional force is described by equation 3.16, where f is the 
frictional coefficient and u is the velocity: 
 𝐹E = 	−𝑓𝑢																																																																																																																																(3.16)  
 
As the particle sediments at constant 𝜔, the sum of these three forces is zero, 
and can be described as follows: 
 0 = 𝑀𝑁 	⋅ 	𝜔?𝑟 −	𝑀𝑁 	 ⋅ 	𝑣𝜌 ⋅ 	𝜔?	𝑟 − 𝑓𝑢																																																																														(3.17) 
 
This can then be rearranged to give equation 3.18: 
 0 = 	𝑀𝑁 	 ⋅ 1 − 𝑣𝜌 ⋅ 	𝜔?𝑟 − 𝑓𝑢																																																																																											(3.18) 
 
Equation 3.19 is then obtained by rearranging equation 3.18 to place all 
macromolecule-related parameters on one side of the equation: 
 𝑀 ⋅	 1 − 𝑣𝜌𝑁𝑓 = 	 𝑢𝜔?𝑟 = 𝑠																																																																																																				(3.19) 
 
Equation 3.19 is the Svedberg equation and provides the sedimentation 
coefficient (s) for the particle. Each macromolecule has a sedimentation 
coefficient that is dependent on its size and shape and is inversely proportional 
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to its frictional coefficient. An alternative way to express equation 3.19 is as 
follows, where Mb is the mass of the particle corrected for buoyancy: 
 𝑠 = 	𝑀7𝑓 																									𝑀7 = 𝑚(1 − 𝜐𝜌)																																																																											(3.20) 
 
The unit of the sedimentation coefficient is seconds, although the unit 
‘Svedberg’ is commonly used, which is equal to 1 × 10-13 seconds, or 100 
femtoseconds. From an SV-AUC experiment, the sedimentation coefficient for a 
particle can be determined by measuring the rate of movement of the boundary 
midpoint over time (figure 3.4). As the boundary moves further away from the 
axis of rotation and hence r increases, the velocity also increases, meaning that 
the rate at which the boundary moves increases. This is described by equation 
3.21, where rbnd is the radial position of the boundary: 
 𝑠 = 	 1𝜔?𝑟 	 ∙ 	𝑑	𝑟7D/𝑑𝑡 																																																																																																																	(3.21) 
 
The rate at which the boundary spreads (or diffuses) provides the diffusion 
coefficient, which is described by equation 3.22, where R is the gas constant 
and T is the absolute temperature: 
 𝐷 =	𝑅𝑇𝑓 																																																																																																																																			(3.22)	
 
Therefore, by combining equations 3.20 and 3.22, it is possible to determine 
the molecular mass (or mass corrected for buoyancy) of a particle, using the 
sedimentation coefficient and the diffusion coefficient obtained from an SV-AUC 
experiment: 
 𝑠𝐷 = 	𝑀7𝑅𝑇																																																																																																																																			(3.23) 
 
The Sedfit analysis software is used to model the distribution of sedimentation 
coefficients c(s) and molecular masses c(M) of the sample.  
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3.2.5.2 Method 
All experiments were performed at 25 °C using a Beckman Optima XL-A 
analytical ultracentrifuge (Beckman-Coulter), and data were analysed using 
Sedfit version 15.01b (Schuck, 2000). The partial specific volume (𝜈) of SAP 
(0.743 mL/g) was estimated using Sednterp (Laue et al., 1992). Using the 
equation described by Woodward and Lebowitz (1979), the 𝜈 for a 40 bp DNA 
duplex was estimated as 0.587 mL/g. Weight average values for the partial 
specific volume of SAP-DNA complexes were calculated, giving a value of 0.718 
mL/g for a 1:1, and 0.729 mL/g for a 2:1, SAP-DNA complex (all stoichiometries 
are referred to assuming SAP is pentameric). 
 
HEX-labelled duplex DNA (annealed and purified as described in sections 3.2.1 
and 3.2.2, respectively) was added to recombinant native sequence SAP in 
reaction buffer (10 mM Tris-HCl pH 7.4, 140 mM NaCl, 10 mM PE, 2 mM CaCl2) 
at varying molar ratios of SAP: DNA.  
 
A two-sector AUC cell was used for each sample. Cells were assembled as 
described in figure 3.5 and torqued to 120 in-lbs., containing 400 μL of sample 
and 425 μL of reaction buffer in the appropriate sectors of each cell. Each 
assembly contained a centrepiece with a 12 mm optical path length. Cells were 
loaded into an An-50 Ti analytical rotor which was left in the centrifuge 
overnight to equilibrate to 25 °C. Experiments were performed at 40,000 rpm, 
and radial scans were recorded at 10-minute intervals at 540 nm. 
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Figure 3.5 Assembly of the AUC cell. 
The individual components of the AUC 
cells were thoroughly cleaned before 
assembly. Once assembled, the screw 
ring was torqued to 120 in-lb. Samples 
were subsequently loaded and the 
loading ports sealed with a plug gasket 
and housing plug. (Figure adapted from 
flow-through centrepiece assembly 
manual, Beckman Coulter 2003). 
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3.3 Results 
3.3.1 DNA binding by native sequence SAP 
SAP is approximately 100 Å (10 nm) in diameter, which is equivalent to the 
length of a 30 bp duplex DNA oligonucleotide (assuming 3.4 Å per base pair for 
B-form DNA). A 10-40 bp range of DNA fragment lengths was therefore chosen 
as suitable to investigate the minimum length required for binding, and hence 
determine the optimal length of DNA to form a crystallisable complex for 
structural analysis using X-ray crystallography. 
 
It was first identified in 1987 that SAP binds single-stranded calf thymus DNA in 
a calcium dependent manner (Pepys & Butler, 1987). Therefore, to test 
whether the same holds true for double stranded DNA, EMSA were performed 
using the 30 bp DNA duplex with 50% G+C content, in the presence and 
absence of 5 mM EDTA. The left half of figure 3.6 shows the EMSA performed 
in the absence of EDTA. The presence of a slow-moving band and a dark smear 
indicate that SAP bound to the free 30 bp DNA. In contrast, these same bands 
were not observed on the right half of the gel that shows the EMSA performed 
in the presence of 5 mM EDTA, indicating that when EDTA is present, DNA 
binding is abolished. All EMSA were therefore performed using 2 mM Ca2+, 
which is approximately the physiological concentration in human serum (Walker 
et al., 1990).  
 
To determine the strength and sequence specificity of the interaction with 
duplex DNA, and also to identify the length of DNA required for binding, EMSA 
were performed using the range of duplex DNA lengths previously specified, 
with varying G+C contents (shown in table 3.1). Figures 3.7 and 3.8 show 
these series of EMSA using the six different lengths of duplex DNA with 50% 
G+C content and the subsequent quantitative analysis. Table 3.2 and figure 3.9 
show the full data obtained from all EMSA using native sequence SAP. Although 
the 10 bp duplex with a G+C content of 75% appears to have bound with a 
capacity of 31.5 nM (and an error of approximately 20%), all other duplexes 
with a length of 15 bp or less bound with a capacity of less than 8.2 nM 
(approximately 16% of the total DNA).   
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Figure 3.6 EMSA performed in the presence of EDTA to investigate the calcium 
dependence of DNA binding by SAP. 
An EMSA was performed using 50 nM, 30 bp DNA (50% G+C content, see table 3.1) with and 
without EDTA. The left half of the gel shows SAP concentrations increasing from 25 nM to 400 
nM, in the presence of 2 mM calcium. The right half of the gel is identical except for the 
addition of 5 mM EDTA.  
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Figure 3.7 EMSA performed using recombinant native sequence SAP with increasing 
lengths of DNA (containing 50% G+C content). 
EMSA were performed as previously described (section 3.2.3.2) using 50 nM DNA, with SAP 
concentrations increasing from 25 nM to 500 nM. DNA duplexes used ranged from 10 bp to 40 
bp and had a G+C content ranging from 25% to 75%. Only the EMSA performed using 
duplexes with 50% G+C content are displayed in this figure. The red bracket highlights a dark 
smear that corresponds to a species with a lower electrophoretic mobility than that of the 
bound DNA at lower SAP concentrations.  
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Figure 3.8 Quantitative analysis of EMSA performed using recombinant native 
sequence SAP with increasing lengths of DNA (containing 50% G+C content). 
Image Gauge version 4.0 software (Fujifilm) was used to quantify the intensity of the bands 
corresponding to free and bound DNA for each of the EMSA shown in figure 3.7. The ‘bound 
versus total’ model (GraFit - Erithacus Software) was subsequently fitted to the data in order to 
determine the binding capacity and Kd. 
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Table 3.2 All data obtained from EMSA using recombinant native sequence SAP. 
A traffic light colour coding system has been used to highlight DNA duplexes that bind SAP with 
a high or low capacity. Where the capacity is very high (greater than 40 nM - 80% of the total 
50 nM) the observed Kd has also been colour coded. Hence, only where both the capacity and 
the Kd are highlighted in green, was exceptionally tight binding observed. This table shows the 
binding capacity and Kd for SAP binding to all duplexes ranging from 10 bp to 40 bp, with G+C 
contents ranging from 25% to 75%. 
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Figure 3.9 All data obtained from EMSA using recombinant native sequence SAP 
Each panel represents double stranded DNA with either 25%, 50% or 75% G+C content. The 
graphs show the estimated Kd (blue) and capacity (red) for each length of double stranded DNA 
(10 bp-40 bp).  
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The DNA duplexes with a length of 25 bp however bound with a capacity of 
between 38.5 nM and 43 nM and all duplexes with a length of 30 bp or more 
bound with a capacity of at least 46.6 (± 1.2) nM. With the exception of the 25 
bp duplex with 25% G+C content (which bound with a Kd of 17.1 nM), all DNA 
duplexes of 25 bp or longer bound with a Kd of at least 8.5 nM. All DNA 
duplexes with a length of 20 bp or less bound with a Kd of between 46 nM and 
620 nM. A dark smear that corresponds to a species with low electrophoretic 
mobility can be seen in figure 3.7 in the lanes corresponding to the highest SAP 
concentrations (red bracket). This corresponds to a species with lower 
electrophoretic mobility than the bound duplex DNA at lower SAP 
concentrations. Further EMSA were performed to investigate the DNA sequence 
specificity of SAP binding and are described in the following section. 
 
3.3.2 DNA sequence specificity of SAP binding 
To investigate the sequence dependence of SAP binding, two further EMSA 
were performed using rearranged or ‘scrambled’ versions of the previous 40 bp 
duplex with 50% G+C content (see table 3.1 for the sequences). These DNA 
duplexes were radiolabelled as previously described, and EMSA performed using 
recombinant native sequence SAP.  
 
Figure 3.10 shows the compared binding between the original DNA duplex and 
the two scrambled sequences, and figure 3.11 shows the full analysis of the 
EMSA. SAP bound all three duplexes with a capacity of between 49.4 nM and 
55.8 nM, and the Kd varied between 0.8 nM and 84.4 nM. The hundred-fold 
difference in the estimated Kd suggests that the sequence of the DNA does 
have an influence on the strength of SAP binding. However, all duplexes were 
fully bound by SAP and estimated values of the Kd were in the nanomolar 
range, which is indicative of strong binding regardless of the sequence. It 
should also be noted that the experimental values for the Kd of the original and 
two scrambled duplexes contain associated error of 81%, 29% and 27%, 
respectively. Nevertheless, the variation in Kd between these three sequences 
appears to be significant. 
 100 
 
 
Figure 3.10 Comparison of binding between three 40 bp duplexes with scrambled 
sequences.  
EMSA were performed using the original 40 bp sequence, with 50% G+C content and two other 
‘scrambled’ versions (table 3.1), in order to investigate the sequence dependence of SAP 
binding. 50 nM DNA was used, with SAP concentrations increasing from 25 nM to 500 nM.  
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Figure 3.11 Quantitative analysis of EMSA performed using 40 bp DNA duplexes 
with scrambled sequences.  
Image Gauge version 4.0 software (Fujifilm) was used to quantify the intensity of the bands 
corresponding to free and bound DNA for the EMSA performed using scrambled duplexes (table 
3.1) (full EMSAs not shown). The ‘bound versus total’ model (GraFit - Erithacus Software) was 
subsequently fitted to the data in order to determine the binding capacity and Kd. Data is shown 
for the two scrambled duplexes in comparison to the original 40 bp duplex with 50% G+C 
content. 
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3.3.3 Mutational analysis of SAP-DNA binding 
As described previously, five SAP mutants – R77Q, H78Q, K87Q, K143Q and 
R193Q - were produced to investigate the putative DNA-binding amino acids. 
Following alignment of orthologous SAP peptide sequences, these residues 
were selected for investigation due to their positive charge and conservation 
(described in chapter 2). EMSA were performed using each of the SAP mutants 
as described in section 3.2.3.2 using the full range of duplex DNA lengths and 
G+C contents shown in table 3.1. Figure 3.12 shows the binding by all of the 
SAP mutants using the 30 bp duplex with 50% G+C content, and figure 3.13 
shows the quantitative analyses of these EMSA. Table 3.3 and figures 3.14 to 
13.18 show the data obtained from all EMSA using mutant SAP.  
 
Most notably, for the EMSA performed using the K143Q and R77Q mutants, 
none of the DNA duplexes were bound with a capacity of greater than 16.4 nM 
and 7.8 nM, respectively. In contrast, the H78Q, K87Q and R193Q mutants 
bound all 40 bp duplexes with a capacity of at least 49.1 nM, 46.6 nM and 43.2 
nM, respectively.  
 
With the exception of the 10 bp duplex with 50% G+C content, the R193Q 
mutant bound only the 40 bp duplexes with a capacity greater than 14 nM. 
Although the 40 bp duplex with 50% G+C content was bound with a capacity of 
43.2 nM and a Kd of 2.3 nM, the two other 40 bp duplexes (with 25% and 75% 
G+C content) were bound with higher Kd of 910 nM and 190 nM, respectively. 
These figures do however contain associated error of 101% and 63%, 
respectively. 
 
The K87Q mutant appeared to have bound all 30 and 40 bp duplexes with a 
capacity of at least 22.6 nM and the 25 bp duplex, with 75% G+C content, with 
a capacity of 32.2 nM. All other duplexes were bound weakly with a capacity of 
no greater than 6.93 nM with the exception of the 25 bp duplex with 25% G+C 
content, which was bound with a capacity of 17.4 nM.  
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Figure 3.12 EMSA performed using SAP mutants in order to investigate the effect of 
the amino acid substitution on SAP-DNA complex stability. 
EMSA were performed using 50 nM 30 bp duplex DNA with 50% G+C content (table 3.1). 
Native sequence and mutant SAP (R77Q, H78Q, K87Q, K143Q and R193Q) was used at 
concentrations ranging from 25 nM to 500 nM.   
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Figure 3.13 Quantitative analysis of EMSA performed using native sequence and 
mutant SAP. 
Image Gauge version 4.0 software (Fujifilm) was used to quantify the intensity of the bands 
corresponding to free and bound DNA for each of the EMSA shown in figure 3.12. The ‘bound 
versus total’ model (GraFit - Erithacus Software) was subsequently fitted to the data in order to 
determine the binding capacity and Kd. 
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Figure 3.14 All data obtained from EMSA using R77Q mutant SAP 
Each panel represents double stranded DNA with either 25%, 50% or 75% G+C content. The 
graphs show the estimated Kd (blue) and capacity (red) for each length of double stranded DNA 
(10 bp-40 bp).  
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Figure 3.15 All data obtained from EMSA using H78Q mutant SAP 
Each panel represents double stranded DNA with either 25%, 50% or 75% G+C content. The 
graphs show the estimated Kd (blue) and capacity (red) for each length of double stranded DNA 
(10 bp-40 bp).  
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Figure 3.16 All data obtained from EMSA using K87Q mutant SAP 
Each panel represents double stranded DNA with either 25%, 50% or 75% G+C content. The 
graphs show the estimated Kd (blue) and capacity (red) for each length of double stranded DNA 
(10 bp-40 bp).  
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Figure 3.17 All data obtained from EMSA using K143Q mutant SAP 
Each panel represents double stranded DNA with either 25%, 50% or 75% G+C content. The 
graphs show the estimated Kd (blue) and capacity (red) for each length of double stranded DNA 
(10 bp-40 bp).  
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Figure 3.18 All data obtained from EMSA using R193Q mutant SAP 
Each panel represents double stranded DNA with either 25%, 50% or 75% G+C content. The 
graphs show the estimated Kd (blue) and capacity (red) for each length of double stranded DNA 
(10 bp-40 bp).  
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None of the duplexes, however, were bound with a Kd of less than 19.1 nM and 
the 40 bp duplex with 75% G+C content was bound with a Kd of 587 nM (with 
an error of 76%). The H78Q mutant appeared to bind more of the duplexes 
with a higher capacity than the native sequence SAP, binding all duplexes of 20 
bp or more with a capacity of at least 46.3 nM. However, these were bound 
with a higher Kd than native sequence SAP, binding the 30 and 40 bp duplexes 
with a Kd between 4.2 nM and 38 nM, and the 20 bp and 25 bp oligos with a Kd 
between 20.2 nM and 530 nM. 
 
3.3.4 Kinetic analysis of SAP-DNA binding 
SwitchSENSE was performed using four DNA duplexes comprising 24, 48, 72 
and 96 bp, respectively, as described in section 3.2.4.2. Figure 3.19 shows the 
upward and downward movements of the duplexes in the absence of protein, 
and demonstrates the principle that the larger the size of the nanolever, the 
slower its movement (lower dynamic response) due to hydrodynamic drag. 
Figures 3.20 to 3.23 show the results of the experiments performed with the 
four duplexes using the dynamic response method. Table 3.4 shows all data 
obtained from switchSENSE experiments using both the dynamic response and 
fluorescence down methods.  
 
Initially the data appear to show no great variation in the kinetic rate constants 
of SAP binding to different lengths of duplex DNA above 24 bp. The kon varied 
between 3.2 M-1s-1 and 7.7 M-1s-1 (measured by dynamic response) and 
between 4.1 M-1s-1 and 5.6 M-1s-1 (measured by fluorescence down). The koff 
varied between 3.5 s-1 and 6.9 s-1 (measured by dynamic response) and 
between 6.6 s-1 and 7.2 s-1 (measured by fluorescence down). However, there 
did appear to be a change in the mode of binding of duplex DNA that is 48 bp 
or longer. Figure 3.24 shows a general trend in the association rate constants 
(and less so in the dissociation rate constants), that rose as the DNA length 
increased from 24 to 48 bp DNA, before declining again as the length increased 
to 96 bp. The dissociation rate constants obtained by the fluorescence down 
method are the exception to this trend as they showed much less change, 
ranging from 6.6 × 10-3 to 7.2 × 10-3 s-1. Overall, these resulted in a trend in 
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the Kd, which decreased as the DNA length increased from 24 bp to 48 bp 
before increasing again as the DNA length increased towards 96 bp. Another 
interesting feature can be seen in figure 3.21. During the association of SAP (at 
a concentration of 27 nM) to the 48 bp DNA, an irregular ‘hump’ appeared. This 
is not an anomaly and is completely repeatable, also being present at the same 
concentration in the fluorescence down measurement (data not shown).    
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Figure 3.19 Measurement of the change in fluorescence during the upward and 
downward movements of the DNA nanolevers.   
When a negative charge was applied to the surface, a measurement of fluorescence was made 
over the first 10 μs to track the upward movement of the DNA. This was repeated when a 
positive charge was applied to the surface, to track the downward movement. It can be seen 
that the shorter the length of the duplex DNA, the faster it reaches a standing, or flattened 
position. This is due to the reduced hydrodynamic drag of the shorter nanolevers, which is a 
function of their size and shape.  
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Figure 3.20 Analysis of SAP binding to a 24 bp DNA duplex using the dynamic 
response method. 
Binding was measured using four concentrations of SAP (0, 9, 27 and 81 nM). The change in 
dynamic response was recorded during the association (A), and the dissociation (B) of SAP. 
This allowed the calculation of the association and dissociation rate constants and therefore the 
Kd. 
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Figure 3.21 Analysis of SAP binding to a 48 bp DNA duplex using the dynamic 
response method. 
Binding was measured using four concentrations of SAP (0, 9, 27 and 81 nM). The change in 
dynamic response was recorded during the association (A), and the dissociation (B) of SAP. 
This allowed the calculation of the association and dissociation rate constants and therefore the 
Kd. 
 
  
 116 
 
Figure 3.22 Analysis of SAP binding to a 72 bp DNA duplex using the dynamic 
response method. 
Binding was measured using four concentrations of SAP (0, 9, 27 and 81 nM). The change in 
dynamic response was recorded during the association (A), and the dissociation (B) of SAP. 
This allowed the calculation of the association and dissociation rate constants and therefore the 
Kd. 
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Figure 3.23 Analysis of SAP binding to a 96 bp DNA duplex using the dynamic 
response method. 
Binding was measured using four concentrations of SAP (0, 9, 27 and 81 nM). The change in 
dynamic response was recorded during the association (A), and the dissociation (B) of SAP. 
This allowed the calculation of the association and dissociation rate constants and therefore the 
Kd. 
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Table 3.4 All kinetic data collected for the binding of SAP and DNA using 
switchSENSE. 
This table contains all kinetic data obtained for SAP binding to a range of DNA duplexes, 
ranging from 24 bp to 96 bp. The association and dissociation rate constants and Kd were 
determined using both the dynamic response and fluorescence down methods.  
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Figure 3.24 Analysis of the kinetic data obtained using switchSENSE. 
The association rate constants (A), dissociation rate constants (B) and Kd (C) obtained using 
switchSENSE were plotted with respect to duplex DNA length in order to identify any trends in 
binding as a function of DNA size.  
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3.3.5 Stoichiometric analysis of the SAP-DNA complex  
SV-AUC was performed, as described in section 3.2.5.2, using the 40 bp DNA 
duplex (with 50% G+C content) which was labelled with HEX dye on the 5’ end 
of one strand. This DNA was prepared as described in sections 3.2.1 and 3.2.2. 
Three samples were constructed containing a 0:1, 2:1 and 8:1 ratio of SAP to 
DNA respectively.  
 
Figure 3.25 shows the c(s) distribution for the sample containing only the DNA 
duplex. A single symmetrical peak was observed with an s-value of 
approximately 3.5 s. When a partial specific volume of 0.587 mL/g was used 
(corresponding to 40 bp HEX-labelled duplex DNA), the estimated average 
molecular mass that this peak represented was 25 kDa, which is in agreement 
with the calculated molecular mass of 25.3 kDa for the 40 bp HEX-labelled 
duplex DNA.  
 
Figure 3.26 shows the c(s) distribution for the sample containing a molar ratio 
of 2:1 SAP to DNA. This figure shows the same peak corresponding to the 
unbound DNA (at approximately 3.5 s), as well as a much shorter, broader 
peak with a large shoulder and an s-value of approximately 8 s, and a second 
peak that was smaller still, with an s-value of approximately 13.5 s. The smaller 
peak with an s-value of 13.5 s was too short and broad to determine a 
molecular mass. However, using a partial specific volume of 0.718 mL/g 
(corresponding to a 1:1 SAP-DNA complex) the average molecular mass that 
the peak with an s-value of 8 s represented was estimated to be 150 kDa, 
which is approximately equivalent to a 1:1 complex of SAP to DNA, calculated 
to be 153 kDa. Although this indicates a stoichiometry of 1:1 binding, this 
cannot be stated with confidence due to the diffuse and asymmetrical nature of 
this peak.  
 
Figure 3.27 shows the c(s) distribution for the sample containing a molar ratio 
of 8:1, SAP to DNA. As in the previous samples, the peak with an s-value of 
approximately 3.5 s remained present. However, in this sample, a broad peak 
with an s-value of approximately 10.5 s was also present, and the area of this 
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peak appeared to be much greater than that of the peak with an s-value of 3.5. 
This large peak was asymmetrical, with a shoulder to the left of the main peak 
(corresponding to an s-value of approximately 8.0 s) and periodic ‘humps’ to 
the right of the main peak. Using a partial specific volume of 0.729 mL/g 
(corresponding to a 2:1 SAP-DNA complex), the average molecular mass that 
this peak represents was estimated to be 280 kDa, which is approximately 
equivalent to the molecular mass of a 2:1 complex of SAP to DNA (calculated to 
be 298 kDa). Due to its non-uniform shape, however, estimation of the 
molecular mass of this peak is unreliable.  
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Figure 3.25 SV-AUC performed on a sample containing only DNA (40 bp). 
Panel A shows the absorbance at 540 nm, measured along the radius of the AUC cell every 10 
minutes. Panel B shows the residual plot and panel C shows the c(s) distribution of the sample. 
The sample appeared to be homogeneous, yielding a single symmetrical peak with an s-value 
of approximately 3.5. Using a partial specific volume of 0.587 mL/g (for the 40 bp HEX-labelled 
DNA duplex), the peak was determined to correspond to a species with a molecular mass of 
25.4 kDa.  
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Figure 3.26 SV-AUC performed on a sample containing a 2:1 molar ratio of SAP to 
DNA (40 bp). 
Panel A shows the absorbance at 540 nm, measured along the radius of the AUC cell every 10 
minutes. Panel B shows the residual plot and panel C shows the c(s) distribution of the sample. 
A peak was observed at the same position as that observed in figure 3.21 with an s-value of 
approximately 3.5. There was also a much smaller, broader peak with a large shoulder present 
at approximately 8 s. Using a partial specific volume of 0.718 mL/g (estimated for a 1:1 SAP-
DNA complex), the average molecular mass calculated for the peak was 149 kDa. This value 
may be unreliable however due to the non-uniform nature of the peak.  
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Figure 3.27 SV-AUC performed on a sample containing an 8:1 molar ratio of SAP to 
DNA (40 bp). 
Panel A shows the absorbance at 540 nm, measured along the radius of the AUC cell every 10 
minutes. Panel B shows the residual plot and panel C shows the c(s) distribution of the sample. 
Using a partial specific volume of 0.729 mL/g (corresponding to that of a 2:1 SAP-DNA 
complex), the large peak with an s-value of approximately 10.5 s was calculated to represent 
an average molecular mass of 282 kDa. This value may be unreliable however due to the non-
uniform nature of the peak. There is a shoulder visible to the left of the main peak with an s-
value of approximately 8 s. This may be the peak observed in figure 3.22. 
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3.4 Discussion 
The aim of the work described in this chapter was to investigate the nature of 
SAP binding to duplex DNA in order to gain information about the strength of 
the interaction, the amino acids that play a role in the stabilisation of the 
complex, the kinetics of complex formation and stoichiometry of binding. A 
secondary aim of this chapter was to uncover any DNA length requirement or 
sequence specificity of SAP binding that could be used to produce a highly 
stable SAP-DNA complex for structural investigation by X-ray crystallography.  
 
Pepys and Butler showed in 1987 that SAP binds to single-stranded DNA in a 
calcium-dependent manner. Using EMSA performed in the presence and 
absence of EDTA (figure 3.6), it was shown that duplex DNA-binding by SAP is 
also calcium dependent, or at least dependent on the presence of divalent 
cations. No slower moving bands or smears were present in the half of the 
EMSA where EDTA was present, indicating that binding was abolished. 
 
EMSA performed using native sequence SAP with a range of duplex DNA 
lengths and G+C contents, showed that SAP bound weakly to duplex DNA of 
approximately 20 bp or shorter, with binding capacities ranging from 2 nM to 
31.5 nM. In contrast, SAP bound tightly to DNA of 25 bp or longer with binding 
capacities ranging from 38.5 nM to 50.4 nM and Kd ranging from 0.7 nM to 
17.1 nM (table 3.2). DNA that is present in circulation tends to be 
approximately 180 bp or longer (Jahr et al., 2001), so it is therefore not 
surprising that SAP appears to bind DNA shorter than 25 bp weakly, as 
fragments of this size would not typically be expected to be present in the 
serum. The tightest binding was observed with 30 and 40 bp DNA (which were 
the longest lengths tested using EMSA), at which length the DNA duplex would 
be able to span the SAP pentamer, comfortably reaching between two calcium-
dependent ligand-binding sites on opposite sides of the protein. The longest 
distance between calcium binding sites on opposite subunits is approximately 
66 Å, which would require B-form DNA duplex of at least 20 bp to span. This 
might suggest that DNA may bind to more than one site on the surface of the 
protein to form a stable complex, and therefore a length of longer than 20 bp 
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is required in order to be able to bind two at once. Figure 3.28 shows scale 
figures of pentameric SAP, a 25 bp duplex, 30 bp duplex and 40 bp duplex. 
When the duplex DNA is 30 bp or longer the G+C content appears to have very 
little effect on the strength of binding to native sequence SAP. The capacity of 
SAP binding varied by only 2.6 nM for 30 bp duplexes and by 1.6 nM for 40 bp 
duplexes with G+C contents ranging from 25% to 75%. Likewise the estimated 
Kd for these interactions varied by 1.5 nM for the 30 bp duplexes and by 0.5 
nM for the 40 bp duplexes (table 3.2). 
 
In some cases the estimated capacity appeared to plateau below the expected 
DNA concentration (50 nM). For example, in table 3.2 it can been seen that 
SAP bound the 25 bp duplex, with 50% G+C content, with a capacity of 38.5 
nM. Figure 3.8 shows that this capacity plateaued early on, when the SAP:DNA 
ratio was approximately 1:1. One of the reasons for the concentration of SAP-
DNA complex being less that that of the total DNA concentration might be that 
a small fraction of the SAP could have aggregated; thereby, possibly becoming 
inactive. Another possibility is that during the construction of the binding 
reactions, there could have been a small amount of adsorption of the SAP onto 
the plastic tube surface, lowering the concentration of SAP in solution. In future 
experiments could be performed in the presence of 0.01% (w/v) bovine serum 
albumin (BSA) or 0.005% (v/v) Triton X-100.   
 
Although it is a clear that there is a size requirement for the length of DNA in 
order to form a complex with SAP, the images in figure 3.7 suggest that more 
than a single complex may have formed. For the EMSA in which 25, 30 and 40 
bp duplexes were used, a dark smear is present at the top of the lanes with the 
highest concentration of SAP, implying the presence of more than one complex 
with a low electrophoretic mobility. This could be an indication of more 
complicated stoichiometry than simple 1:1 binding, or could be the result of 
SAP binding in more than one position on the DNA. The EMSA show that SAP 
bound to all of the DNA duplexes longer than 20 bp despite the variations in 
their sequence, indicating that SAP may not bind with strict sequence 
specificity.  
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Figure 3.28 Comparison of pentameric SAP and DNA duplexes.  
Pentameric SAP and DNA duplexes (25, 30 and 40 bp) are shown to scale. The PDB ID of 
pentameric SAP used is 3KQR and structures of the 25 bp, 30 bp and 40 bp DNA duplexes 
(50% G+C) were generated using the SCFBio DNA sequence to structure tool (Arnott, 
Campbell-Smith & Chandrasekaran, 1976). This figure was using the PyMOL Molecular Graphics 
System, Version 1.5 Schrödinger, LLC.  
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It is possible that SAP may be able to adopt multiple binding modes, which 
could give rise to multiple different complexes with varying degrees of 
electrophoretic mobility (Bullen et al., 2015; Nikitina et al., 2007).  
 
The sequence of the DNA however does appear to have a significant effect on 
the strength of the SAP-DNA interaction. EMSA performed using scrambled 40 
bp duplexes with 50% G+C content (and compared to the original 40 bp duplex 
with 50% G+C content) yielded a range of Kd with approximately 100-fold 
difference. However, the weakest of these interactions had a Kd of 84.4 nM, 
suggesting that the binding was still strong. In light of stoichiometric 
investigation of SAP-DNA binding (section 3.3.5), future experiments will be 
performed using shorter (25-30 bp) duplexes in order to prevent 
stoichiometries greater than 1:1. An experiment using systematic evolution of 
ligands by exponential enrichment (SELEX), starting with a random pool of DNA 
sequences could perhaps be used in order to determine a sequence with the 
highest possible binding affinity.  
 
Although Kd were successfully determined using EMSA, the protein and DNA are 
not truly at equilibrium during the electrophoresis. The EMSA provides a 
‘snapshot’ of equilibrium at the point of loading onto the gel. Any dissociation 
that occurs during electrophoresis leaves a smear between the bound and 
unbound DNA bands, as the protein is unable to catch up with and re-bind the 
DNA. Conversely, the ‘cage-effect’ theory (Cann, 1989) suggests that the 
protein and DNA may be artificially held together, resulting in a more stable 
complex. Therefore, in order to reinforce the data obtained from EMSA, 
switchSENSE was used (section 3.3.4) to determine another set of Kd values 
and also obtain kinetic data for SAP binding to duplex DNA. 
 
Mutational analysis highlighted two key amino acids that are critical for the 
stability of the SAP-DNA complex, Arg 77 and Lys 143. These amino acids 
appear to play an important role, because when these residues were 
substituted, very little DNA was bound (table 3.3). His 78 and Lys 87 on the 
other hand must have less involvement in DNA binding, because although the 
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estimated Kd were higher than those observed for native sequence SAP-DNA 
binding, the DNA was still bound with a relatively high capacity. Figure 3.29 
shows the position of each of the amino acids on the surface of SAP. Arg 77 
and Lys 143 are situated on the B face of the SAP pentamer, either side of the 
two calcium ions in the ligand-binding site. When these residues were 
substituted, DNA-binding was almost entirely abolished. As these two 
prominent, positively-charged amino acids are situated close to the ligand-
binding site, and it is known that DNA-binding is calcium dependent, it is likely 
that this region forms part of the main binding site for DNA.  
 
However, it has previously been hypothesised that the sugar-phosphate 
backbone of DNA cannot interact directly with the calcium ions due to steric 
hindrance (Pepys et al., 1997). As Arg 77 and Lys 143 appear to be pivotal for 
DNA-binding, it is unclear therefore how the calcium ions are involved in this 
interaction. It may be that they are only required be present in the ligand-
binding site in order to maintain the tertiary structure of the protein, and 
therefore the integrity of the DNA-binding site.  
 
The K87Q mutant required duplex DNA to be at least 30-40 bp for strong 
binding, as opposed to the native sequence SAP that required DNA of only 25 
bp (see table 3.3). This may indicate that Lys 87, which is situated on the inside 
of the ring between subunits, may act as an ‘anchor’ for DNA duplexes shorter 
than 30 bp that are unable to bridge binding sites on opposite subunits. Arg 
193 appears to be very important for binding, perhaps the most critical after 
Arg 77 and Lys 143. Sitting on the extremity of the ring, it is tempting to think 
of DNA wrapping around the pentamer, somewhat like a nucleosome, as they 
appear similar in shape and dimension (see figure 5.10).  However, it is unclear 
how the DNA would be positioned in order to interact with the other important 
residues. Some proteins are able to bend double stranded DNA during the 
formation of a complex (Goosen & van der Putte, 1995; Klein & Marahiel, 
2002), and it is possible that SAP could do the same, in order to interact with 
several of the putative DNA-binding residues on two or more monomers 
simultaneously. 
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Figure 3.29 View of the B face for a single SAP monomer, showing the position of 
the putative DNA-interacting amino acids in relation to the ligand-binding site. 
The five amino acids are shown within the three-dimensional structure of SAP and have each 
been colour-coded to highlight their contribution to the stability of the SAP-DNA complex (red 
having the greatest contribution, orange having less of a contribution and yellow having the 
least contribution). Whist it is unclear how duplex DNA lies over the surface in order to interact 
with each of these residues, the area surrounding the calcium ions seems to be a very likely 
position for interaction with the sugar-phosphate DNA backbone. This figure was using the 
PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC.  
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Of the amino acids investigated, His 78 appeared to have the least involvement 
with the stabilisation of the complex. However, in physiological conditions (pH 
7.4), the imidazole ring of histidine is not likely to be protonated, which occurs 
below pH 6. It may be that the differences in binding observed using the H78Q 
mutant (compared to the native sequence SAP) were due to the glutamine 
residue interacting with its neighbour, Arg 77, which appears to play an 
important role in DNA-binding.  
 
Kinetic analyses confirmed that SAP binds to double stranded DNA with a low 
nanomolar Kd, with values ranging from 9.0 nM to 17.7 nM for all lengths 
tested. Although these values appear to be slightly different to those 
determined using EMSA (at least for the 24 bp duplex which is the most similar 
in size to the 25 bp duplex tested using EMSA), this could be because of the 
different sequences that were used. As shown in section 3.3.2, the DNA 
sequence appears to have a significant effect on the relative strength of the 
interaction between SAP and DNA, even though the binding always appears to 
be strong if the length of the duplex is greater than 20 bp.    
 
There appears to be a change in the mode of SAP binding when the length of 
the duplex DNA reaches 48 bp, as indicated by a change in the general trend of 
the Kd versus duplex length (figure 3.24). These data may indicate that the 
increase in duplex DNA length from 24 bp to 48 bp facilitates the addition of a 
second SAP pentamer. Figure 3.21 shows that during association in the 
presence of 27 nM SAP, the change in dynamic response was initially relatively 
fast, but then plateaued giving rise to the hump. The dynamic response then 
decreased further before it reached a plateau at equilibrium. This suggests that 
there could have been some movement of SAP on the DNA - repositioning, or 
perhaps sliding along the duplex. Whilst it may seem unlikely, it may be 
possible that the DNA can thread through the central pore of the SAP 
pentamer, therefore allowing it to slide along the DNA duplex. Theoretically, the 
pore in the centre of the pentamer is of sufficient diameter (approximately 20 
Å) to allow a B-form DNA duplex to pass through. The mutational analyses 
described previously show that the Lys 87 residue is involved in DNA binding. 
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This amino acid is situated next to, and protrudes into, the inside of the pore. If 
this were the case however, it is unclear how the residues Arg 77 and Lys 143, 
which were shown to be most important for DNA binding, would interact with 
the DNA. Some proteins contain more than a single DNA binding domain and, 
therefore, are able to bind DNA in more than one conformation or binding 
mode (reviewed by Siggers & Gordân, 2014). It may be possible that SAP is 
also able to bind DNA in several modes, perhaps interacting with the putative 
DNA-binding residues at different times.   
 
Stoichiometric analysis using SV-AUC highlighted the complexity of SAP-DNA 
binding. The c(s) distribution for the sample that contained only HEX-labelled 
duplex DNA showed a single peak with an s-value of approximately 3.5, 
indicating that a single monodisperse DNA species was present (figure 3.25). 
For the sample containing a 2:1 molar ratio of SAP to DNA, two further peaks 
(though both much shorter and broader than the free DNA peak) were 
observed, one with an s-value of approximately 8 s (figure 3.26), and another, 
smaller and broader still, with an s-value of approximately 14 s. The average 
molecular mass represented by the larger of the two new peaks (8 s) was 
estimated to be 149 kDa when a partial specific volume of 0.718 mL/g was 
used, which corresponds to a complex with a 1:1 SAP to DNA stoichiometry. 
The calculated molecular mass of this complex was 152.6 kDa. No molecular 
mass could be assigned to the smaller peak (14 s). 
 
Due to the broad and asymmetrical nature of the peaks, it was difficult to 
assign a definitive molecular mass because there were likely to be several 
species present with different sizes and/or shapes (and hence, sedimentation 
coefficients). A significant proportion of the DNA appears to have remained 
unbound by the SAP. This is interesting, considering the low nanomolar Kd 
determined by EMSA and switchSENSE. It is unclear why this may be the case, 
but it may highlight the possible caging effect of EMSA, producing artificially 
stable complexes. This cage effect would not be observed in an AUC 
experiment, in which the SAP and DNA are free in solution. It may also 
highlight the effect of mass transport occurring at the sensor surface during 
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switchSENSE experiments. This can occur when the protein dissociates from 
one surface-tethered ligand and then immediately re-associates with another, 
thus providing an artificially low dissociation rate constant, which leads to an 
artificially low Kd.  
 
The large peak observed in figure 3.27 (showing the c(s) distribution for the 
sample containing an 8:1 molar ratio of SAP to DNA) indicates that there was a 
range of complexes present in the sample, with a range of sedimentation 
coefficients. Using a partial specific volume of 0.729 mL/g, which corresponds 
to a complex with a 2:1 SAP to DNA stoichiometry, the average molecular mass 
represented by the peak was estimated to be 282 kDa. This is comparable to 
the calculated molecular mass for a 2:1 SAP-DNA complex, which is 297.9 kDa. 
However, whilst it is likely that two pentamers are able to bind to a 40 bp 
duplex, it was not possible to accurately assign a molecular mass to this peak, 
as it represented a large range of complexes, as indicated by its breadth and 
the presence of periodic humps, probably indicating that a variety of 
stoichiometries and binding modes were present in the sample.  
 
The experiments described in this chapter show that SAP-DNA binding appears 
to be rather complex. The interaction between SAP and DNA appears to be 
strong (for duplex DNA of 25 bp or longer), and there are a number of specific 
positively charged residues that are crucial for the formation of a stable 
interaction. But rather than forming a single discrete complex, the SAP-DNA 
interaction appears to involve a number of possible stoichiometries and/or 
binding modes, that are difficult to distinguish. Using the information gained 
from these experiments, structural investigation using DNA of 25 bp or longer 
will be undertaken in an attempt to uncover the structural basis of the 
interaction in molecular detail.  
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4. Structural analysis of the SAP-
DNA complex and mutant SAP 
 
4.1 Overview 
There is currently no structural information available regarding the SAP-DNA 
complex. The apparent complexity of this interaction was highlighted in chapter 
3, where it was shown that the SAP-DNA binding might involve several modes 
or stoichiometries, and that SAP appears to be able to bind any sequence of 
duplex DNA longer than approximately 20 bp. Therefore, in order to investigate 
the structure of the SAP-DNA complex, and thus, improve our understanding of 
its nature and possible function, structural analysis of the complex was 
attempted using X-ray crystallography. Attempts were therefore made to 
crystallise SAP in complex with double stranded DNA, using a variety of 
conditions. Although these attempts were ultimately unsuccessful, the process 
of SAP-DNA co-crystallisation that was undertaken is presented in this chapter. 
Structures were determined from four separate crystals (that later proved to be 
SAP only) during this process, and these are also presented in this chapter. 
These include two SAP structures that presented unique unit cell dimensions.    
 
In addition to SAP-DNA co-crystallisation, the structures of the previously 
mentioned recombinant SAP mutants were also investigated. By comparing the 
amino acid sequences of human SAP with those of various orthologues (that do 
not exhibit DNA-binding), five amino acids (Arg 77, His 78, Lys 87, Lys 143 and 
Arg 193) were highlighted as potentially playing a role in the stabilisation of the 
SAP-DNA interaction (see chapter 2). Following mutational analysis, four of 
these residues were shown to be heavily involved in forming a complex with 
DNA, as when these residues were mutated, DNA was bound very weakly, or 
not at all. Structural analysis of these mutants was therefore required in order 
to determine whether their apparent loss of affinity for DNA was truly due to 
the removal of a DNA-interacting amino acid, or rather, due to greater 
destabilisation of the SAP pentamer. Therefore, X-ray crystallographic analysis 
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of these SAP mutants (R77Q, H78Q, K87Q, K143Q and R193Q) was undertaken 
in order to investigate the effect of the mutations on the structure of 
pentameric SAP. Two of these SAP mutants, K87Q and R193Q SAP, were 
successfully crystallised with very similar unit cell dimensions to that of native 
sequence SAP. Using these crystals X-ray diffraction data was collected and 
their structures are presented in this chapter compared to the native sequence 
structure 3KQR. 
 
The structure of recombinant human SAP was previously determined in 2013 to 
a resolution of 2.2 Å, using SAP that contained an N-terminal His-tag (Orr and 
Kolstoe, unpublished). This structure is shown in figure 4.1 in comparison with 
the previously determined structure of ex vivo human SAP (3KQR) (Mikolajek et 
al., 2011). These structures correlate closely, as indicated by the RMSD for the 
alpha carbons of subunit A, which remains lower than 0.8 Å, except for those of 
the flexible loop between residues 23 and 31 where the RMSD rises to 1.1 Å. 
This provides further evidence that the recombinant SAP, which is expressed 
using the HEK 293 cell mammalian expression system, is very similar to 
physiological SAP. In this chapter several more structures of recombinant SAP 
are presented. In contrast to the structure displayed in figure 4.1, none of 
these recombinant proteins contains a His-tag, as they were each purified using 
PE-affinity chromatography as described in chapter 2.  
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Figure 4.1 Comparison of ex vivo and recombinant SAP. 
The previously described structure of ex vivo SAP (grey) is shown aligned with the structure of 
recombinant His-tagged SAP (purple), which was determined in 2013 (Orr & Kolstoe, 
unpublished). The graph below shows the RMSD of all alpha carbons of subunit A when the two 
structures are compared. This figure was using the PyMOL Molecular Graphics System, Version 
1.5 Schrödinger, LLC. RMSD calculations were performed using Superpose (Krissinel & Henrick, 
2004).  
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4.2 X-ray crystallography 
4.2.1 Protein crystallisation 
It is impossible to predict the exact conditions that will yield crystals for any 
particular protein, and sampling several different conditions using a sparse 
matrix screen is therefore usually performed in order to elucidate promising 
components. There are numerous factors that influence protein crystallisation 
including temperature, pH and ionic strength, but the most important factor in 
determining whether or not a protein will crystallise is sample purity, which 
needs to be at least 90% to 95% (Benvenuti & Mangani, 2007). Most protein 
crystallisation conditions contain a buffer, to stabilise the protein in its normal 
physiological state, and a precipitant such as polyethylene glycol (PEG) or 
ammonium sulphate, which reduce protein solubility by competing with the 
proteins to form interactions with water molecules. For vapour diffusion 
methods, the protein sample is used to dilute a small volume of crystallisation 
buffer and is subsequently placed in a sealed chamber along with a larger 
volume of undiluted crystallisation buffer. Water slowly diffuses from the 
protein sample to the crystallisation buffer containing the higher precipitant 
concentration, facilitating a slow and controlled concentration of the protein 
(figure 4.2a). The two most common techniques, the hanging drop and sitting 
drop, are outlined in figures 4.2b and 4.2c.  
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Figure 4.2 Crystallisation of macromolecules by vapour diffusion. 
Panel A shows the path of a typical vapour diffusion experiment. The protein containing 
solution is mixed, typically in a 1:1 ratio, with well solution containing a precipitant, and the 
drop sealed in a chamber in close proximity to undiluted well solution. The figure shows the 
relative change in concentrations of protein and precipitant within the drop. As water diffuses 
from the drop to the well solution, the concentration of the protein and precipitant in the drop 
concentrate. When the protein concentration reaches a certain point, crystal nucleation occurs 
around a particle such as dust, hair or protein aggregate. As the crystals start to increase in 
size, the concentration of protein in the drop is depleted, preventing precipitation by further 
concentration. Panels B and C show the two most common forms of vapour diffusion 
experiments, hanging drop and sitting drop respectively.  
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4.2.2 Properties of protein crystals 
Macromolecular crystals comprise regular repeating patterns of proteins that 
form a lattice. The unit cell of the lattice is the smallest repeating element that 
describes the entire crystal, and each unit cell packs perfectly against the next 
so that there is no space between. There are 14 possible lattice arrangements, 
these are called the Bravais lattices and they belong to the seven crystal 
systems (figure 4.3). The unit cell usually contains more than one asymmetric 
unit, which is the simplest repeating unit and is related to the other asymmetric 
units within the unit cell by a set of 32 possible symmetry operations (or 11 for 
chiral molecules) called point groups. When applied, these symmetry operations 
translate each asymmetric unit back to the same point, forming a closed group. 
Combining the 14 Bravais lattices with the 32 point groups provides 230 
different crystallographic space groups, only 65 of which are relevant for 
protein crystallography due to the chiral nature of biological macromolecules. 
These space groups describe the contents and internal symmetry of the unit 
cell, including rotational and screw axes.   
 
The unit cell can be described by the length of its edges (a, b and c) and the 
angles between them (α, β and γ) as shown in figure 4.3. It can be divided into 
an infinite number of parallel, equidistant planes called Bragg planes, which are 
described by Miller indices (figure 4.4). The spacing between these planes is 
related to, and can be determined by, the reflections observed by X-ray 
diffraction. Bragg’s Law describes the conditions that lead to an observable 
reflection following X-ray diffraction.  
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Figure 4.3 The seven crystal systems. 
The seven crystal systems are defined by the length of their edges (a, b and c) and the angles 
between them (α, β and γ), as well as by their internal symmetry. Each of the 14 Bravais 
lattices belongs to one of these systems, which when combined with the 32 point groups, 
provides the 230 possible unit cells. However, only 65 of these unit cells are relevant to 
biological macromolecules. Figure adapted from Crystallography Made Crystal Clear – Gale 
Rhodes.   
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Figure 4.4 Bragg planes and Miller indices. 
A unit cell can be divided into an infinite number of parallel, 3-dimensional planes called Bragg 
planes. The above example shows a tetragonal unit cell divided by a set of (234) planes. Miller 
indices are used to describe these planes. For example, the (234) planes divide this unit cell in 
two along the A edge, in three along the B edge and in four along the C edge. Figure adapted 
from Crystallography Made Crystal Clear – Gale Rhodes. 
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4.2.3 X-ray diffraction by protein crystals 
X-rays are a form of high-energy electromagnetic radiation that comprises 
discrete packets of energy (photons) that can also be described as oscillating 
with a wavelength typically between 0.01 and 10 nm. For X-ray crystallography, 
X-rays at the lower end of this range with higher energy (so called ‘hard X-
rays’) are used, with wavelengths typically ranging from 0.1-0.2 nm. The 
procession of the photons can be described as waves using sine or cosine 
functions, and are defined by their wavelength (frequency), amplitude and 
phase. When X-rays pass through a crystal, the vast majority of the radiation 
passes straight through with no effect. A small fraction of the X-rays however 
induce oscillations of the electrons within the crystal at the same frequency as 
the incoming radiation. The electrons subsequently emit waves of radiation, 
and where these waves are coherent (i.e. in phase and constructive), a 
scattered X-ray is observed. This is called coherent scattering. This scattering, 
or diffraction, by the Bragg planes can be used to determine their spacing. 
 
As shown in figure 4.5, only when the spacing between the Bragg planes 
satisfies the following equation, and constructive interference between 
diffracted X-rays is achieved, is a reflection observed: 
 2𝑑 sin 𝜃 = 𝑛𝜆																																																																																																																												(4.1) 
 
Where d (or dhkl) is the distance between the parallel Bragg planes, θ is the 
glancing angle of the X-ray and λ is the X-ray wavelength. Each reflection can 
be described as a complex three-dimensional wave (the sum of several simple 
waves), with an amplitude, frequency and phase. These waves contain 
information regarding the electron density at the Bragg planes and therefore 
every atom within the crystal contributes to each reflection. As shown in figure 
4.6, these reflections are present within a sphere called the Ewald sphere and 
correspond to reciprocal space, that is, they are inversely related to the real 
space within the crystal where electron density is situated.  
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Figure 4.5 Bragg’s law. 
Bragg’s law states that X-ray diffraction from a crystal will occur only when 2dhkl sinθ is equal to 
the X-ray wavelength, or multiples thereof, where dhkl corresponds to the distance between 
brag planes, and θ is equal to the incident angle of the X-ray. Only when these conditions are 
satisfied does constructive interference occur between the diffracted X-rays (instead of 
destructive interference) and in order to produce a reflection.   
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Figure 4.6 The Ewald construction. 
The Ewald sphere is centred on the crystal and has a radius of 1/λ. The limiting sphere (or 
resolution sphere) is centred on the origin of the reciprocal lattice and has a radius of 1/Dmax 
(the maximum resolution). For the conditions of Bragg’s law to be satisfied, and for a reflection 
to be recorded, the reciprocal lattice points must come into contact with the edge of the Ewald 
sphere (red dots). As the crystal is rotated in the beam, the reciprocal lattice also rotates, 
giving rise to a cone of reflections. However, only reciprocal lattice points situated within the 
limiting sphere can generate a reflection.   
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The relationship between real space and reciprocal space can be described as: 
 𝑎ℎ	, 𝑏𝑘 	, 𝑐𝑙 																																																																																																																																								(4.2) 
 
Where a, b and c are the unit cell edges (figure 4.3) and h, k and l are indices 
in reciprocal space, centred on the origin of the reciprocal lattice (at the beam 
centre). This dictates that a single reflection corresponds to a set of parallel 
planes and the distance between the reflections is inversely related to the 
spacing between the Bragg planes. The further the reflection is from the origin 
(beam centre), the smaller the distance between the planes, which therefore 
provides higher resolution information about the electron density within the unit 
cell.  
 
Reflections can be described as the sum of all X-rays diffracted by a set of 
Bragg planes and can be summarised using Fourier mathematics by the 
following equation, called the structure factor equation, which is used to relate 
the reflections observed in reciprocal space to the electron density observed in 
real space: 
  
𝐹{S| = 𝜌(𝑥, 𝑦, 𝑧) 𝑒?({WSW|)𝑑𝑥	𝑑𝑦	𝑑𝑧																																																																(4.3) 
 
Where ρ(x, y, z) corresponds to the electron density. To obtain the electron 
density, given the structure factors obtained from the observed reflections, a 
Fourier transform is applied as follows: 
 𝜌 𝑥, 𝑦, 𝑧 = 	  𝐹{S|𝑒R? {WSW||S{ 																																																																					(4.4)  
 
However, although the amplitudes of the structure factors can be determined 
from the intensities of the reflections ( 𝐹{S| ∝ 𝐼{S| ), and the frequencies can 
be determined from the position of the reflections, all information regarding the 
phase of the structure factors is lost and cannot be directly determined. This 
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presents one of the major problems for structure determination using 
macromolecular crystallography.  
 
4.2.4 Data collection 
Data collection is obtained from X-ray diffraction using high energy 
monochromatic X-rays, which are necessary because more than one 
wavelength would give rise to more than one sphere of reflection (as shown in 
figure 4.6) and would be impossible to index. Synchrotron radiation sources 
such as the Diamond Light Source (depicted in figure 4.7) offer significant 
advantages over laboratory-based sources as they provide high-brilliance, micro 
focussed X-ray beams with precise and adjustable wavelengths. As well as high 
brilliance, the speed and efficiency of pixel array detectors available at 
synchrotrons means that data collections take only minutes at a synchrotron, 
where they may take several hours when using a laboratory source.  
 
The majority of data collections are performed at temperatures of 
approximately 100 K. Crystals are quickly cryocooled (in the presence of a 
cryoprotectant) by either submerging in liquid nitrogen or mounting the crystal 
directly onto a goniostat (a platform upon which a crystal is attached for data 
collection and can be rotated 360° in several angles whilst in the X-ray beam) 
and cooling using a cryostream. The crystal can then either be used for data 
collection or stored in liquid nitrogen. The main advantage of 
cryocrystallography is that radiation damage (caused by radicals generated by 
the ionising X-ray radiation) is significantly reduced. The lifetime of a crystal 
cooled to 100 K can be expected to increase by a factor of approximately 70 
compared to room temperature (Nave & Garman, 2005). Another advantage of 
cooling the protein crystal to such low temperatures is that movement within 
flexible regions of the protein is reduced and can lead to clearer electron 
density maps at high resolutions.  
 
The most common method of diffraction data collection (and the method used 
throughout this thesis) is the rotation method, in which the crystal is rotated in 
the X-ray beam in small (typically 0.1-1.5°) increments about the phi (φ) angle.  
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Figure 4.7 A schematic diagram of the Diamond Light Source. 
The Diamond (Dipole and multipole output for the nation at Daresbury) Light Source is 
situated at Harwell, Oxfordshire. It is able to produce much more intense X-rays than a home 
source diffractometer, by bending an accelerated electron beam with an energy of 3 GeV.   
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For a 360° data collection, this is repeated 3600 times, although depending on 
the unit cell symmetry, a 360° data collection may not be necessary.    
 
Diffracted X-rays are recorded using a detector that can measure the position 
and intensity of incoming reflections. There are two types of detector 
commonly used for modern protein X-ray crystallography; these are the charge-
coupled device (CCD) detectors and hybrid photon counting (HPC) detectors.  A 
single module of a CCD detector (that can contain an array of 4000×4000 
modules) consists of a thin phosphor sheet placed immediately in front of a 
fibre-optic taper, which leads to a CCD chip. An incoming X-ray is converted 
into visible light by the phosphor sheet and the light subsequently travels 
through the fibre-optic taper where the photon sensitive CCD chip records it 
and converts it into an electrical charge. However, more recently HPC detectors 
have become more common for use in X-ray diffraction experiments, 
particularly when using synchrotron sources. HPC detectors comprise a pixel 
array, each pixel consisting of a silicon sensor layer that is bump-bonded onto 
an electronic chip. When an X-ray contacts the sensor layer, it is directly 
converted into a current, by the generation of electron-hole pairs, which is then 
transferred to the chip (Allé et al., 2016). HPC detectors offer a much greater 
dynamic range and signal to noise ratio than CCD detectors, as well as a much 
faster detection rate.  
 
Indexing is the process of recording the intensity and position of each observed 
reflection (by assigning a Miller index), therefore allowing the determination of 
the unit cell. For the datasets presented in this chapter, iMosflm (Battye et al., 
2011) or otherwise xia2 (Winter et al., 2013) automatic indexing was used, 
which makes use of XDS. iMosflm initially selects around 200 spots, which are 
subsequently integrated to determine their intensity, giving a set of reciprocal 
lattice points. A fast Fourier transform (FFT) is then performed to convert these 
lattice points into unit cell dimensions in real space. Once the dimensions of the 
unit cell have been calculated, they are distorted to fit the 14 Bravais lattices. 
The position of the calculated reciprocal lattice points are then compared to 
those that would be expected for each of the determined space groups, and a 
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penalty system used to select the space group with the highest symmetry and 
lowest penalty (Powell, 1999). The data is then fully integrated, providing a full 
list reflection intensities relating to reciprocal lattice points. 
 
In order to judge the quality of the data, the Rmerge metric can be used, which is 
a measure of the discrepancy between symmetry-related reflections (or Friedel 
pairs). The Rmerge is described by the following equation: 
 𝑅JiJ = 𝐼 ℎ𝑘𝑙 − 𝐼 ℎ𝑘𝑙{S| 𝐼 ℎ𝑘𝑙{S| 																																																																																			(4.5)	
    
where 𝐼 ℎ𝑘𝑙  is the intensity of a particular reflection, and 𝐼 ℎ𝑘𝑙  is the average 
of all symmetry-related reflections. The data quality is considered to be good 
when the Rmerge is less than 0.2. The Rmerge can, however, be an unreliable 
metric for assessing data quality as it has been shown to increase with 
increasing redundancy (Diederichs & Karplus, 1997), therefore falsely 
discriminating against datasets with high multiplicity. This can however be 
rectified by using another metric called the Rmeas, which is a redundancy-
independent version of the Rmerge. The Rmeas is described as follows: 
 
𝑅Jh^ = 𝑛𝑛 − 1 𝐼 ℎ𝑘𝑙 − 𝐼 ℎ𝑘𝑙D{S| 𝐼 ℎ𝑘𝑙{S| 																																																																		(4.6)	
    
where n is the multiplicity of the dataset. Other useful matrices for analysing 
data quality are 𝐼/𝜎(𝐼)  and CC1/2. These are particularly useful when 
determining where to set the resolution cut-off. 𝐼/𝜎(𝐼) (Reflection 
intensity/error) is the signal to noise ratio, which should be greater than 2.0 in 
the highest resolution shell. The CC1/2 can be determined by randomly dividing 
the experimental data into two sets, so that each set contains half of the 
recorded measurements of each reflection. The Pearson’s correlation coefficient 
between the two sets is then calculated, which measures the strength of the 
correlation between them. Data is typically omitted at resolutions corresponding 
to a drop in the CC1/2 to below 0.5.     
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Following integration the data must be scaled and merged (also termed data 
reduction). This process merges individual reflections that have been recorded 
multiple times. However, because these reflections are not all recorded at the 
same time, their intensity can vary due to radiation damage degrading the 
crystal, or fluctuations in the X-ray beam intensity. As these reflections are 
identical, their intensities should also be the same. The relative intensities of 
identical reflections are therefore scaled. For all datasets described in this 
chapter, scaling and merging was either performed using AIMLESS (Winn et al., 
2011) or was automatically processed using xia2, which makes use of XSCALE.    
 
4.2.5 Phase calculation  
Whilst the amplitude and frequency of a diffracted X-ray can be determined 
from a diffraction experiment using the intensity and position of a measured 
reflection, all information regarding its phase is lost. In order to construct an 
electron density map the phases of the structure factors must first be 
calculated, either experimentally using direct methods, or computationally, by 
‘borrowing’ the phases from an homologous structure. Isomorphous 
replacement and anomalous scattering using heavy-atom derivatives are two 
commonly used direct methods of phase calculation.  
 
For isomorphous replacement, two crystals are used for X-ray diffraction, one 
native and one heavy-atom derivative. The phases of the heavy-atom structure 
factors (the reflections that relate to Bragg planes intersecting the heavy-
atoms) can be calculated by locating the heavy-atoms within a Patterson map. 
The construction of a Patterson map can be performed using the data directly 
obtained from a diffraction experiment, as only the intensities (squared 
structure factor amplitudes) are required. The Patterson map is described as 
follows, and is essentially the same as the equation for the calculation of the 
electron density map (equation 4.4), although in this case all phases are set to 
zero.  
 𝜌 𝑢, 𝑣, 𝑤 = 	  ( 𝐹{S| )?𝑒R? {WSW||S{ 																																																											(4.7)        
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Instead of describing the location of electron density within the unit cell, the 
Patterson map provides information about the vectors between atoms. For very 
simple chemical structures (or heavy-atom substructures), it is possible to 
determine the location of atoms and therefore also compute the phase. This is 
not possible for protein structures, for which the Patterson maps are extremely 
complicated. Once the heavy-atom structure factors have been calculated 
(complete with phases), this information can be used to calculate the phases of 
the native protein structure factors, which are geometrically related as 
described by the following equation: 
 𝐹 = 𝐹 − 𝐹																																																																																																																									(4.8) 
 
where Fp is the native protein structure factor, FPH is the derivative protein 
structure factor, and FH is the heavy atom structure factor.  
 
For phase determination using anomalous scattering, a single heavy-atom 
derivative crystal is used. However, two data collections are performed at 
different wavelengths, with one wavelength being close to the absorption edge 
of the respective heavy-atom. When the wavelength is close to the absorption 
edge, the heavy atoms absorb and reemit a fraction of the incoming radiation 
with an altered phase and intensity. In these cases, Friedel’s law (ℎ𝑘𝑙 = ℎ𝑘𝑙), 
which states that reflections with conjugate phases (i.e. Friedel pairs) have 
identical intensity, does not hold. The location of the heavy-atoms can be 
calculated using the Patterson methods described previously, and once their 
location, and hence phases, are known, the vectors representing anomalous 
scattering contributions can also be calculated. This allows the calculation of 
structure factor phases of the non-anomalous scattering dataset using the 
following equation: 
 𝐹? = 𝐹 + 𝛥𝐹i + 𝛥𝐹																																																																																																								(4.9) 
 
where 𝐹? is the anomalous scattering dataset using the wavelength close to 
the heavy-atom absorption edge, 𝐹 is the non-anomalous scattering dataset, 
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and 𝛥𝐹i and 𝛥𝐹 are the anomalous scattering vectors in the real and imaginary 
planes respectively.  
 
Currently the most common method of phase calculation, and the method used 
throughout this thesis, is molecular replacement using PHASER (McCoy et al., 
2007). Molecular replacement relies on the availability of a protein (search) 
model with a high degree of homology to the target protein, from which the 
phases may be ‘borrowed’. A Patterson map is first constructed for both the 
search model and the target protein using the diffraction data. These maps are 
then compared and aligned in order to obtain estimates of the phases and 
calculate the structure factors of the target protein. However, it is often much 
more complicated as the search model and target protein are rarely in the same 
orientation within the unit cell. In these cases (non-isomorphous phasing), it is 
essential to first properly orient the search model Patterson map to align with 
that of the target protein. In three-dimensional space this presents a significant 
challenge, but can be simplified by breaking the alignment down into an initial 
rotational search followed by a translational search. The search model 
Patterson map is first rotated in small increments about the x, y and z axes to 
align the peaks corresponding to intramolecular atomic vectors, which are 
located close to the origin. Maximum likelihood estimation is used to find the 
best orientation by judging how well the current model describes the observed 
data. Following the rotation search, the search model Patterson map is then 
translated in the x, y and z dimensions until the peaks overlap and initial 
estimates of structure factor phases can be calculated, and hence, an initial 
electron density map. In order to judge the best solution (and determine 
whether molecular replacement was successful) the Translation Function Z-
score (TFZ) is typically used. The TFZ is computed by determining the mean 
Log Likelihood Gain (LLG) of a random set of translations and the RMSD of the 
random set compared to the LLG of the current solution. The LLG is defined as 
the difference in likelihood between the current model and that of a random 
model. The TFZ is the LLG of the current model after the mean has been 
subtracted and then divided by the RMSD. The TFZ therefore describes the 
number of standard deviations away the current model is from the mean. 
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Typically a TFZ of greater than 8 indicates that molecular replacement has been 
successful.  
 
A process of iterative refinement is subsequently used to improve the initial 
model and decrease the residual index factor (R factor), which is the main 
metric used to describe discrepancy between the calculated and observed 
models. The R factor is calculated as follows: 
 𝑅 = 𝐹C7^ − 𝐹h|𝐹C7^ 																																																																																																							(4.10)	
   
where, for each reflection, 𝐹C7^  is the structure factor amplitude calculated 
from the observed reflection intensity, and 𝐹h|  is the structure factor 
amplitude calculated from the current model. For a good molecular replacement 
solution, the R factor can be expected to be below 0.3 (30% discrepancy 
between the observed data and the current model). 
 
4.2.6 Refinement 
Following phase calculation, a molecular model (a pdb file containing atomic 
coordinates) of the search model is generated within the newly calculated 
electron density map. In order to improve the fit of the model to the electron 
density, the atomic positions can be altered and water molecules and ligands 
can be incorporated into the areas of unmodelled electron density. Two 
electron density maps are typically generated called the composite map (2FO-
FC) and the difference map (FO-FC) where FO are the observed structure factors 
and FC are the calculated structure factors. Composite maps are preferable to 
direct maps (generated directly from observed structure factors) because they 
help to reduce the bias in the structure generated by using the observed 
structure factors with the calculated phases, which have been ‘borrowed’ from 
the molecular replacement search model. The Fo-Fc difference map is useful 
because it shows where there is positive electron density (where there are 
atoms missing in the calculated model), and where there is negative electron 
density (where the calculated model contains atoms not present in the 
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observed data). Model building programs such as Coot (Emsley et al., 2010) 
can subsequently be used to model the protein and ligands to the positive 
electron density, and remove atoms from negative density.   
 
As well as manually manipulating the protein model, structure refinement 
programs are available to improve the model and calculated phases based on a 
number of parameters, such as atomic geometry (bond angles and lengths), 
atomic displacement parameter (also known as B-factor, this relates to the 
deviation of an atom from its mean position due to thermal motion) and also 
real-space refinement (fitting atoms directly to the electron density). For the 
structures described in this chapter, refinement was performed using either 
Phenix.refine (Adams et al., 2010) or Refmac5 (Murshudov et al., 1997).  
 
Improvement in the modal is usually judged by an improvement (or lowering) 
of the R factor, or Rwork (equation 4.10). However, the Rwork can be artificially 
improved by over-refinement. To prevent this, another residual index factor is 
calculated as per equation 4.11, this time using the 𝐹h|  for a ‘free’ set of 
reflections (around 5% of the data) that has been set aside and not used for 
any of the refinement steps. This is called the Rfree. It is therefore possible to 
ensure that the model is not over-refined by ensuring that the Rwork and the 
Rfree do not differ by more than approximately 5%.   
 𝑅EiJJ = 𝐹C7^ − 𝐹h|EiJJ^JY 𝐹C7^EiJJ^JY 																																																																																					(4.11) 
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4.3 Methods 
4.3.1 Construction of 96-well sparse matrix (sitting drop) 
crystallisation screens 
Commercially available sparse matrix screens, typically Nucleix (Qiagen), JCSG-
plus (Molecular Dimensions) or PACT premier (Molecular Dimensions) (see 
appendix 10 for conditions), were used to fill the reservoirs of a polystyrene 96-
well MRC crystallisation plate (Molecular Dimensions), with 70 μL being 
aliquotted into each reservoir. Plates were then placed into a HoneyBee X8 
crystallisation robot (Cronus Technologies), and 10 nL of the reservoir solution 
dispensed into each corresponding well. The robot was then used to dispense 
10 nL of protein (or protein-DNA) sample into the first well, and sample buffer 
into the second well of each grid point. Plates were subsequently sealed using 
ClearVue sealing sheets (Molecular Dimensions) and incubated at 16 °C for 
crystal growth.      
 
4.3.2 Construction of 24-well (hanging-drop) manual 
crystallisation screens 
High-vacuum silicone grease (Dow Corning) was applied to the rim of each well 
of a 24-well plate (Greiner Bio-One). Subsequently, 1 mL of well solution was 
dispensed to each corresponding well. A 4 μL drop, typically containing a 1:1 
mixture of protein sample and well solution, was placed onto a glass cover slip, 
which was carefully inverted and pressed onto the corresponding well, ensuring 
an air-tight seal. This was repeated for each of the wells before the plate was 
incubated at 16 °C for crystal growth. See appendix 10 for all manual 
crystallisation screen conditions.      
 
4.3.3 Collection and cryocooling of crystals 
Suitable crystals were collected from the crystal growth plates using mounted 
round litholoops (Molecular Dimensions) with diameters ranging from 0.1 mm 
to 1.0 mm chosen to approximately match the crystal size. Crystals were briefly 
washed in a solution of mother liquor containing an appropriate cryoprotectant 
(if required) before being mounted on the goniostat of the in-house 
diffractometer (Xcalibur Nova, Oxford Diffraction) and rapidly cooled to 100 K 
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using a cryostream (Cryojet, Oxford Diffraction). Loops containing cryocooled 
crystals were subsequently transferred to loading pucks (Diamond Light Source) 
that were submerged in liquid nitrogen. Once full (each puck holds up to 16 
mounted litholoops), the pucks were transferred to a liquid nitrogen storage 
dewar for long-term storage, or to a dry shipper for transport to the Diamond 
Light Source.   
 
4.4 Results 
4.4.1 Attempted crystallisation of the SAP-DNA complex 
4.4.1.1 First round of SAP-DNA crystallisation screens  
SAP-DNA co-crystallisation screens were initially constructed using the 25 bp 
DNA duplex with 50% G+C content used for EMSA analysis (Table 3.1). This 
was the shortest duplex DNA length analysed that bound to SAP with a low 
nanomolar Kd. The shortest possible length was preferable so as to remove any 
excess unbound DNA that might prevent the formation of an ordered crystal 
(Hollis, 2007). Recombinant native SAP was mixed with the 25 bp duplex 
(single stranded oligonucleotides had been previously annealed and purified as 
described in sections 3.2.1 and 3.2.2) in TC+PE buffer (10 mM Tris-HCl pH 7.4, 
140 mM NaCl, 2 mM CaCl2, 10 mM PE) to a final concentration of 6 mg/mL SAP 
and a 4:1 molar ratio of SAP to DNA. Using this complex, a 24-well manual 
hanging drop crystallisation screen (using the standard SAP screen conditions -
see appendix 10) was subsequently constructed. A 96-well sparse matrix screen 
was also constructed using the Nucleix suite of conditions, which is a screen 
that was designed specifically for the co-crystallisation of protein–DNA 
complexes. Several conditions appeared to yield suitable crystals, which were 
collected and cryocooled as previously described (4.3.3).  
 
4.4.1.2 Native SAP 1 dataset 
Following X-ray diffraction experiments at beamline I04-1 Diamond Light 
Source, each of the crystals that had been collected appeared to contain an 
almost identical unit cell to that of native SAP. The Matthews coefficient 
(defined as the unit cell volume/protein molecular weight) was determined to 
be 2.32 for this monoclinic unit cell containing a single SAP pentamer and a 
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single 25 bp duplex in the asymmetric unit (Matthews, 1968). This value 
corresponds to a single unit cell containing 52.75% solvent compared to 53.6% 
for the native protein. Protein crystals have been reported to contain anywhere 
from 27% to 78% solvent, but most commonly containing approximately 43% 
(Kantardjieff & Rupp, 2003). It was therefore possible that these crystals might 
contain DNA as well as protein. The best data set (with the highest resolution, 
highest completeness and lowest Rmeas, determined initially using xia2 
automatic data reduction) was therefore selected for processing. This data set 
was collected at 100 K, using 0.15° oscillations for 360°. The crystallisation 
conditions in which this crystal was grown are displayed in table 4.1, and figure 
4.8 shows a picture of the crystal following cryocooling (see Native SAP 1). 
Indexing was performed using iMosflm and scaling and merging performed 
using AIMLESS. The data was cut at a resolution of 1.8 Å, which correlates to a 
CC1/2 of 0.5. The unit cell dimensions and data collection statistics for this 
dataset are displayed in table 4.2.  
 
Subsequent molecular replacement was performed using PHASER, with native 
SAP (3KQR) used as a search model. The TFZ following molecular replacement 
was 8.8, indicating that a solution had been found successfully. In addition, 
when the electron density difference map (FO-FC) for the structure was 
examined, large positive density peaks were observed around the calcium-
binding sites that corresponded to the calcium ions and PE. This provided 
further evidence that molecular replacement was successful, as these atoms 
were not included in the search model. An initial round of refinement was 
performed using Refmac5, after which the FO-FC electron density difference 
map was examined, in order to look for evidence of DNA present in the crystal. 
However, there appeared to be no positive electron density that suggested the 
presence of DNA. Upon inspection of the protein packing within the crystal unit 
cell (shown in figure 4.9), it was found that it was identical to the packing 
observed in the native SAP structure (3KQR). One of the crystal contacts that 
was observed in this structure was a salt bridge between Arg 77 of one SAP 
pentamer with Asp 161 of an adjacent pentamer.  
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Table 4.1 The crystallisation conditions in which the Native SAP 1 crystal were 
grown. 
 
 
Figure 4.8 Native SAP 1 crystal. 
This figure shows the Native SAP 1 crystal after mounting and cryocooling. This image was 
taken prior to X-ray diffraction data being collected at the Diamond Light Source.  
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Table 4.2 Summary of the crystallographic data processing and refinement statistics 
for the Native SAP 1 structure. 
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Figure 4.9 Packing of SAP within the Native SAP 1 crystal. 
This monoclinic unit cell is identical to that of previously described SAP structures, with a unit 
cell of a=94.5 Å, b=69.48 Å, c=101.71 Å, α=90°, β=97.17°, γ=90°. There does not appear to 
be sufficient space for 25 bp duplex to be present within the crystal. Also, Arg 77 (an amino 
acid which was previously highlighted as being integral in the SAP-DNA interaction) appears to 
form a salt bridge with Asp 161 of a neighbouring pentamer. This figure was using the PyMOL 
Molecular Graphics System, Version 1.5 Schrödinger, LLC. 
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As described in chapter 3, Arg 77 was found to be a key residue in the 
stabilisation of the SAP-DNA complex, so it was therefore unlikely that there 
was any DNA present with this conformation of SAP pentamers within the unit 
cell. Nevertheless several more rounds of refinement were performed and the 
final refinement statistics for this structure are displayed in table 4.2. 
 
4.4.1.3 Native SAP 2 dataset 
Interestingly, after several days at room temperature crystals also appeared to 
grow in the protein-DNA stock that was used to construct the previous 
crystallisation screens. Several crystals were collected and washed in a solution 
of mother liquor containing approximately 15% glycerol. However, using an in-
house diffractometer - Xcalibur Nova (Oxford Diffraction) with a sealed-tube 
copper X-ray source (40 kV, 0.8 mA, 1.54 Å), it was found that after 
cryocooling these crystals did not diffract. Therefore, a room temperature 
crystal mounting kit (MicroRT, MiTeGen) was used to seal the mounted crystal 
within a capillary, which contained 40 μL of mother liquor in order to maintain 
the humidity and keep the crystal hydrated. Table 4.3 shows the crystallisation 
conditions in which the crystal grew, and figure 4.10 shows an image of the 
mounted crystal. A full 360° of X-ray diffraction data was collected using the in-
house diffractometer, with 1° oscillations.  
 
Automatic indexing and data reduction was performed using CrysAlisPro 
software (Agilent Technologies). The data was cut at a resolution of 2.9 Å, 
which correlated to a CC1/2 of 0.52. This crystal also appeared to present the 
same unit cell dimensions as native SAP, which are displayed in table 4.4 along 
with the data collection statistics (see Native SAP 2). Subsequent molecular 
replacement was performed using PHASER, with the native SAP structure 
(3KQR) used as a search model. The final TFZ of the molecular replacement 
solution was 35.1, indicating that it was strong. Following an initial round of 
refinement using Refmac5, the crystal packing was examined and found to be 
identical to the previous SAP structure, again suggesting that DNA was not 
present. Several more rounds of refinement were performed, and the final 
refinement statistics are displayed in table 4.4.  
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Table 4.3 The crystallisation conditions in which the Native SAP 2 crystal were 
grown. 
 
 
Figure 4.10 Native SAP 2 crystal. 
This image shows the Native SAP 2 crystal mounted on the goniometer of the in-house 
diffractometer. Other crystals that were grown in in the same conditions were damaged by 
cryocooling and subsequently did not diffract. Data diffraction was therefore performed at room 
temperature, with the mounted crystal sealed within a capillary. 
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Table 4.4 Summary of the crystallographic data processing and refinement statistics 
for the Native SAP 2 structure. 
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4.4.1.4 Initial native SAP structures 
Figures 4.11 and 4.12 show the RMSD of all the alpha carbons along the length 
of a single subunit for the two native SAP structures (Native SAP 1 and Native 
SAP 2), respectively, compared to those of the ex vivo SAP structure (3KQR). 
Both structures appear to align very closely with the ex vivo SAP, with the 
RMSD of the first structure (Native SAP 1) remaining below 0.34 Å with the 
exception of the terminal residues and the loop between residues 23 and 31. 
The second structure (Native SAP 2), the data for which was collected at room 
temperature, displays less uniform RMSD values along the length of the 
subunit, but still remaining below 0.7 Å, with the exception of the flexible loop. 
Figure 4.13 shows the two native SAP structures coloured by B-factor. The B-
factors of the native SAP 2 structure appear to be significantly greater than 
those of the native SAP 1 structure. This is likely to be partly due to the lower 
resolution of the native sequence 2 structure, but also due to the data 
collection having been performed at room temperature, allowing a much 
greater degree of thermal motion.  
 
As the data collection for the Native SAP 2 structure was performed at room 
temperature, it is not surprising that the RMSD values display greater variation. 
The overall B-factor of 34.71 for the Native SAP 2 structure compared to 10.47 
for the Native SAP 1 structure correspond to the greater degree of thermal 
motion exhibited by the SAP at room temperature compared to SAP at 100 K. 
The increased movement of atoms in the room temperature crystal is likely to 
have contributed to the lower resolution of the diffraction data collected. This 
may also be due to radiation damage, as crystals used for X-ray diffraction at 
room temperature are damaged far quicker than cryocooled crystals (Garman & 
Owen, 2006). Radiation damage typically results in lower resolution data.  
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Figure 4.11 Comparison of the Native SAP 1 structure with that of ex vivo SAP. 
The top figures show the Native SAP 1 structure aligned with that of the previously described 
structure of native SAP (3KQR). The proteins appear to align closely along the main chain, with 
the only noticeable difference being the loop between residues 23 and 31. This is highlighted by 
the graph below, in which the RMSD of all alpha carbons of subunit A are displayed. The RMSD 
remains below 0.34 Å for all alpha carbons, with the exception of the terminal amino acids, and 
the flexible loop. This figure was using the PyMOL Molecular Graphics System, Version 1.5 
Schrödinger, LLC. RMSD calculations were performed using Superpose (Krissinel & Henrick, 
2004).    
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Figure 4.12 Comparison of the Native SAP 2 structure with that of ex vivo SAP. 
The upper images show the Native SAP 2 structure aligned with that of the previously described 
ex vivo SAP. The lower graph shows the RMSD of all alpha carbons in subunit A when 
compared to the ex vivo SAP. As is the case with the other SAP structures, the only significant 
deviation from the ex vivo structure is the flexible loop between residues 23 and 31. This 
structure does appear to exhibit a greater variation in the RMSD values of the alpha carbons 
than the Native SAP 1 dataset, but they typically remain below 0.7 Å, with the exception of the 
flexible loop. This figure was using the PyMOL Molecular Graphics System, Version 1.5 
Schrödinger, LLC. RMSD calculations were performed using Superpose (Krissinel & Henrick, 
2004).   
 167 
 
 
 
Figure 4.13 Native SAP structures coloured according to B-factor 
This figure shows the native SAP 1 and native SAP 2 structures (viewed from the A face) 
coloured according to their B-factor. The thickness of the ribbon also corresponds to B-factor, 
with the thicker areas indicating a greater degree of thermal motion than the thinner areas. 
This figure was using the PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC.      
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4.4.1.5 Second round of SAP-DNA crystallisation screens 
Crystallisation screens were next constructed that contained the 30 bp DNA 
duplex with 50% G+C content (shown in table 3.1), as this duplex exhibited 
stronger binding by SAP than the 25 bp duplex, and it was thought that a more 
stable complex would aid crystallisation. The molar ratio of SAP:DNA was also 
reduced to 2:1, a ratio at which all DNA was observed to be bound by SAP 
using EMSA (see chapter 3), in order to try and encourage complex formation 
instead of crystallisation of the SAP alone. The SAP and duplex DNA (prepared 
as previously described) were mixed together in a 2:1 molar ratio in TC+PE 
buffer (10 mM Tris-HCl pH 7.4, 140 mM NaCl, 2 mM CaCl2, 10 mM PE), 
resulting in a final SAP concentration of 7.3 mg/mL. This mixture was used to 
construct three sparse matrix screens using the Nucleix suite, JCSG+ and PACT 
premier conditions.  
 
After incubation for a week at 16 °C, small microcrystals appeared to grow in 
three of the conditions of the Nucleix suite screen (solutions 5, 9 and 59), and 
in one of the conditions of the JCSG+ screen (solution B8). Although these 
crystals were too small to collect X-ray diffraction data, 24-well manual focus 
screens were constructed around these conditions using the same SAP-DNA 
stock, in order to encourage the growth of diffraction quality crystals (the 
conditions of these screens can be found in appendix 10, listed as focus screen 
1, 2, 3 and 4).  
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4.4.1.6 Native SAP 3 dataset 
A number of crystals were collected from the focus screens and cryocooled as 
previously described, prior to X-ray diffraction experiments performed at 
beamline I03 of the Diamond Light Source. Each of these crystals presented 
identical unit cell dimensions to those of native SAP, with the exception of a 
single crystal collected from well B2 of focus screen 3 (see table 4.5 for 
crystallisation conditions of Native SAP 3, and figure 4.14 for a picture of the 
mounted crystal). This crystal appeared to present unique orthorhombic unit 
cell dimensions. Data was collected at 100 K, with 360° of data collected in 0.1° 
oscillations. Automatic data reduction was performed using xia2 3dii (which 
makes use of XDS and XSCALE to index, scale and merge the raw diffraction 
data) and the resolution of the collected data was cut at 2.09 Å, which 
correlated with a CC1/2 of 0.5. A summary of the data collection statistics for 
this dataset is shown in table 4.6. Data reduction was followed by molecular 
replacement using PHASER, with the native SAP structure (3KQR) used as a 
search model. A single pentamer was searched for in the asymmetric unit, 
which provided a theoretical unit cell containing 44.83% solvent without DNA 
present, or 43.62% solvent with DNA present. The final TFZ of the molecular 
replacement solution was 25.4, indicating that it was successful. After an initial 
round of refinement using Refmac5, the crystal packing and electron density 
were examined. Figure 4.15 shows the crystal packing for the Native SAP 3 
structure. The crystal packing suggests that although the volume of this unit 
cell is larger than that of the previously described SAP structures, it is unlikely 
to contain DNA, with close packing of pentamers observed in the regions 
expected to interact with DNA. There was also no visible evidence of positive 
electron density in the FO-FC map to suggest that DNA was present. Because 
this structure did not appear to contain DNA, it was not refined further.  
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Table 4.5 The crystallisation conditions in which the Native SAP 3 crystal were 
grown. 
 
 
Figure 4.14 Native SAP 3 crystal. 
This figure shows the Native SAP 3 crystal after mounting and cryocooling. This image was 
taken prior to X-ray diffraction data being collected at the Diamond Light Source.  
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Table 4.6 Summary of the crystallographic data processing of the Native SAP 3 
structure. 
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Figure 4.15 Packing of SAP within the Native SAP 3 crystal. 
The Native SAP 3 crystal presented a unique orthorhombic unit cell, in which SAP has not 
previously crystallised (a=65.9 Å, b= 96.8 Å, c=177.87Å, α=90°, β=90°, γ=90°). This figure 
shows the conformation of SAP pentamers within the unit cell. This unit cell was estimated to 
contain 44.83% solvent without DNA present, or 43.62% solvent with DNA present. This figure 
was using the PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC. 
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4.4.1.7 Third round of SAP-DNA crystallisation screens  
It has been suggested that due to unavoidable single stranded DNA 
contamination of annealed DNA duplexes (and therefore inaccurate calculation 
of duplex DNA concentration), a protein to DNA molar ratio of 1:1.2 is optimal 
to ensure the formation of a crystallisable protein-DNA complex (Yang, 2006). 
Although there is a slight excess of DNA, it is unlikely for duplex DNA above 12 
bp to crystallise by itself. It has also been suggested that duplex DNA with 
single stranded ‘sticky’ ends be used, with the 5’ and 3’ single stranded regions 
being complementary, in order to facilitate end to end packing (Hollis, 2007).  
 
SAP-DNA complexes were therefore constructed using the previously described 
30 bp duplex with 50% GC content, and also a duplex of the same sequence, 
but with single stranded overhangs. The sequences of all DNA duplexes used 
for crystallisation are displayed in table 4.7. These mixtures contained a 1:1.2 
molar ratio of SAP to DNA and a final SAP concentration of 9 mg/mL in TC+PE 
buffer (10 mM Tris-HCl pH 7.4, 140 mM NaCl, 2 mM CaCl2, 10 mM PE). They 
were subsequently used to construct 96-well sparse matrix screens (nucleix, 
JCSG+ and PACT premier), as well as a 24-well manual screen using the 
standard SAP conditions. A further 24-well manual screen was constructed 
containing the same standard SAP conditions with the addition of 2 mM CuSO4 
in each well. It was thought that the addition of copper might disrupt the 
regular crystal lattice that forms readily with SAP, in which crystal contacts are 
formed involving putative DNA-interacting residues (Prof. Steve Wood, personal 
communication). Although these screens did yield several crystals, analysis of 
the unit cells of these crystals by X-ray diffraction at beamline I02 of the 
Diamond Light Source indicated that they were all SAP only, with the exception 
of one that grew in well C6 of the standard SAP screen. 
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 Table 4.7 All DNA sequences used for crystallisation screens. 
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4.4.1.8 Native SAP 4 dataset 
The crystal that was collected from well C6 of the standard SAP screen (see 
table 4.8 for conditions), was cryocooled as previously described and 360° of 
diffraction data was collected in 0.1° oscillations at 100 K. A picture of the 
mounted crystal after cryocooling is displayed in figure 4.16. Automatic data 
reduction using xia2 3dii indicated different (and much larger) unit cell 
dimensions to those usually observed in native SAP structures. The unit cell 
dimensions and data collection statistics are displayed in table 4.9. The 
resolution of the data was cut at 2 Å, which correlated to a CC1/2 of 0.5, and 
subsequent molecular replacement was performed using PHASER with the 
native SAP structure (3KQR) used as a search model. A Matthews coefficient of 
2.44 indicated that the unit cell most likely contained 54.95% solvent, with 
three SAP pentamers and three duplexes present in the asymmetric unit (or 
55.95% solvent in the absence of DNA). Three pentamers were therefore 
searched for in the asymmetric unit, yielding a final TFZ of 16.55, indicating 
that it was a successful solution. 
 
As before, an initial round of refinement using Refmac5 was performed and the 
crystal packing and electron density examined. Figure 4.17 shows the crystal 
packing for the Native SAP 4 structure. As with the Native SAP 3 structure, the 
crystal packing and lack of suitable positive electron density in the FO-FC map 
suggest that there was no DNA present. Further rounds of refinement were not 
therefore performed.  
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Table 4.8 The crystallisation conditions in which the Native SAP 4 crystal were 
grown. 
 
 
Figure 4.16 Native SAP 4 crystal. 
This figure shows the Native SAP 4 crystal after mounting and cryocooling. This image was 
taken prior to X-ray diffraction data being collected at the Diamond Light Source.  
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Table 4.9 Summary of the crystallographic data processing of the Native SAP 4 
structure. 
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Figure 4.17 Packing of SAP within the Native SAP 4 crystal. 
As with the Native SAP 3 crystal, the Native SAP 4 crystal appeared to present a unique unit cell 
in which SAP had not previously been reported to crystallise (a=140.43 Å, b=68.58 Å, c=224.96 
Å, α=90°, β=100.32°, γ=90°). This figure shows the conformation of SAP pentamers within the 
unit cell. This unit cell was estimated to contain 54.95% solvent without DNA present, or 
55.95% solvent with DNA present. This figure was using the PyMOL Molecular Graphics System, 
Version 1.5 Schrödinger, LLC. 
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4.4.1.9 Fourth round of SAP-DNA crystallisation screens  
Further crystallisation screens were constructed using the 30 bp duplex with 
50% G+C content, as well as four new 30 bp duplexes with random sequences 
ranging from 77% G+C content to 80% G+C content (table 4.7). In order to 
completely eliminate the problem of single stranded DNA contamination in the 
crystallisation screens, the four new duplexes were designed as 64 base, single 
stranded oligonucleotides. The 3’ and 5’ 30 bases were complementary to one 
another and were separated by four thymines. This means that upon rapid 
heating and slow cooling (see section 3.2.1 for DNA annealing protocol) the 
single stranded DNA would fold in half to form a 30 bp duplex with a hairpin at 
its centre. These DNA duplexes were used to construct complexes with a 1:1.2 
molar ratio of SAP-DNA in TC+PE buffer (10 mM Tris-HCl pH 7.4, 140 mM NaCl, 
2 mM CaCl2, 10 mM PE). In order to try and stabilise the complex, the mixtures 
were subsequently dialysed gradually into TC+PE buffer containing a lower 
NaCl concentration of 40 mM, and a pH of 6.0. It was hoped that reducing the 
ionic strength of the buffer conditions might also reduce ionic shielding, and 
therefore result in a stronger complex. Also, by reducing the pH to 6.0, more of 
the histidine side chains would become protonated and therefore possibly help 
to stabilise the interaction.  
 
These five complexes had a final SAP concentration of 5 mg/mL and were used 
to construct five 24-well manual screens using the standard SAP screen 
conditions, albeit with the modified NaCl concentration of 40 mM and the 
modified pH of 6.0. However, all crystals that were subsequently obtained from 
these screens presented an identical unit cell to that of native SAP following X-
ray diffraction analysis at beamline I03 of the Diamond Light Source.    
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4.4.2 Analysis of mutant SAP  
4.4.2.1 Crystallisation screens 
All SAP mutants were concentrated to between 2 mg/mL and 10 mg/mL in 
TC+PE buffer (10 mM Tris-HCl pH 7.4, 140 mM NaCl, 2 mM CaCl2, 10 mM PE) 
so that the protein would be in its physiological pentameric form. These 
samples were used to construct 96-well sparse matrix screens as described in 
section 4.3.1, using the Nucleix, JCSG-plus and PACT premier screens. The 
Nucleix screen was included because, although its conditions have been 
optimised for the co-crystallisation of protein-DNA complexes, the results 
displayed in section 4.4.1 indicate that native sequence SAP appears to 
crystallise readily under these conditions. A 24-well manual screen (standard 
SAP screen) was also constructed for each mutant as described in section 4.3.2. 
The conditions of all screens can be found in appendix 10. Of all the mutants, 
only the K87Q and R193Q SAP appeared to produce suitable crystals. The K87Q 
mutant crystallised in solution 17 of the nucleix screen, and the R193Q mutant 
crystallised in well A5 of the standard SAP manual screen (table 4.10). To 
assess whether the crystals required additional cryoprotectant, a sample of the 
mother liquor was cryocooled before collecting the crystals from the growth 
plates. If the solution became opaque and icy then cryoprotectant was 
required. Whilst the K87Q SAP crystal did not appear require additional 
cryoprotectant (although some ice was present after cryocooling), the R193Q 
SAP crystal was washed in a solution of mother liquor containing approximately 
15% (w/v) glycerol prior to cryocooling. The K87Q and R193Q crystals are 
shown in figure 4.18 after cryocooling.  
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Table 4.10 The crystallisation conditions used to obtain K87Q and R193Q SAP 
crystals. 
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Figure 4.18 Mutant SAP crystals. 
Panel A shows the K87Q crystal, and panel B shows the R193Q crystal after mounting and 
cryocooling. These images were taken prior to X-ray diffraction data being collected at the 
Diamond Light Source.  
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4.4.2.2 Data collection 
X-ray diffraction data collection was performed at the Diamond Light Source on 
beamlines I02 and I04 for the K87Q and R193Q mutant SAP crystals, 
respectively. For each crystal, 360° of diffraction data was collected at 100 K 
using 0.15° oscillations for the K87Q SAP and 0.1° oscillations for the R193Q 
SAP. Data was collected to a maximum of 1.94 Å and 1.2 Å for the K87Q and 
R193Q SAP, respectively. Following data collection, xia2 3d and xia2 3dii 
automatic data reduction was performed for the K87Q and R193Q diffraction 
data, respectively. The refined unit cell dimensions and data collection statistics 
are displayed in table 4.11. The data collected from both mutant proteins were 
refined to very similar unit cell dimensions to that of the native protein. The 
K87Q SAP diffraction data was processed to a maximum resolution of 2.11 Å, as 
this was the maximum resolution of the data collected and corresponds to a 
CC1/2 of 0.7. The R193Q SAP was processed to a maximum resolution of 1.36 Å, 
which corresponded, to a CC1/2 of 0.5. Molecular replacement was performed 
for both mutants using PHASER, with ex vivo SAP (3KQR) as a search model 
after removing the calcium atoms and bound ligand. The final TFZ were 13.5 
and 8.5 for K87Q and R193Q, respectively, which suggested molecular 
replacement had been successful. Iterative cycles of refinement were 
performed using Phenix.refine for the K87Q structure and Refmac5 for the 
R193Q structure. The final refinement statistics are displayed in table 4.11 for 
the two structures.  
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Table 4.11 Summary of the crystallographic data processing and refinement 
statistics for the K87Q and R193Q mutant SAP structures. 
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4.4.2.3 The K87Q and R193Q SAP structures 
Figure 4.19 shows the 2FO-FC and FO-FC electron density maps surrounding the 
mutated residues (on one subunit only) of the K87Q and R193Q SAP structures 
during various rounds of iterative refinement. Initially the native lysine of the 
K87Q structure did not appear to be surrounded by negative electron density as 
might be expected. However, the electron density did appear to be weak in the 
2FO-FC map. In contrast, the FO-FC map for the R193Q SAP structure (which 
was solved to a higher resolution of 1.36 Å compared to 2.11 Å for the K87Q 
SAP) shows a negative electron density peak surrounding the end of the 
arginine side chain, and a positive electron density peak in the middle of the 
side chain. Residues 87 of the K87Q model and 193 of the R193Q model were 
initially replaced with an alanine and a second round of refinement performed. 
Following refinement, positive electron density was present in the FO-FC map of 
the K87Q structure indicating missing atoms in the amino acid side chain. For 
the R193Q structure, the previously observed negative electron density peak 
had disappeared, and the positive electron density peak had grown stronger. 
The respective amino acids of both structures were therefore replaced with 
glutamines and the side chains fitted to the positive density. A third round of 
refinement was then performed, after which no difference density appeared to 
be present surrounding the new glutamine side chains. 
 
Figures 4.20 and 4.21 show the final electron density of the composite 2FO-FC 
maps surrounding the new amino acids of the respective structures, compared 
with the corresponding amino acids of the native structure (Orr and Kolstoe, 
2013, unpublished). The electron density surrounding the mutated amino acids 
appeared to have changed shape when compared to the native structure, 
although this was less pronounced for the K87Q structure. This is likely due 
both to the lower resolution of the K87Q structure (2.11 Å instead of 1.36 Å for 
the R193Q structure) and also due to the flexibility of this residue, which is 
situated adjacent to a solvent channel within the crystal. This is reflected by a 
relatively large B-factor of 39.51 for this amino acid. However, the electron 
density of both mutant SAP structures appears to confirm that the mutations 
were successful.  
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Figure 4.19 Process of replacing mutated residues within the protein model. 
Following the first round of refinement, the amino acids corresponding to mutations were 
replaced with alanine. This meant that following the next round of refinement; the positive 
electron density of the FO-FC map became clearer, making it easier to place the mutated 
residues. Figures produced using Coot (Emsley et al., 2010). 
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Figure 4.20 Composite electron density (2FO-FC) maps surrounding the mutated Q87 
residue. 
The composite electron density maps surrounding amino acids 85 to 89 of the native and 
mutant SAP show that the mutation is correct. The electron density surrounding the mutated 
amino acid is clearly different to the corresponding amino acid in the native structure and fits 
the new glutamine residue well. Both maps are contoured to 1.0 σ. This figure was using the 
PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC. 
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Figure 4.21 Composite electron density (2FO-FC) maps surrounding the mutated 
Q193 residue. 
The composite electron density maps surrounding amino acids 191 to 195 of the native and 
mutant SAP show that the mutation is correct. The electron density surrounding the mutated 
amino acid is clearly different to the corresponding amino acid in the native structure and fits 
the new glutamine residue well. Both maps are contoured to 1.5 σ. This figure was using the 
PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC. 
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Figure 4.22 shows a single subunit of both the K87Q and R193Q structures, 
including the calcium ions and PE, compared to that of the native ex vivo 
structure (3KQR). There appeared to be very little difference in the structures, 
with the atoms along the main chain of each mutant aligning very closely with 
those of the native protein. Figure 4.23a shows the RMSD of each alpha carbon 
along a single subunit of both mutant structures compared to those of the ex 
vivo structure. The RMSD remains below 0.8 Å for all amino acids along the 
main chain, with the exception of flexible loop (residues 23-31) between the B 
and C β-sheets. This loop sits adjacent to a solvent channel within the crystal 
and therefore has a greater degree of movement, which results in poor electron 
density covering this region. This is highlighted by Figure 4.23b, which shows 
the B-factors for the alpha carbons along the length of subunit A for both 
structures. The highest B-factors are observed between residues 23 and 31, 
indicating a greater degree of thermal motion. However, B-factors are also 
related to the resolution of the structures, which is why overall the B-factors for 
the K87Q structure, which was solved to a resolution of 2.11 Å, are higher than 
those of the R193Q structure, which was solved to a resolution of 1.36 Å.   
 
Interestingly there appears to be no significant difference in the position of the 
main chain atoms of the mutated amino acids compared to the native structure. 
The B-factor of the Gln 87 amino acid of the K87Q structure is relatively high at 
39.51, but this residue is situated within the central pore of the SAP pentamer 
and does not appear to be involved in any non-covalent interactions.   
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Figure 4.22 Comparison of single monomers of the native sequence SAP (3KQR) 
structure with those of the K87Q and R193Q structures.  
The native sequence SAP monomer (viewed from the B face) is shown in grey, and the K87Q 
and R193Q SAP monomers are shown in blue and green, respectively. The residues of interest 
on each monomer are depicted in stick form. The conformation of the protein main chain 
appears to be very similar in each case, as well as the conformation of the calcium-binding site. 
The mutations do not appear to have caused any significant alteration in the structure of the 
SAP. This figure was using the PyMOL Molecular Graphics System, Version 1.5 Schrödinger, 
LLC. 
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Figure 4.23 Comparison of mutant alpha carbon RMSD values (compared to native 
SAP) and B-factors. 
The top graph shows the RMSD values for all the alpha carbons of subunit A (compared to 
native SAP) for the K87Q (blue) and R193Q (green) mutants. The lower graph shows the B-
factors of the alpha carbons of subunit A. It is clear that the loop between residues 23 and 31 is 
the most flexible region of the protein. This loop (between the B and C β-sheets) is situated 
close to a solvent channel within the crystal. The Lys 87 (or in this case Gln 87) residue is also 
situated in a solvent channel. RMSD calculations were performed using Superpose (Krissinel & 
Henrick, 2004).    
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4.5 Discussion 
All crystallisation conditions that were tested for the co-crystallisation of SAP 
and DNA were unsuccessful, as all crystals that were obtained contained 
uncomplexed SAP only. As the ex vivo protein appears to crystallise much more 
slowly than the recombinant protein, future crystallisation screens could be 
performed using the ex vivo rather than the recombinant protein, in order to 
encourage protein-DNA interactions instead of protein-protein interactions. The 
precise amino acids that are involved in pentamer-pentamer contacts, within 
the SAP crystal, should also be investigated with respect to their involvement in 
the SAP-DNA interaction. Those that appear to have little to no effect on DNA-
binding by SAP could be substituted, therefore facilitating the destabilisation of 
the normal crystal lattice without weakening the SAP-DNA complex. This may 
also help to encourage the growth of crystals containing DNA. 
 
As described in chapter 3, stoichiometric analysis indicated that more than a 
single SAP-DNA complex is likely to be formed, with various binding modes and 
stoichiometries possible. In order to obtain protein-DNA crystals, it is necessary 
for the sample to be pure and homogeneous. The SAP-DNA interaction does 
not therefore appear to be particularly conducive to crystallisation. SELEX might 
be performed therefore to provide the best chance of forming a stable, 
crystallisable complex. SELEX would involve introducing SAP to a pool of DNA 
duplexes containing a large number (1012 to 1018) of different sequences (Chai 
et al., 2011). As shown in chapter 3, DNA-binding by SAP always appears to be 
strong (so long as the length of the DNA is 25 bp or more). However, the 
sequence of the DNA does have a significant effect on the affinity (with the Kd 
measured for SAP binding to three different DNA sequences, that had the same 
nucleotide content, varying by more than two orders of magnitude). Therefore, 
in a pool of 1012 to 1018 different sequences, there is bound to be a significant 
variation in the strength of the complexes that form. The DNA duplexes that 
exhibit the strongest binding to SAP would be selected for by separating the 
bound DNA from the free, probably by means of a pull-down. PCR would then 
be performed in order to amplify the DNA duplexes that bound, and the process 
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would be repeated continually until a single DNA duplex remained, which 
exhibited the strongest possible affinity for SAP.  
 
Furthermore, it may be possible to crosslink the SAP and DNA covalently. This 
technique has been used with success on a number of occasions, in which an 
amino acid on the outside of the protein of interest is mutated to a cysteine and 
subsequently linked to a thiolated DNA species (He & Verdine, 2002; Huang et 
al., 1998). This may be the only option available to obtain a pure and stable 
SAP-DNA complex, although selection of the location in which to introduce a 
cysteine mutation must be undertaken carefully. This could both destabilise the 
protein and therefore lead to reduced expression, or if expression is successful, 
could facilitate the formation of a physiologically irrelevant protein-DNA 
complex. If crosslinking were successful however, the SAP-DNA complex could 
be more rigorously purified, for example using size exclusion chromatography.    
 
It was surprisingly shown that native sequence recombinant SAP crystallised 
readily, even in a highly aqueous solution and the absence of a precipitant. The 
data collected from one of these crystals at room temperature showed that 
cryocooling SAP crystals to 100 K has little effect on the structure of SAP. This 
SAP structure (Native SAP 2) displayed an RMSD of below 0.7 Å for all alpha 
carbons in subunit A when compared to the previously described native SAP 
structure, for which the data was collected at 100 K (3KQR). It did however 
highlight that the recombinant protein appears to crystallise far more readily 
that the ex vivo protein. This may be due to the ex vivo SAP displaying a 
greater degree of heterogeneity than the recombinant protein. Although the 
structure of the N-linked glycan attached at Asn 32 of SAP typically displays less 
heterogeneity than other glycoproteins, it sometimes lacks its terminal sialic 
acid, which subsequently targets the protein for removal from circulation 
(Tennent & Pepys, 1994). Also, it has been shown that ex vivo SAP undergoes 
significant glycation whilst in circulation, and therefore contains several 
covalently bonded sugars that are not present in the recombinant SAP (Dr. Jean 
Van Den Elsen, Department of Biology & Biochemistry, University of Bath, 
 194 
personal communication - unpublished). The homogeneity of the recombinant 
protein may therefore encourage much more rapid crystallisation.  
 
Another difference between the recombinant SAP and ex vivo SAP is the 
presence of three non-native amino acids (Glu-Thr-Gly) on the N-terminus of 
each monomer of the recombinant protein (see section 2.3.6). However, there 
was no clear electron density present in any of the datasets using recombinant 
SAP to suggest that these residues form an ordered structure, or participate in 
crystal contacts. It is, therefore, unlikely the presence of these residues is the 
reason that the recombinant protein appears to crystallise more readily than the 
ex vivo protein. 
 
The structures of the K87Q and R193Q mutant SAP described in section 4.4.2 
indicated that the mutation of the native sequence SAP was successful and that 
the correct amino acids had been incorporated. As described in chapter three, 
the Lys 87 and Arg 193 amino acids were shown to play an important role in 
the stabilisation of the SAP-DNA complex, as both mutant proteins appeared to 
have a significantly reduced affinity for double stranded DNA when compared to 
native sequence SAP. The structures of these two mutants proteins were shown 
to be very similar to that of native sequence SAP, with RMSD values lower than 
0.8 Å for all alpha carbons (of subunit A), with the exception of the flexible loop 
between residues 23 and 31. The crystals obtained for these mutants also each 
presented an identical monoclinic unit cell to that of native sequence SAP. This 
indicates that the loss in DNA-binding affinity of these mutants is not due to a 
significant alteration in the protein structure, but rather that the residues 
themselves are integral in the interaction. However, the remaining mutants 
(including the R77Q and K143Q mutants which exhibited the weakest DNA-
binding) did not crystallise. These mutations correspond to amino acids that are 
situated very close to, or are even involved in pentamer to pentamer contacts 
within the native sequence SAP crystal. It is possible therefore that the 
mutations disrupt the normal crystal packing observed by SAP. Further 
conditions will therefore need to be tested in an attempt to encourage these 
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remaining mutants to form crystals that are suitable for X-ray diffraction 
experiments.  
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5. Preliminary investigation of 
SAP-nucleosome binding 
 
5.1 Overview 
Following the discovery that SAP binds to DNA (Pepys & Butler, 1987) it was 
subsequently shown that SAP binds to and solubilises native long chromatin 
and in doing so displaces histone 1 (H1) (Butler et al., 1990). Butler et al. 
showed that nucleosome core particles derived from chicken erythrocytes 
bound with an apparent 2:1 stoichiometry to (what were thought to be) SAP 
decamers. As discussed in section 1.4.2, although it is now known that SAP is 
pentameric in physiological conditions, SAP was thought to be decameric at the 
time of these previous experiments. These experiments were performed in the 
presence of 2 mM CaCl2, so it is therefore likely that the SAP that bound to 
nucleosome cores was actually in a pentameric, rather than decameric form. 
Pepys and Butler reported that a single complex with a unique sedimentation 
coefficient was formed with a ratio of approximately 0.6 moles decameric SAP 
to 1 mole of nucleosome cores using sucrose gradient ultracentrifugation. This 
may suggest therefore that a 1:1 stoichiometry was in fact observed between 
SAP pentamers and nucleosome cores.   
 
However, there have been no recent attempts to characterise the interaction 
between nucleosomes and pentameric SAP. In this chapter therefore, a range 
of experiments are described. These include electrophoretic mobility shift assay 
(EMSA), sedimentation velocity-analytical ultracentrifugation (SV-AUC) and 
surface plasmon resonance (SPR) that were performed in order to investigate 
the affinity, kinetics and stoichiometry of binding between pentameric SAP and 
nucleosomes. For all experiments described in this chapter, recombinant 
reconstituted human nucleosomes or nucleosome core particles (NCP) were 
used with recombinant human SAP. Furthermore, conditions always contained 
calcium chloride and phosphoethanolamine (PE) to ensure that SAP remained 
pentameric (section 1.4.1).  
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Electrophoretic mobility shift assay (EMSA) were first used to verify that 
pentameric SAP binds NCP. NCP are histone octamers complexed with 147 bp 
DNA and therefore contain no long lengths of uncomplexed DNA. These were 
chosen as a suitable binding model because, as demonstrated by the 
experiments described in chapter 3, SAP binds tightly to free double-stranded 
DNA. If full nucleosomes were instead to be used (comprising histone octomers 
complexed with DNA of at least 165 bp), the excess DNA could potentially 
provide additional binding sites for SAP and may therefore demonstrate 
artificially tight binding. A DNA fragment 151 bp in length, 601NL DNA, was 
used for the reconstitution of NCP (section 5.2.1), which contains the 147 bp 
nucleosome positioning sequence and an additional 4 bp remaining following 
restriction endonuclease digestion. 
 
Sedimentation velocity analytical ultracentrifugation (SV-AUC) was next used to 
investigate the stoichiometry of the interaction between SAP and NCP, and 
finally surface plasmon resonance (SPR) was used to quantify the strength of 
the interaction and to obtain estimates for the kinetic rate constants and 
equilibrium dissociation constants (Kd). Biotinylated nucleosomes were used 
instead of NCP for the experiments performed using SPR. These nucleosomes 
were immobilised to the sensor surface via surface-tethered streptavidin, and 
the longer fragment of DNA (185 bp instead of 151 bp) therefore provided 
some distance from the sensor surface. Reconstituted nucleosomes containing 
185 bp 601.2 DNA were therefore used for these experiments (section 5.2.3.2).  
 
5.2 Methods 
5.2.1 EMSA 
Recombinant reconstituted human NCP (gifted by Dr. John Cashman and Dr. 
Alan Thorne of the Institute of Biomedical and Biomolecular Sciences, University 
of Portsmouth) containing 151 bp 601NL DNA (plasmid containing 601NL DNA 
gifted by Dr. Till Bartke of the Medical Research Council Clinical Sciences 
Centre, Imperial College London) (appendix 11) were 32P end-labelled as 
described in section 3.2.1. NCP were first desalted into reaction buffer (10 mM 
Tris-HCl pH 7.5, 50 mM NaCl) using Illustra NAP-10 gravity columns (GE 
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Healthcare) before proceeding with the protocol as previously described in 
section 3.2.3.2. The concentration of radiolabelled NCP was subsequently 
estimated by UV spectrophotometry assuming 50 ng/μL dsDNA = 1 absorbance 
unit (260 nm), and samples were diluted to a concentration of 500 nM. Free 
601NL DNA was also labelled and used as a control. EMSA were performed as 
described in section 3.2.3.2, with each reaction containing 50 nM radiolabelled 
NCP and increasing concentrations of recombinant native sequence SAP (0, 25, 
50, 75, 100, 150, 200, 300, 400 and 500 nM). Following electrophoresis, gels 
were dried using a 583 Electrophoresis Gel Dryer (Bio-Rad) and exposed 
overnight to a BAS-IP MS 2325 imaging plate (Fujifilm). Images were visualized 
using a Fujifilm FLA-5000 phosphorimager (Fujifilm) 
 
5.2.2 SV-AUC 
SV-AUC was performed as described in section 3.2.5.2. Recombinant native 
sequence SAP was combined at various molar ratios with reconstituted human 
NCP in reaction buffer (10 mM Tris-HCl pH 7.4, 140 mM NaCl, 10 mM PE, 2 mM 
CaCl2). Samples were centrifuged using an An-50 Ti analytical rotor at 20,000 
rpm in a Beckman Optima XL-A analytical ultracentrifuge (Beckman-Coulter), at 
25 °C. Radial scans were performed at 10-minute intervals, measuring 
absorbance at 260 nm. Data analysis was performed using Sedfit version 
15.01b (Schuck, 2000). Values for the partial specific volume of recombinant 
SAP and human NCP used were 0.743 mL/g (determined using Sednterp (Laue 
et al., 1992)) and 0.645 mL/g (Ausio et al., 1989), respectively.  
 
5.2.3 SPR 
 Background 
All experiments were performed using a Biacore T200 system (GE Healthcare) 
with a streptavidin sensor chip SA (GE Healthcare). The Biacore T200 
instrument utilises the phenomenon of surface plasmon resonance to 
investigate the interactions of macromolecules. As shown in figure 5.1, one 
binding partner (called the ligand) is typically immobilised within a dextran 
matrix on top of a thin gold surface. On the opposite side laser light is reflected 
off the surface through a prism to a detector. At a specific frequency and 
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incidence angle (called the resonance angle) the photons from the laser light 
generate delocalised electron oscillations at the gold surface called surface 
plasmons. Also, at this angle, there is a sharp decrease in the intensity of the 
reflected light that is measured at the detector. As the plasmon waves are very 
sensitive to the conditions at the surface, the change in resonance angle can be 
recorded in real-time to measure changes in the sensor surface due to 
molecular binding interactions.    
 
For the experiments described here, a streptavidin sensor surface (containing 
streptavidin bound to the dextran matrix) was used, to which the ligand 
(biotinylated nucleosomes) were immobilised. This method of ligand 
immobilisation utilises the strong binding between streptavidin and biotin, an 
interaction that has a Kd of approximately 40 fM (Green, 1990). The other 
binding partner (called the analyte), in this case SAP, was flown over the 
surface containing the immobilised nucleosomes. Any interactions that then 
occurred between the SAP and nucleosomes were measured as a change in the 
resonance angle caused by the increase in mass on the sensor surface. The 
change in resonance angle is measured in arbitrary resonance units (RU). The 
data obtained from an SPR experiment is very similar to that obtained from a 
switchSENSE experiment, and the association and dissociation rate constants, 
and thus the Kd, can be determined as previously described in section 3.2.4.1.  
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Figure 5.1 An overview of surface plasmon resonance analysis. 
Panel (A) shows biotinylated nucleosomes (the ligand) immobilised to the sensor surface via 
streptavidin tethered to the dextran matrix. As SAP (the analyte) flows over the surface and 
binds to the nucleosomes, a change in the refractive index close to the surface causes a change 
in the resonance angle. This is measured as a change in position of the area of minimum 
intensity using arbitrary resonance units (RU). The change in RU is plotted against time to 
provide a sensorgram (B), from which the kinetic rate constants and Kd may be determined.   
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 Immobilisation of biotinylated nucleosomes 
Immobilisation running buffer (10 mM Tris-HCl pH 7.5, 50 mM NaCl, 0.005% 
(v/v) Triton X-100) was filtered and degassed before being used to prime the 
Biacore T200 and flow cells 1 and 2. A flow rate of 10 μL/min was set. Three 
consecutive 1-minute injections of wash buffer 1 (1 M NaCl, 50 mM NaOH) 
were applied to each flow cell in order to wash the surface prior to 
immobilisation. Biotinylated nucleosomes (gifted by Dr. John Cashman and Dr. 
Alan Thorne) containing 185 bp 601.2 DNA (plasmid containing 601.2 DNA 
gifted by Dr. Till Bartke) (appendix 11) were desalted into immobilisation 
running buffer using Illustra NAP-10 gravity columns (GE Healthcare), before 
being concentrated to 294 nM using Vivaspin 2, 10 kDa MWCO concentrators 
(GE Healthcare). The concentration of nucleosomes was estimated by UV 
spectrophotometry assuming 50 ng/μL dsDNA = 1 absorbance unit (260 nm). 
Nucleosomes were subsequently injected into flow cell 2 for an hour at a flow 
rate of 5 μL/min. Following immobilisation, the Biacore needle and sample loop 
were washed with wash buffer 2 (1 M NaCl, 50 mM NaOH, 50% (v/v) 
isopropanol).      
 
 Analysis of SAP-nucleosome binding 
Reaction buffer (10 mM Tris-HCl pH 7.4, 100 mM NaCl, 5 mM PE, 200 μM 
CaCl2) was filtered and degassed before being used using to prime the Biacore 
T200 and flow cells 1 and 2. Native sequence recombinant SAP was dialysed 
into reaction buffer overnight using a 10 kDa MWCO Slide-A-Lyzer dialysis 
cassette (Thermo Scientific). Serial dilutions of SAP (200 μL in volume) were 
constructed for each experiment using the SAP stock (diluted into reaction 
buffer). Dilutions were each subsequently aliquotted into 800 μL Biacore vials 
(GE Healthcare) and were sealed with rubber caps. Vials were placed into the 
Biacore sample rack and dilutions injected consecutively into flow cells 1 and 2 
with a typical contact time of between 15 and 120 seconds. The flow rate used 
for all binding experiments was 30 μL/min. The flow cell surfaces were 
regenerated between each dilution by the injection of regeneration buffer (10 
mM Tris-HCl pH 7.4, 100 mM NaCl, 5 mM EDTA). EDTA was used to remove the 
calcium ions and disrupt the SAP pentamer, thus, reversing binding to NCP. The 
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NCP structure, however, should be resistant to disruption by EDTA, indeed, 
EDTA is a common ingredient in NCP storage buffers (Luger et al., 1999). All 
data analysis was performed using the Biacore T200 evaluation software. 
 
5.3 Results 
5.3.1 EMSA analysis 
In order to test whether SAP binds to human NCP, an EMSA was performed 
using recombinant human SAP and 32P-labelled recombinant reconstituted 
human NCP (section 5.2.1). Figure 5.2 shows the EMSA performed using SAP-
NCP molar ratios of 0, 0.5, 1, 1.5, 2, 3, 4, 6, 8 and 10:1. As reconstituted NCP 
invariably contain a small proportion of free uncomplexed DNA (John Cashman 
& Alan Thorne, personal communication), two further controls comprising free 
601NL DNA, and 10:1 SAP-601NL DNA were also loaded, so that SAP-NCP 
complexes could be distinguished from SAP-DNA complexes. 
 
The extreme left lane contains only 32P-labelled NCP, which is represented by 
the dark band. The fainter band in this lane with greater electrophoretic 
mobility than the NCP corresponds to the small proportion of free DNA that is 
invariantly present following recombinant nucleosome reconstitution. The band 
corresponding to NCP displayed slightly reduced electrophoretic mobility with 
increasing concentrations of SAP. Binding appears to have occurred at 
approximately a 3:1 molar ratio of SAP:NCP, reaching a near full shift at a 
molar ratio of 10:1 SAP:NCP. An accurate Kd could not however be determined 
using this EMSA due to the poor resolution between the bound and free NCP 
bands. It could, however, be estimated that the Kd was approximately 0.3 μM 
to 0.4 μM, because between these concentrations of SAP the proportion of 
bound NCP appears to have increased to greater than 50% of the total NCP 
population. The free 601NL DNA also appears to have been bound by SAP, with 
a number of complexes observed in the samples containing molar ratios of 
greater than 1.5:1 SAP-NCP. This is indicated by the presence of a large ‘smear’ 
that electrophoresed with greater mobility than a more prominent band 
representing a larger complex. At a molar ratio of 10:1 SAP-DNA a near full 
shift is observed as nearly all the free DNA was bound by SAP.  
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Figure 5.2 SAP-nucleosome core particle EMSA. 
EMSA performed using 50 nM NCP and increasing concentrations of SAP, in order to test 
whether recombinant human SAP binds to recombinant reconstituted NCP, prior to further 
biophysical analysis. In order to differentiate between SAP complexes formed with NCP and 
those complexes formed with the free DNA (that is invariably present in reconstituted NCP), a 
DNA only control was included containing 0:1 and 10:1 molar ratios of SAP-DNA. These 
samples are shown in the two lanes on the extreme right.     
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The main complex appears to possess a much-reduced electrophoretic mobility 
compared to the SAP-NCP complex. Further analysis using SV-AUC and SPR was 
performed in order to gain quantitative information regarding the affinity, 
kinetics and stoichiometry of the interaction.    
 
5.3.2 SV-AUC analysis 
SV-AUC was performed in order to further the work described by Butler et al. 
(1990), whom demonstrated that there is an apparent 2:1 stoichiometry 
between chicken erythrocyte NCP and SAP decamers. For this experiment 
recombinant reconstituted human NCP were used, and the conditions ensured 
that recombinant native sequence SAP would be maintained in a pentameric 
state. Three samples were constructed containing 0:1, 2:1 and 8:1 molar ratios 
of SAP-NCP, each sample containing 150 nM NCP. The data obtained from 
these three samples are displayed in figures 5.3, 5.4 and 5.5, respectively.  
 
A large peak with an s-value of approximately 12.0 s was observed in the 
sample containing NCP only (figure 5.3). The molecular mass represented by 
this peak was determined to be approximately 200 kDa, using a partial specific 
volume of 0.645 mL/g, which corresponds to single NCP. This is in close 
agreement with the molecular mass of a single NCP, which was estimated to be 
197 kDa. The smaller peak with an s-value of approximately 6.0 s is thought to 
correspond to the small proportion of free 601NL DNA in the sample. The 
smallest peak (with an s-value of 1-2 s) could not be assigned to any known 
species. Whilst it is possible that this peak corresponds to an unknown small 
species, it may also be an anomaly that occurred during data fitting as a result 
of correlation between the baseline parameters and the theoretical 
sedimentation pattern at smin (the sedimentation distribution minima) (Schuck, 
2005).    
 
In the sample containing a 2:1 molar ratio of SAP-NCP (figure 5.4), a peak with 
an s-value of approximately 6.5 s was observed, and was larger than the peak 
with an s-value of 6 s in the previous sample. The molecular mass that this 
peak represents was estimated to be approximately 125 kDa when a partial 
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specific volume of 0.743 mL/g was used (corresponding to pentameric SAP). 
Due to its slight absorbance at 260 nm, a peak corresponding to SAP was 
expected to be present. The molecular mass represented by this peak is in 
good agreement with that of a single SAP pentamer, which was calculated to be 
127 kDa. The peak corresponding to single NCP (with an s-value of 
approximately 12.0 s) was observed in the same position as in the previous 
sample, and no higher order complexes were obvious.  
 
In the sample containing an 8:1 molar ratio of SAP-NCP (figure 5.5), the area 
under curve of the peak corresponding to SAP appeared to increase with the 
corresponding increase in SAP concentration. Figure 5.6 (displaying the c(s) 
distribution of each sample overlaid) shows that this peak also shifted slightly 
from having an s-value of approximately 6.5 s to one of approximately 7.0 s. 
Using a partial specific volume of 0.743 mL/g, the molecular mass represented 
by these peaks was determined to be 125 kDa and 140 kDa, respectively. The 
peak corresponding to NCP remained in the same position although, as shown 
in figure 5.6, the height of the peak decreased with increasing SAP 
concentration. Figure 5.5 shows that at the highest concentration of SAP, a 
very small peak was also observed with an s-value of approximately 22 s 
(magnified in figure 5.6). In terms of a complex containing only SAP and NCP, 
the closest fit that could be estimated for this peak corresponds to a 2:1 (SAP-
NCP) complex. Using a partial specific volume of 0.699 mL/g, the molecular 
mass represented by this peak was determined to be approximately 500 kDa. A 
2:1 complex between a single SAP pentamer and NCP would have a theoretical 
molecular mass of 468 kDa. When this area of the c(s) distribution was 
magnified for all samples (between 16 s and 36 s – figure 5.6), a peak was also 
observed at around 24 s in the sample containing NCP only. This peak did not 
appear to be present in the other samples (at the same position) and it is 
unclear precisely to what species this peak corresponds.  
 
SPR was subsequently performed in an attempt to quantify the strength of the 
interaction by obtaining values for the Kd and kinetic rate constants. 
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Figure 5.3 SV-AUC analysis performed on a sample containing only NCP. 
Panel A shows the absorbance at 260 nm, measured along the radius of the AUC cell every 10 
minutes. Panel B shows the residual plot and panel C shows the c(s) distribution of the sample. 
The large peak at approximately 12 s was determined to correspond to a molecular mass of 
200 kDa (using a partial specific volume of 0.645 mL/g, which corresponds to NCP). The small 
peak at approximately 6 s was thought to correspond to the small proportion of free 151 bp 
601NL DNA that is an invariant constituent of reconstituted NCP.   
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Figure 5.4 SV-AUC analysis performed on a sample containing a 2:1 molar ratio of 
SAP to NCP. 
Panel A shows the absorbance at 260 nm, measured along the radius of the AUC cell every 10 
minutes. Panel B shows the residual plot and panel C shows the c(s) distribution of the sample. 
The large peak with an s-value of 12 s (corresponding to free NCP) in figure 5.3 was observed 
in this sample at the same position. The smaller peak at approximately 6.5 s appeared to 
correspond to a molecular weight of 125 kDa when a partial specific volume of 0.743 mL/g was 
used (which corresponds to pentameric SAP). The SAP appeared to sediment at approximately 
the same position as the free DNA (observed at approximately 6 s in figure 5.3) covering this 
peak.    
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Figure 5.5 SV-AUC analysis performed on a sample containing an 8:1 molar ratio of 
SAP to NCP. 
Panel A shows the absorbance at 260 nm, measured along the radius of the AUC cell every 10 
minutes. Panel B shows the residual plot and panel C shows the c(s) distribution of the sample. 
The peak representing SAP (observed in figure 5.4) appeared to have increased in size and 
shifted slightly from an s-value of approximately 6.5 s to 7 s. The large peak with an s-value of 
12 s (corresponding to free NCP) in figures 5.3 and 5.4 was observed in this sample at the 
same position. A small, broad peak with an s-value of approximately 22 s was also observed. 
This peak can be observed more clearly in figure 5.6. 
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Figure 5.6 Overlaid c(s) distributions following SV-AUC analysis of SAP-NCP binding. 
The c(s) distributions from all samples analysed using SV-AUC were overlaid in order to 
compare the relative size and position of the peaks. This figure illustrates that as the SAP 
concentration was increased from 300 nM to 1.2 μM, the relative size of the observed peak 
corresponding to pentameric SAP increases, and the size of the peak corresponding to NCP 
decreases. A small peak with an s-value of 22 s also appears to arise with an increase in SAP 
concentration (shown in the magnified section). When a partial specific volume of 0.699 mL/g is 
used (the theoretical partial specific volume for a 2:1 SAP-NCP complex), the molecular mass 
represented by this peak is approximately 500 kDa. There is also a small peak with an s-value 
of approximately 24 s present in the sample containing only NCP, and it is unclear what this 
peak relates to.  
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5.3.3 SPR analysis 
 Nucleosome immobilisation 
Figure 5.7 shows the change in RU over time as biotinylated nucleosomes were 
immobilised onto the streptavidin sensor surface using the protocol described in 
section 5.2.3.2. Flow cell one was used as the control flow cell onto which no 
nucleosomes were immobilised, and all of the SPR data presented in this thesis 
represents the signal measured from flow cell two with the signal from flow cell 
one subtracted. Following immobilisation, the net increase in resonance units 
(proportional to the number of nucleosomes immobilised) was 430 RU.  
 
 SAP-nucleosome binding 
A serial dilution of SAP comprising eight samples ranging in concentration from 
221.7 nM to 3.8 μM was initially used. These samples were injected sequentially 
into flow cells one and two for 2 minutes duration before being washed off with 
reaction buffer and the chip was subsequently regenerated using regeneration 
buffer. Figure 5.8a shows the change in resonance units during binding for 
each concentration of SAP. A large response was recorded at all concentrations 
and each response curve very quickly reached a plateau before exhibiting 
biphasic dissociation that was initially rapid and subsequently slower. Unusually, 
a drop in response was recorded at each concentration of SAP after 
approximately one minute. This anomaly appeared to be systematic and 
occurred during every repeat experiment. The injection time was reduced for 
subsequent experiments in an attempt to remove the anomaly; however, the 
drop in signal persistently occurred approximately half way through each 
injection and also occurred when experiments were performed using a newly 
prepared surface (not shown). It is unclear what caused this phenomenon, but 
because a steady equilibrium was reached for each concentration of SAP used, 
it was still possible to determine the Kd for the interaction. The resonance units 
were plotted against SAP concentration at two individual time points that 
represent equilibrium (before and after the anomaly), and using a steady-state 
affinity fit two separate Kd values were determined (shown in figure 5.8b). 
These were 1.4 μM and 1.3 μΜ, respectively. Although the Kd for the interaction 
could be determined from this experiment, the concentrations of SAP used 
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appeared to be too high to obtain information regarding the kinetics of the 
interaction. This was because equilibrium was reached rapidly, which coupled 
with the aforementioned anomalous drop in signal, meant that none of the 
available binding models could be fitted to the obtained data. The maximum RU 
(Rmax) observed for time points 1 and 2 was 1660 RU and 1760 RU, 
respectively. For a 1:1 interaction between SAP:NCP, the theoretical Rmax would 
be approximately 253 RU (Rmax following immobilisation of NCP (430 RU) 
multiplied by the ratio between the molecular mass of one SAP pentamer (127 
kDa) and one NCP (216 kDa)). The Rmax observed during this experiment 
suggest the formation of SAP-NCP complexes with stoichiometries of 6.6:1 and 
6.9:1 SAP:NCP, for the two time points, respectively. These stoichiometries 
indicate that the Kd values obtained from this experiment, which assume a 1:1 
interaction, are not likely to be accurate.         
 
Subsequently an experiment was performed using four concentrations of SAP 
ranging from 3.125 nM to 25 nM, which were each injected for 15 seconds 
instead of 2 minutes. This was performed in order to increase the time taken to 
achieve equilibrium and to attempt to reduce the effects of the anomalous drop 
in signal so that kinetic rate constants might be determined. The results from 
this experiment are displayed in figure 5.9, which shows the heterogeneous 
ligand model (Biacore T200 evaluation software – GE Healthcare) fitted to the 
data. This model accounts for two separate species of ligand immobilised on 
the sensor surface, which in the case of this experiment corresponds to the 
reconstituted nucleosomes and also the small proportion of free DNA. Using this 
model, rate constants and Kd were determined for the two ligands. One 
interaction corresponded to lower affinity binding, with a kon of 3.8 × 10-5 M-1  
s-1, a koff of 176 × 10-3 s-1 and thus a Kd of 460 nM; and the other interaction 
corresponded to higher affinity binding, with a kon of 88.6 × 10-5 M-1 s-1, a koff 
of 9.7 × 10-3 s-1 and thus a Kd of 1.1 nM. The residuals calculated for this fit 
(figure 5.9b) suggest that there was at most approximately 4% discrepancy 
between the recorded data and the binding model throughout, except for the 
dissociation phase measured using 3.125 nM SAP, where the discrepancy rose 
to approximately 10%.  
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Figure 5.7 Sensorgram showing the immobilisation of biotinylated nucleosomes 
onto flow cell 2 of a streptavidin sensor chip. 
Following 3 consecutive 1-minute washes of wash buffer, biotinylated nucleosomes at a 
concentration of 294 nM were injected into flow cell 2, at a flow rate of 5 μL/min, for 1 hour. 
The final response recorded as a result of nucleosome immobilisation (the difference in 
response before and after immobilisation) was 430 RU.  
 
 
  
 213 
 
 
Figure 5.8 Determination of the SAP-nucleosome binding Kd using a steady-state fit. 
Panel A shows the sensorgram corresponding to SAP nucleosome binding at a range of SAP 
concentrations ranging from 221.7 nM to 3.8 μM. Each concentration of SAP was injected for 2 
minutes at a flow rate of 30 μL/min. Panel B shows two steady-state fits obtained by selecting 
two time points at equilibrium. Two points were chosen due to the occurrence of an 
unexplained anomalous drop in the response approximately half way through the injection of 
SAP at each concentration. Although it is unclear what caused the drop in response, equilibrium 
was achieved before and after the anomaly, allowing Kd to be determined.  
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Figure 5.9  Kinetic analysis of SAP-nucleosome binding. 
Panel A shows the sensorgram corresponding to SAP nucleosome binding at four 
concentrations of SAP - 3.125, 6.25, 12.5 and 25 nM. SAP was injected at a flow rate of 30 
μL/min for 15 seconds at a time. The heterogeneous ligand model (Biacore T200 evaluation 
software – GE Healthcare) was fitted to the data, which takes into account two separate ligands 
immobilised on the sensor surface (in this case corresponding to biotinylated nucleosomes and 
a small proportion of uncomplexed DNA). The residuals corresponding to the discrepancy 
between the data and the binding model are shown in panel B.     
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The low nanomolar Kd corresponding to the higher affinity binding appears to 
be comparable to those determined by EMSA and switchSENSE for double-
stranded DNA (chapter 3). The Rmax observed for the higher affinity and lower 
affinity interactions was 106 RU and 7.4 RU, respectively. Therefore, the 
stoichiometries were estimated to be 0.4:1 (1:2.5) SAP:NCP for the higher 
affinity interaction, and 0.03:1 (1:33) SAP:NCP for the lower affinity interaction. 
As in the previous experiment, the estimated stoichiometries for these 
interactions suggest that the SAP-NCP interaction is not 1:1. The Kd values 
obtained from this experiment, therefore, may not accurately represent SAP-
NCP binding.    
 
5.4 Discussion 
Initial EMSA analysis of SAP-NCP binding indicated that pentameric SAP bound 
to NCP with an affinity corresponding to a high nanomolar Kd. This figure 
appeared to be in approximately the region of 0.3 μM to 0.4 μM, as between 
these concentrations of SAP, more than half the NCP appeared to shift from the 
free to the bound position (figure 5.2). A more accurate figure could not be 
determined using EMSA alone as the electrophoretic mobility of the SAP-NCP 
complex was not sufficiently retarded to provide significant separation of the 
bound and free species. The free 151 bp 601NL DNA present in the NCP 
samples was also bound by SAP to form a large complex with low 
electrophoretic mobility. As discussed in chapter 3, double stranded DNA of 151 
bp may have the potential to bind at least five SAP pentamers, therefore giving 
rise to a large complex of around 730 kDa. 
 
SV-AUC analysis of SAP-NCP binding was not able to provide an accurate 
estimation of the interaction stoichiometry between SAP and NCP. The data 
show that both single, uncomplexed pentameric SAP and NCP sedimented 
where expected (and the estimated molecular masses of these species were in 
agreement with their actual values), although the s-value of the peak 
corresponding to SAP did shift slightly from approximately 6.5 s to 7 s as the 
concentration of SAP was increased. The molecular mass represented by these 
peaks was determined to be 125 kDa and 140 kDa, respectively. If self-
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association of the SAP pentamers were the cause of this apparent shift in 
sedimentation position, a molecular mass significantly greater than 140 kDa 
would be expected for the larger species. It is possible that this shift in 
apparent sedimentation position may be have been caused by the increase in 
concentration of the protein between the samples (Cole et al., 2008).  
 
The level of binding between SAP and NCP (observed as higher molecular 
weight complexes) did however appear to be negligible. At a molar ratio of 8:1 
SAP-NCP, a peak was observed at approximately 22 s (figure 5.6) and the 
closest fit that could be obtained (using the partial specific volume for several 
theoretical stoichiometries) was that of a 2:1 SAP-NCP complex. However, It is 
likely that this peak (and the shoulder corresponding to complexes with greater 
sedimentation coefficients) corresponded to complexes that also contained an 
element of free DNA bound to SAP, which increases the complexity further. 
 
In the sample containing NCP only, a small peak was observed with an s-value 
of approximately 24 s (can be seen in figure 5.6). It is possible that this peak 
represents a very small proportion of aggregated histones and/or excess 
histones that remain following NCP reconstitution (Dyer et al., 2004). As the 
peak disappears in the presence of SAP, it may be possible that, if this peak 
does represent aggregated histones, the SAP might be able to bind to and 
break up the larger complex. 
 
Figure 5.6 shows a decrease in size of the peak corresponding to NCP with a 
corresponding increase in SAP concentration and the occurrence of a very small 
proportion of larger complexes. This data indicates that although some binding 
probably occurred between SAP and NCP, it was likely to be a weak and/or 
transient interaction. Future experiments could be performed using 
fluorescently labelled NCP in order to remove any signal corresponding to 
protein absorption, thus allowing easier assignment of the peaks with large s-
values. It could also be repeated using chicken erythrocyte derived NCP that 
contain no uncomplexed DNA.  
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SPR analysis of SAP-NCP binding initially provided two estimates of the Kd using 
a steady-state fit. These values were 1.4 μM and 1.3 μΜ. However, the 
estimated stoichiometry for this interaction was approximately 6.6:1 - 6.9:1 
SAP:NCP. This is probably due to SAP aggregation on the sensor surface, as it 
is unlikely that a single NCP could bind to seven SAP pentamers simultaneously. 
As this does not represent 1:1 binding, the Kd values obtained from this 
experiment do not reliably describe the interaction.   
 
Further kinetic analysis using a heterogeneous ligand binding model provided 
two further Kd, one relating to a high affinity interaction and one relating to a 
lower affinity interaction. These values were 1.1 nM and 0.5 μM, respectively. 
Assuming that the two heterogeneous ligands correspond to biotinylated 
nucleosomes and to uncomplexed 601.2 DNA, it can be assumed that the 
higher affinity interaction relates to the SAP-DNA binding. The apparent low 
nanomolar Kd observed for this interaction is in agreement with the Kd obtained 
for other SAP-DNA interactions using EMSA and switchSENSE (chapter 3). The 
observed association rate constant is however higher and the dissociation rate 
constant lower than those observed using switchSENSE. This may be due to the 
nucleosome free DNA being longer than any of the DNA used for previous 
switchSENSE experiments and perhaps therefore facilitating the binding of 
several SAP pentamers, making an accurate determination of binding rate 
constants difficult.  
 
The lower affinity binding may therefore correspond to the SAP-nucleosome 
interaction. This figure of 0.46 μM is, however, significantly lower than the Kd 
estimated using a steady-state fit of 1.3 μM to 1.4 μM (although relatively close 
to the approximate Kd estimated from qualitative EMSA analysis of 0.3 μM - 0.4 
μM). However, the stoichiometry of the SAP-NCP binding in this experiment was 
estimated to be 0.03:1 (or 1:33) SAP:NCP. This, coupled with the low Rmax 
suggests that the strength of the interaction in these conditions is negligible, as 
the SAP is only occupying approximately 3% of the available NCP.    
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The difference between SAP-NCP binding observed using the two methods (and 
different concentrations of SAP) could be due to mass transport effects, which 
relates to two problems. The first is depletion of the analyte in solution close to 
the surface due to sequestration by the ligand, which therefore causes the 
formation of an analyte concentration gradient. For interactions with particularly 
fast association rates, analyte binding will be limited by the rate of diffusion of 
the analyte towards the surface. The second problem is due to the density of 
ligand immobilised to the surface. If the density is too great then during the 
dissociation phase, it may be possible for the analyte to dissociate from one 
ligand and then immediately re-associate with another (Schuck & Zhao, 2010). 
This means that artificially low dissociation rates will be observed. There are 
two ways of overcoming mass transport effects: these are to increase the flow 
rate (typically to at least 30 μL/min) in order to increase the diffusion rate of 
the analyte, and to decrease the immobilised ligand density to prevent re-
attachment. In order to therefore investigate whether mass transport had any 
effect on the results recorded from these experiments, future experiments will 
be performed using a higher flow rate initially and also using a lower level of 
immobilised nucleosomes.   
 
One complication with using recombinant reconstituted NCP is that there is 
always a small fraction of free double stranded DNA present. This is especially 
problematic when using biotinylated DNA to immobilise the NCP to a 
streptavidin sensor surface. One possible method for avoiding this issue would 
be to immobilise an NCP specific, or more specifically a histone specific, 
antibody via amine coupling to the sensor surface. This could then be used to 
trap NCP only, allowing free DNA to be washed off.    
 
These experiments suggest that pentameric SAP has a significantly lower 
affinity for nucleosomes than it does for double stranded DNA. This may 
suggest that if SAP performs the role of a DNA scavenger, it preferentially 
targets free DNA, or areas of chromatin not bound by histones, rather than the 
protein itself. This is in agreement with the findings of Butler et al., who 
demonstrated that SAP displaces histone H1. Histone H1 stabilise the 30 nm 
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fibre form of chromatin and are bound to the linker DNA (which is between 10 
bp and 80 bp in length) in between adjacent nucleosomes (Felsenfeld & 
Groudine, 2003). Once removed, the chromatin reverts to the less compacted 
11 nm fibre, or ‘beads on a string’, form. As demonstrated in chapter 3, SAP 
binds with high affinity to all sequences of double-stranded DNA longer than 25 
bp. The linker DNA therefore represents an ideal target for binding by 
pentameric SAP. Figure 5.10 shows scale figures of pentameric SAP and NCP to 
show their relative sizes.  
 
Although the observed binding was not as strong as that of SAP binding to free 
DNA, interactions with low micromolar Kd are still biologically significant. 
Therefore, to further investigate this interaction (and to differentiate between 
protein-protein and protein-DNA interactions), future experiments could 
investigate SAP binding to the histone octamer alone, to confirm whether this 
has any significant contribution. Experiments could also be performed to 
investigate SAP binding to di-nucleosomes joined by a single piece of linker 
DNA, to see whether a more reliable estimate for the stoichiometry of this 
interaction can be determined.   
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Figure 5.10 Pentameric SAP and NCP shown to scale. 
The structures of pentameric SAP (PDB ID 3KQR) and NCP (PDB ID 2CV5) are shown to scale. 
The NCP displayed in this figure contains 146 bp DNA. The length of the linker DNA between 
nucleosomes (not shown) is typically between 10 bp and 80 bp in length and may therefore 
present a likely binding-site for pentameric SAP. See chapter 3 and figure 3.28.  This figure was 
using the PyMOL Molecular Graphics System, Version 1.5 Schrödinger, LLC.      
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6. Summary 
 
The primary aim of this project was to characterise the SAP-DNA interaction in 
terms of its strength, sequence specificity and stoichiometry, and to elucidate 
the structural mechanism of SAP-DNA binding.  
 
SAP is glycosylated and this may have been the reason that previous attempts 
to express recombinant protein in E. coli proved unsuccessful, invariably leading 
to insoluble inclusion bodies that could not be refolded. Chapter 2 describes the 
cloning and expression of native sequence SAP performed in human HEK 293 
cells and the subsequent production of stably expressing cell lines. The 
expressed protein was purified using PE-affinity chromatography and verified 
using SDS-PAGE and analytical size-exclusion chromatography. The purified 
protein appeared to be sufficiently pure and correctly folded, as a single peak 
was observed using size-exclusion chromatography that eluted in the same 
position as ex vivo SAP. However, because the recombinant SAP was expressed 
and secreted from the HEK 293 cells using the RPTPμ signal peptide, three non-
native residues (Glu-Thr-Gly) were present on the N-terminus of each 
monomer. These residues are not present in ex vivo SAP.  
 
To obtain an initial indication of the DNA binding motif the amino acid sequence 
of SAP was aligned against that of various mammalian orthologues some of 
which have been shown not to bind to DNA. This highlighted potential residues 
that may be important for forming the SAP-DNA complex. Five positively 
charged residues were selected (Arg 77, His 78, Lys 87, Lys 143 and Arg 193) 
as they were conserved only throughout primate SAP (that does bind DNA). 
Site-directed mutagenesis was performed to produce mutant constructs 
corresponding to these five residues. R77Q, H78Q, K87Q, K143Q and R193Q 
SAP were expressed using transient expression in HEK 293T cells and purified 
using PE-affinity chromatography.      
 
 222 
Chapter 3 describes various biophysical analyses that were used to investigate 
the affinity and stoichiometry of SAP-DNA binding using recombinant SAP. 
EMSA analysis was used to investigate the binding of native sequence SAP with 
a range of DNA duplexes that varied in length and in G+C content. This 
analysis suggested that there is a clear DNA size requirement for the formation 
of a strong complex, as all duplex DNA of 25 bp or longer bound with a low 
nanomolar Kd, duplexes with a length of 20 bp bound with a significantly lower 
affinity, and binding by duplexes with a length of 15 bp showed negligible 
binding. SwitchSENSE analysis also showed that there was strong binding 
between SAP and DNA duplexes ranging in length from 24 bp to 96 bp, 
confirming low nanomolar dissociation constants. It was also determined that 
the DNA sequence did have an effect on the stability of the SAP-DNA complex 
by performing EMSA with identical nucleotide content but scrambled sequences. 
Whilst the values for the Kd that were measured from this experiment were in 
the low nanomolar range, and therefore indicative of strong binding, they 
varied by two orders of magnitude. This indicated that although SAP does not 
appear to exhibit strict DNA-sequence specific binding, certain sequences might 
facilitate the formation of more stable complexes.  
 
EMSA performed using SAP mutants suggested that the Arg 77 and Lys 143 
residues in particular, but also Lys 87 and Arg 193 play a role in the 
stabilisation of the SAP-DNA complex. However, mutation of the His 78 residue 
appeared to have a negligible effect on the SAP-DNA binding. These mutational 
analyses, combined with the previous results suggesting that there is a DNA 
length requirement of at least 25 bp for strong binding, indicate that duplex 
DNA may lie across the SAP pentamer and interact with more than one binding 
site simultaneously. 
 
SV-AUC analysis indicated that the stoichiometry of SAP-DNA binding is 
complicated. For a complex containing 40 bp duplex DNA (and native sequence 
SAP) it is likely that a population of complexes containing various 
stoichiometries and binding modes is present.  
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Chapter 4 describes the steps that were taken to co-crystallise SAP with various 
DNA sequences. Recombinant SAP appeared to crystallise readily, however 
there was no evidence that any crystals contained DNA despite a number of 
attempts to modify the crystallisation conditions and DNA binding partner. Two 
structures are presented in which SAP appeared to crystallise with unique unit 
cells. Crystallisation of the SAP mutants was more successful with crystals 
obtained for two of the five mutants and structures subsequently solved 
following X-ray diffraction experiments at the Diamond Light Source. The 
structures of the K87Q and R193Q mutants, solved to a resolution of 2.11 Å 
and 1.36 Å, respectively, are also described in chapter 4. The structures of 
these mutants indicate that they have little effect on the structure of the 
protein as a whole, and therefore their apparent effect in the reduction of 
binding to DNA is not due to any change in the protein’s tertiary or quaternary 
structure. 
 
To explore the broader physiological implications of this work, chapter 5 
describes the interaction between SAP and recombinant human nucleosome 
core particles (NCP). Initial EMSA analysis appeared to support the observations 
made by Butler, Tennant and Pepys in 1990, who showed that ex vivo SAP 
bound to chicken erythrocyte NCP. As with the previous SAP-DNA binding 
experiments, subsequent stoichiometric analysis could not provide an accurate 
determination of the SAP-NCP stoichiometry. SV-AUC appeared to show very 
weak binding with only a very small peak present that may indicate the 
presence of an SAP-NCP complex, but kinetic analysis of SAP-NCP binding 
indicated that the Kd is probably in the low micromolar region. This suggested 
that the affinity of SAP for DNA is far greater than it is for NCP. It has been 
shown previously that SAP binds to and solubilises native long chromatin, and 
in doing so, displaces histone H1 (Butler et al., 1990). The observation that SAP 
binds to NCP far more weakly than it does to double stranded DNA may 
indicate that it binds preferentially to the linker DNA between histones (which 
between approximately 10 bp and 80 bp in length), rather than the 
nucleosomes themselves, in order to solubilise chromatin.   
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SAP is constitutively expressed and concentrations are maintained at 30 to 50 
mg/L in human serum. This, coupled with its apparent strict evolutionary 
conservation, suggests that SAP has a significant biological function. Although 
this function is not clear, previous reports suggested that SAP might play a role 
in the clearance of nuclear material from the serum, possibly in order to 
prevent an antinuclear autoimmune response, such as that observed in 
systemic lupus erythematosus (SLE) (Breathnach et al., 1989). The 
observations described in this thesis provides evidence for this hypothesis, as 
SAP has been shown to bind double stranded DNA (of physiologically relevant 
size) with high affinity, and without any strict sequence dependence. 
Furthermore SAP does not appear to form a single, discrete complex with DNA, 
but instead seems to adopt several possible binding modes. These observations 
are consistent with suggestions made by Wang et al. in 2011 that SAP 
sequesters plasmid DNA used for DNA vaccination in humans. The work 
described here provides further evidence that pre-treatment of patients with 
SAP depleting therapies (such as CPHPC) would be likely to improve the 
effectiveness of DNA vaccination in humans. 
 
SAP appears to bind some sequences of double stranded DNA with a higher 
affinity than others. For future work, therefore, SELEX could be used to 
determine the optimum DNA sequence for SAP binding. Not only could the 
information gained from this type of experiment be used to establish whether 
SAP has a specific physiological DNA target, but it would also provide a high-
affinity ligand for future structural analysis.     
 
Cryo-EM is another technique that could be useful for future investigation into 
the interaction between SAP and nucleosomes. Although a relatively recent 
technique, cryo-EM is now rivalling X-ray crystallography in the level of detail it 
can achieve, and can currently be used to obtain structures with a resolution up 
to approximately 2.5 Å (Liu et al., 2017). The large size of the SAP-nucleosome 
interaction (greater than 300 kDa for a 1:1 complex) means that it would be a 
good candidate for structural analysis using cryo-EM, without the need for 
crystallisation.  
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Appendices  
Appendix 1  
Plasmid preparation protocols  
 
Appendix 1.1 Promega PureYield mini prep kit protocol.  
Miniprep of plasmid DNA was performed using the alternative protocol for larger volumes. This 
protocol obtained from https://www.promega.co.uk. 
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Continued on the following page. 
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Appendix 1.2 Qiagen Plasmid Plus Mega kit protocol. 
Megaprep of plasmid DNA was performed using the Plasmid Plus Mega protocol, which is 
marked with circles. This protocol was obtained from https://www.qiagen.com/gb/. 
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Appendix 2   
pOPINTTG plasmid sequence 
 
 
Continued on the following page. 
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Appendix 2.1 The pOPINTTG plasmid nucleotide sequence. 
The pOPINTTG plasmid is used for protein expression in HEK 293 cells. The cloning site is 
flanked by the restriction sites for KpnI and PmeI, and follows the RPTPμ signal peptide 
sequence. Downstream of the cloning site is a His-tag coding sequence followed by a stop 
codon.  
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Appendix  3   
Mutagenic primer design 
 
 
 
Appendix 3.1 Agilent QuikChange II Site-Directed Mutagenesis kit – primer design 
guidelines. 
This protocol was obtained from https://www.agilent.com/. 
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Appendix 4   
Protein marker 
 
 
 
Appendix 4.1 Bio-Rad Precision Plus Protein Dual Colour Standard. 
A 5 μL volume of the Precision Plus Protein Dual Color Standard was typically loaded onto a 
12% polyacrylamide gel. This figure shows Precision Plus Protein Dual Color Standard 
electrophoresed on a 4-20% acrylamide gradient gel. 
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Appendix  5  
SAP cloning information 
 
 
 
Appendix 5.1 pOPINTTG vector information and SAP PCR primers. 
The table above was adapted from the OPPF cloning and expression screening protocol, which 
can be found at https://www.oppf.rc-harwell.ac.uk/OPPF/. The PCR primers used to amplify the 
SAP coding DNA sequence from the parent vector are shown below. The pOPIN vector InFusion 
tags are underlined, and the incorporated stop codon highlighted in red.  
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 Appendix 6   
 
Recombinant SAP sequencing data 
 
  
Continued on the following page. 
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Appendix 6.1 Electropherogram showing native sequence SAP coding DNA within 
the pOPINTTG plasmid. 
This figure shows the SAP coding DNA within the pOPINTTG plasmid, downstream of the RPTPμ 
signal peptide sequence and followed by a stop codon (*) prior to the His-tag. Sequencing was 
performed by Source Bioscience using the pTT_fwd sequencing primer.  
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Appendix 7   
Mutagenic primer sequences 
 
 
 
Appendix 7.1 Sequences of primers used for site-directed mutagenesis. 
This figure shows the sequences of all primers used for QuikChange II site-directed 
mutagenesis. Values for the Tm of the primers were calculated using the description in appendix 
3. 
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Appendix 8  
Mutant SAP sequence data 
 
Appendix 8.1 Electropherograms showing the regions of the mutant SAP constructs 
containing the mutation. 
The mutated codons are highlighted in pink. Sequencing was performed by Source Bioscience 
using the pTT_fwd sequencing primer. 
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Appendix 9  
 
DNA used for switchSENSE 
 
 
 
Appendix 9.1 DNA used for switchSENSE. 
This figure shows one strand of each of the four DNA duplexes used for switchSENSE analysis 
of SAP-DNA binding. 
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Appendix 10  
Crystallisation conditions 
 
  
Continued on the following page. 
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Appendix 10.1 Qiagen Nucleix suite sparse matrix screen conditions. 
The Nucleix suite sparse matrix screen was optimised for the co-crystallisation of protein-DNA 
complexes. A HoneyBee X8 crystallisation robot (Cronus Technologies) was used to construct 
the crystallisation screens in 96-well MRC crystallisation plates (Molecular Dimensions). These 
conditions were obtained from https://www.qiagen.com/gb/. 
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Continued on the following page. 
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Appendix 10.2 Molecular dimensions JCSG+ sparse matrix screen. 
A HoneyBee X8 crystallisation robot (Cronus Technologies) was used to construct the 
crystallisation screens in 96-well MRC crystallisation plates (Molecular Dimensions). These 
conditions were obtained from https://www.moleculardimensions.com. 
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Continued on the following page. 
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Appendix 10.3 Molecular dimensions PACT premier sparse matrix screen. 
A HoneyBee X8 crystallisation robot (Cronus Technologies) was used to construct the 
crystallisation screens in 96-well MRC crystallisation plates (Molecular Dimensions). These 
conditions were obtained from https://www.moleculardimensions.com 
 
. 
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Appendix 10.4 Standard SAP screen - manual 24-well crystallisation screen. 
Manual 24-well hanging drop screens were constructed by mixing 2 μL of protein (or protein-
DNA) solution with 2 μL of well solution on glass cover slips. Cover slips were subsequently 
inverted and placed on top of the corresponding wells, which had been greased in advance in 
order to make an airtight seal. Screens were then incubated at 16 °C. 
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Appendix 10.5 Focus screen 1 - manual 24-well crystallisation screen. 
This screen was designed with its conditions based around those of solution 5 of the Nucleix 
suite. 
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Appendix 10.6 Focus screen 2 - manual 24-well crystallisation screen. 
This screen was designed with its conditions based around those of solution 9 of the Nucleix 
suite. 
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Appendix 10.7 Focus screen 3 - manual 24-well crystallisation screen. 
This screen was designed with its conditions based around those of solution B8 of the JCSG+ 
screen. 
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Appendix 10.8 Focus screen 4 - manual 24-well crystallisation screen. 
This screen was designed with its conditions based around those of solution 59 of the Nucleix 
suite. 
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Appendix 10.9 Standard SAP screen with copper sulphate - manual 24-well 
crystallisation screen. 
The conditions of this screen are identical to the standard SAP screen but with the addition of 
CuSO4, which was used in an attempt to disrupt the normal protein-protein contacts. 
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Appendix 10.10 Standard SAP screen with low salt and low pH - manual 24-well 
crystallisation screen. 
The conditions of this screen are identical to the standard SAP screen but with a lower NaCl 
concentration of 40 mM and a lower pH of between 6.0 and 7.0. This was used in an attempt to 
reduce the ionic shielding between SAP and DNA, and also to protonate the histidine residues. 
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Appendix 11  
Reconstituted nucleosome DNA and protein sequences 
 
 
Appendix 11.1 pUC19-16x601NL sequence. 
This plasmid (gifted by Dr. Till Bartke, Medical Research Council Clinical Sciences Centre, 
Imperial College London) provides the 151 bp 601NL when digested with EcoRI and EcoRV.  
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Appendix 11.2 pUC19-16x601.2 sequence. 
This plasmid (gifted by Dr. Till Bartke, Medical Research Council Clinical Sciences Centre, 
Imperial College London) provides the 185 bp 601NL when digested with EcoRI and EcoRV.  
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Appendix 11.3 Histone amino acid sequences. 
This figure shows the recombinant histone amino acid sequences that were expressed, purified 
and used to make reconstituted human NCP (with either 601NL or 601.2 DNA) by Dr. John 
Cashman (Institute of Biomedical and Biomolecular Sciences, University of Portsmouth). 
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